(Mark One)
|
||
þ
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
For the fiscal year ended December 31, 2004 | ||
or | ||
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
For the transition period from to |
Delaware
|
95-3797439 | |
(State or other jurisdiction of
incorporation or organization) |
(I.R.S. Employer
Identification No.) |
|
1911 Walker Avenue
Monrovia, California (Address of principal executive offices) |
91016
(Zip Code) |
1
Item 1. | Business |
| the Preloaded Injector, a three-piece silicone IOL preloaded into a single-use disposable injector, | |
| toric silicone IOLs to treat astigmatic abnormalities, | |
| STAARVISC tm II, a viscoelastic material which is used as a tissue protective lubricant and to maintain the shape of the eye during surgery, | |
| STAAR SonicWAVE tm Phacoemulsification System, which is used to remove a cataract patients cloudy lens and has low energy and high vacuum characteristics, and | |
| Cruise Control, a disposable filter which allows for a significantly faster, cleaner phacoemulsification procedure and is compatible with all phacoemulsification equipment utilizing Venturi and peristaltic pump technologies. |
2
| obtaining the approval of the FDA to market the ICL and the TICL in the United States; | |
| obtaining the approval of the ICL and the TICL in new international markets; and | |
| expanding the market share of the ICL and the TICL in existing international markets. |
| increasing the awareness of ophthalmologists of the advantages of our proprietary Collamer material as an alternative to either silicone or acrylic for the manufacture of IOLs; | |
| improving the injector systems for our lenses; and | |
| obtaining U.S. approval for our preloaded injector technology and expanding it to all of our lenses. |
3
| Improve patient outcomes, | |
| Minimize patient risk and discomfort, and | |
| Simplify ophthalmic procedures or post-operative care for the surgeon and the patient. |
4
5
6
7
Regulatory Requirements |
| set standards for medical devices, | |
| require proof of safety and effectiveness prior to marketing devices which the FDA believes require pre-market clearance, | |
| require test data approval prior to clinical evaluation of human use, | |
| permit detailed inspections of device manufacturing facilities, | |
| establish good manufacturing practices that must be followed in device manufacture, | |
| require reporting of serious product defects to the FDA, and | |
| prohibit device exports that do not comply with the Act unless they comply with established foreign regulations, do not conflict with foreign laws, and the FDA and the health agency of the importing country determine export is not contrary to public health. |
8
Warning Letters and the 483 Observations |
9
FDA Review of the ICL |
| improving regulatory and compliance systems and procedures, | |
| obtaining approval for the ICL, | |
| completing enrollment in the U.S. clinical trials for the TICL, | |
| redesigning the three-piece Collamer IOL, | |
| designing an insertion system for the three-piece Collamer IOL, | |
| improving insertion and delivery systems for our other foldable products, |
10
| improving manufacturing systems and procedures for all products to reduce manufacturing costs and improve yields, and | |
| developing products and extending foreign registrations. |
11
Item 2. | Properties |
Item 3. | Legal Proceedings |
12
Item 4. | Submission of Matters to a Vote of Security Holders |
Item 5. | Market for Registrants Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities |
Period | High | Low | |||||||
2005
|
|||||||||
First Quarter (through March 25, 2005)
|
$ | 7.300 | $ | 3.830 | |||||
2004
|
|||||||||
Fourth Quarter
|
$ | 6.400 | $ | 3.500 | |||||
Third Quarter
|
7.480 | 2.880 | |||||||
Second Quarter
|
9.730 | 6.250 | |||||||
First Quarter
|
11.260 | 7.230 | |||||||
2003
|
|||||||||
Fourth Quarter
|
$ | 12.000 | $ | 8.360 | |||||
Third Quarter
|
15.440 | 9.750 | |||||||
Second Quarter
|
15.250 | 5.050 | |||||||
First Quarter
|
6.550 | 3.050 |
13
Item 6. | Selected Financial Data |
Fiscal Year Ended | ||||||||||||||||||||
December 31, | January 2, | January 3, | December 28, | December 29, | ||||||||||||||||
2004 | 2004 | 2003 | 2001 | 2000 | ||||||||||||||||
(In thousands except per share data) | ||||||||||||||||||||
Statement of Operations
|
||||||||||||||||||||
Sales
|
$ | 51,685 | $ | 50,409 | $ | 47,880 | $ | 50,237 | $ | 53,986 | ||||||||||
Royalty and other income
|
| 49 | 368 | 549 | 448 | |||||||||||||||
Total revenues
|
51,685 | 50,458 | 48,248 | 50,786 | 54,434 | |||||||||||||||
Cost of sales
|
25,542 | 22,621 | 24,099 | 28,203 | 26,329 | |||||||||||||||
Gross profit
|
26,143 | 27,837 | 24,149 | 22,583 | 28,105 | |||||||||||||||
Selling, general and administrative expenses
|
||||||||||||||||||||
General and administrative
|
9,253 | 9,343 | 8,959 | 8,746 | 8,593 | |||||||||||||||
Marketing and selling
|
20,302 | 19,509 | 16,833 | 20,043 | 21,254 | |||||||||||||||
Research and development
|
6,246 | 5,120 | 4,016 | 3,800 | 4,215 | |||||||||||||||
Other charges
|
500 | 390 | 1,454 | 7,780 | 15,276 | |||||||||||||||
Total selling, general and administrative expenses
|
36,301 | 34,362 | 31,262 | 40,369 | 49,338 | |||||||||||||||
Operating loss
|
(10,158 | ) | (6,525 | ) | (7,113 | ) | (17,786 | ) | (21,233 | ) | ||||||||||
Total other expense, net
|
(88 | ) | (637 | ) | (785 | ) | (724 | ) | (4,630 | ) | ||||||||||
Loss before income taxes and minority interest
|
(10,246 | ) | (7,162 | ) | (7,898 | ) | (18,510 | ) | (25,863 | ) | ||||||||||
Income tax provision (benefit)
|
1,057 | 1,127 | 8,805 | (3,649 | ) | (6,758 | ) | |||||||||||||
Minority interest
|
29 | 68 | 75 | 139 | 87 | |||||||||||||||
Net loss
|
$ | (11,332 | ) | $ | (8,357 | ) | $ | (16,778 | ) | $ | (15,000 | ) | $ | (19,192 | ) | |||||
Basic net loss per share
|
$ | (0.58 | ) | $ | (0.47 | ) | $ | (0.98 | ) | $ | (0.88 | ) | $ | (1.25 | ) | |||||
Diluted net loss per share
|
$ | (0.58 | ) | $ | (0.47 | ) | $ | (0.98 | ) | $ | (0.88 | ) | $ | (1.25 | ) | |||||
Weighted average number of basic shares
|
19,602 | 17,704 | 17,142 | 17,003 | 15,378 | |||||||||||||||
Weighted average number of diluted shares
|
19,602 | 17,704 | 17,142 | 17,003 | 15,378 | |||||||||||||||
Balance Sheet Data
|
||||||||||||||||||||
Working capital
|
$ | 19,103 | $ | 15,883 | $ | 7,095 | $ | 16,780 | $ | 24,153 | ||||||||||
Total assets
|
51,973 | 47,376 | 45,220 | 64,650 | 79,745 | |||||||||||||||
Notes payable and current portion of long-term debt
|
3,004 | 2,950 | 5,845 | 8,216 | 7,944 | |||||||||||||||
Stockholders equity
|
37,840 | 35,219 | 30,551 | 46,142 | 58,060 |
14
Item 7. | Managements Discussion and Analysis of Financial Condition and Results of Operations |
History |
| STAAR developed, patented, and licensed the first foldable intraocular lens, or IOL, for cataract surgery. Made of pliable material, the foldable IOL permitted surgeons for the first time to replace a cataract patients natural lens with minimally invasive surgery. The foldable IOL quickly became the standard of care for cataract surgery throughout the world. STAAR introduced its first versions of the lens, made of silicone, in 1991. | |
| In 1996, STAAR commenced commercial sales of its VISIAN tm ICL (ICL) in certain foreign countries, and in 1997, the ICL received CE Marking which allowed STAAR to market the product in the European Union. Using the unique biocompatible properties of the Collamer material, the ICL is implanted in front of the patients natural lens to treat refractive errors, such as myopia (nearsightedness) and hyperopia (farsightedness). In 2003, the ICL became the first phakic IOL to receive an approvable recommendation from the FDAs Ophthalmic Devices Panel. Currently, the ICL is approved for sale in 38 countries and has been implanted in approximately 40,000 eyes worldwide. | |
| In 1998, STAAR introduced the Toric IOL, the only implantable lens approved for the treatment of astigmatism. The Toric IOL was STAARs first venture into the refractive market in the United States. | |
| In 2000, STAAR introduced an IOL made of our proprietary Collamer® lens material, a unique biocompatible polymerized collagen. Collamer mimics the clarity and refractive qualities of the natural human lens better than acrylic lens materials, and is better tolerated by the eye than either silicone or acrylic. | |
| In 2001, STAAR commenced commercial sales of its VISIAN tm Toric ICL (TICL) on a limited basis in certain foreign countries, and in 2002, the TICL received CE Marking which allowed STAAR to market the product in the European Union. | |
| In 2004, STAAR, through its joint venture company, Canon Staar, introduced the first preloaded lens injector system in international markets. The Preloaded Injector offers surgeons improved convenience and reliability. The Preloaded Injector is not yet available in the U.S. |
15
Principal Products |
| Silicone IOLs, in both three-piece and one-piece designs; | |
| Silicone Toric IOLs, used in cataract surgery to treat astigmatism; | |
| Collamer® IOLs, in a one-piece design, with a three-piece redesigned lens scheduled for introduction in the second quarter of 2005; | |
| the Preloaded Injector, a three-piece silicone IOL preloaded into a single-use disposable injector; | |
| STAARVISC tm II, a viscoelastic material, which is used as a tissue protective lubricant and to maintain the shape of the eye during surgery; | |
| SonicWAVE tm Phacoemulsification System, which is used to remove a cataract patients cloudy lens and has low energy and high vacuum characteristics; | |
| Cruise Control, a disposable filter used to increase safety and control during phacoemulsification; and | |
| Other auxiliary products for cataract surgery, manufactured by others, which strengthen our ability to offer an expanded range of procedural products. |
Significant Factors Affecting Our Business and Recent Highlights |
16
17
18
Percentage of Total Revenues | Percentage Change | |||||||||||||||||||||
December 31, | January 2, | January 3, | 2004 vs. | 2003 vs. | ||||||||||||||||||
2004 | 2004 | 2003 | 2003 | 2002 | ||||||||||||||||||
Total revenues
|
100.0 | % | 100.0 | % | 100.0 | % | 2.4 | % | (4.6 | )% | ||||||||||||
Cost of sales
|
49.4 | % | 44.8 | % | 49.9 | % | 12.9 | % | (6.1 | )% | ||||||||||||
Gross profit
|
50.6 | % | 55.2 | % | 50.1 | % | (6.1 | )% | 15.3 | % | ||||||||||||
Costs and expenses:
|
||||||||||||||||||||||
General and administrative
|
17.9 | % | 18.5 | % | 18.6 | % | (1.0 | )% | 4.3 | % | ||||||||||||
Marketing and selling
|
39.3 | % | 38.7 | % | 34.9 | % | 4.1 | % | 15.9 | % | ||||||||||||
Research and development
|
12.1 | % | 10.1 | % | 8.3 | % | 22.0 | % | 27.5 | % | ||||||||||||
Other charges
|
1.0 | % | 0.8 | % | 3.0 | % | 28.2 | % | (73.2 | )% | ||||||||||||
Total costs and expenses
|
70.3 | % | 68.1 | % | 64.8 | % | 5.6 | % | 9.9 | % | ||||||||||||
Operating loss
|
(19.7 | )% | (12.9 | )% | (14.7 | )% | 55.7 | % | (8.3 | )% | ||||||||||||
Other expense, net
|
(0.1 | )% | (1.3 | )% | (1.7 | )% | (86.2 | )% | (18.9 | )% | ||||||||||||
Loss before income taxes
|
(19.8 | )% | (14.2 | )% | (16.4 | )% | 43.1 | % | (9.3 | )% | ||||||||||||
Income tax provision (benefit)
|
2.0 | % | 2.2 | % | 18.2 | % | (6.2 | )% | (87.2 | )% | ||||||||||||
Minority interest
|
0.1 | % | 0.1 | % | 0.2 | % | (57.4 | )% | (9.3 | )% | ||||||||||||
Net loss
|
(21.9 | )% | (16.5 | )% | (34.8 | )% | 35.6 | % | (50.2 | )% |
19
20
21
22
23
Payments Due by Period | |||||||||||||||||||||
Less | More | ||||||||||||||||||||
Than | 1-3 | 3-5 | Than | ||||||||||||||||||
Contractual Obligations | Total | 1 Year | Years | Years | 5 Years | ||||||||||||||||
(In thousands) | |||||||||||||||||||||
Notes payable
|
$ | 3,004 | $ | 3,004 | $ | | $ | | $ | | |||||||||||
Capital lease obligations
|
105 | 92 | 11 | 2 | | ||||||||||||||||
Operating lease obligations
|
2,286 | 927 | 1,307 | 52 | | ||||||||||||||||
Purchase obligations
|
1,222 | 1,022 | 200 | | | ||||||||||||||||
Open purchase orders
|
1,212 | 1,212 | | | | ||||||||||||||||
Other long-term liabilities
|
542 | | 542 | | | ||||||||||||||||
Total
|
$ | 8,371 | $ | 6,257 | $ | 2,060 | $ | 54 | $ | | |||||||||||
24
| Revenue Recognition and Accounts Receivable. The Company recognizes revenue when realized or realizable and earned, which is when the following criteria are met: persuasive evidence of an arrangement exists; delivery has occurred; the sale price is fixed and determinable; and collectibility is reasonably assured. We record revenue from product sales when title and risk of ownership has been transferred to the customer, which is typically upon delivery to the customer. The exception to this recognition policy is revenue from IOLs distributed on a consignment basis, which is recognized upon notification of implantation in a patient. |
The Company may bundle the sale of phacoemulsification equipment to customers with multi-year agreements to purchase minimum quantities of foldable IOLs. The Company recognizes the revenue from the equipment based on monthly purchases of minimum quantities of IOLs over the life of the agreement. | |
Revenue from license and technology agreements is recorded as income, when earned, according to the terms of the respective agreements. | |
The Company generally permits returns of product if such product is returned within the time allowed by the Company, and in good condition. Allowances for returns are provided for based upon an analysis of our historical patterns of returns matched against the sales from which they originated. To date, historical product returns have been within the Companys estimates. | |
The Company maintains provisions for uncollectible accounts for estimated losses resulting from the inability of its customers to remit payments. The Company continuously monitors collections and payments from its customers and maintains a provision for estimated credit losses based upon its historical experience and any specific customer collection issues that have been identified. |
| Stock-Based Compensation. We measure stock-based compensation for option grants to employees and members of the Board of Directors using the intrinsic value method. The fair value of each option grant for determining the pro forma impact of stock-based compensation expense is estimated on the date of grant using the Black-Scholes option-pricing model with weighted average assumptions. These assumptions consist of expected dividend yield, expected volatility, expected life, and risk-free interest rate. If the assumptions used to calculate the value of each option grant do not properly reflect future activity, the weighted average fair value of our grants could be impacted. | |
| Income Taxes. We account for income taxes under the asset and liability method, whereby deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. We evaluate the need to establish a valuation allowance for deferred tax assets based upon the amount of existing temporary differences, the period in which they are expected to be recovered and expected levels of taxable income. A valuation allowance to reduce deferred tax |
25
assets is established when it is more likely than not that some or all of the deferred tax assets will not be realized. As of the years ended December 31, 2004 and January 2, 2004, the valuation allowance fully offsets the value of deferred tax assets on the Companys balance sheet. |
We expect to continue to maintain a full valuation allowance on future tax benefits until an appropriate level of profitability is sustained, or we are able to develop tax strategies that would enable us to conclude that it is more likely than not that a portion of our deferred tax assets would be realizable. |
| Inventories. Inventories are valued at the lower of first-in, first-out cost or market. On a regular basis, we evaluate inventory balances for excess quantities and obsolescence by analyzing estimated demand, inventory on hand, sales levels and other information. Based on these evaluations, inventory balances are reduced, if necessary. | |
| Impairment of Long-Lived Assets. Intangible and other long lived-assets are reviewed for impairment whenever events such as product discontinuance, plant closures, product dispositions or other changes in circumstances indicate that the carrying amount may not be recoverable. In reviewing for impairment, the Company compares the carrying value of such assets to the estimated undiscounted future cash flows expected from the use of the assets and their eventual disposition. When the estimated undiscounted future cash flows are less than their carrying amount, an impairment loss is recognized equal to the difference between the assets fair value and their carrying value. | |
| Goodwill. Goodwill, which has an indefinite life and was previously amortized on a straight-line basis over the periods benefited, is no longer amortized to earnings, but instead is subject to periodic testing for impairment. Intangible assets determined to have definite lives are amortized over their remaining useful lives. Goodwill of a reporting unit is tested for impairment on an annual basis or between annual tests if an event occurs or circumstances change that would reduce the fair value of a reporting unit below its carrying amount. As provided under SFAS No. 142, an annual assessment was completed during 2004, and no impairment was identified. As of December 31, 2004, the carrying value of goodwill was $7.5 million. | |
| Patents and Licenses. The Company also has other intangible assets consisting of patents and licenses, with a gross book value of $11.5 million and accumulated amortization of $6.1 million as of December 31, 2004. Amortization is computed on the straight-line basis over the estimated useful lives, which are based on legal and contractual provisions, and range from 10 to 20 years. |
We have a history of losses and anticipate future losses. |
We have only limited working capital. |
26
We have limited access to credit and could default on the terms of our loan agreement. |
We have only limited access to financing. |
We have received a going concern opinion from our registered public accounting firm, which may negatively impact our business. |
We have received 483 Inspectional Observations and Warning Letters from the FDA, which until resolved to the satisfaction of the FDA will continue to delay approval of the ICL and could limit our existing business in the United States. |
Our success depends on the ICL, which has not been approved for use in the United States. |
27
Our future success depends on the successful marketing of the ICL in the United States market. |
Our core domestic business has suffered declining sales, which sales of new products have only partially offset. |
We depend on independent manufacturers representatives. |
28
Product recalls have been costly and may be so in the future. |
We could experience losses due to product liability claims. |
We compete with much larger companies. |
Most of our products have single-site manufacturing approvals, exposing us to risks of business interruption. |
29
The global nature of our business may result in fluctuations and declines in our sales and profits. |
We obtain some of the components of our products from a single source, and an interruption in the supply of those components could reduce our revenue. |
Our activities involve hazardous materials and emissions and may subject us to environmental liability. |
We risk losses through litigation. |
30
We depend on key employees. |
We have licensed our technology to our joint venture company and have granted certain rights to the partners that could be exercised in the event of a change in control of the Company. |
If we fail to keep pace with advances in our industry or fail to persuade physicians to adopt the new products we introduce, customers may not buy our products and our revenue may decline. |
31
Resources devoted to research and development may not yield new products that achieve commercial success. |
Failure of users of our products to obtain adequate reimbursement from third-party payors could limit market acceptance of our products, which could affect our sales and profits. |
| Major third-party payors for hospital services, including government insurance plans, Medicare, Medicaid and private health care insurers, have substantially revised their payment methodologies during the last few years, resulting in stricter standards for reimbursement of hospital and outpatient charges for some medical procedures, including cataract procedures and IOLs; | |
| Numerous legislative proposals have been considered that, if enacted, would result in major reforms in the United States health care system, which could have an adverse effect on our business; | |
| Our competitors may reduce the prices of their products, which could result in third-party payors favoring our competitors; | |
| There are proposed and existing laws and regulations governing maximum product prices and the profitability of companies in the health care industry; and | |
| There have been recent initiatives by third-party payors to challenge the prices charged for medical products. Reductions in the prices for our products in response to these trends could reduce our revenues. Moreover, our products may not be covered in the future by third-party payors, which would also reduce our revenues. |
We are subject to extensive government regulation, which increases our costs and could prevent us from selling our products. |
32
We depend on proprietary technologies, but may not be able to protect our intellectual property rights adequately. |
We may not successfully develop and launch replacements for our products that lose patent protection. |
33
Our Certificate of Incorporation could delay or prevent an acquisition or sale of our company. |
Our bylaws contain other provisions that could have an anti-takeover effect, including the following: |
| only one of the three classes of directors is elected each year; | |
| stockholders have limited ability to remove directors; | |
| stockholders cannot call a special meeting of stockholders; and | |
| stockholders must give advance notice to nominate directors. |
Anti-takeover provisions of Delaware law could delay or prevent an acquisition of our company. |
Future sales of our Common Stock could reduce our stock price. |
The market price of our Common Stock is likely to be volatile. |
34
35
Item 7A. | Quantitative and Qualitative Disclosures About Market Risk |
Item 8. | Financial Statements and Supplementary Data |
Item 9. | Changes in and Disagreements with Accountants on Accounting and Financial Disclosure |
Item 9A. | Controls and Procedures |
36
37
Item 9B. | Other Information |
Item 10. | Directors and Executive Officers of the Registrant |
Item 11. | Executive Compensation |
Item 12. | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters |
Item 13. | Certain Relationships and Related Transactions |
Item 14. | Principal Accountant Fees and Services |
38
Item 15. | Exhibits and Financial Statement Schedules |
Page | ||||
(1)
|
Financial statements required by Item 15 of this form are filed as a separate part of this report following Part IV | |||
Report of Independent Registered Public Accounting Firm | F-2 | |||
Report of Independent Registered Public Accounting Firm | F-3 | |||
Consolidated Balance Sheets at December 31, 2004 and January 2, 2004 | F-4 | |||
Consolidated Statements of Operations for the years ended December 31, 2004, January 2, 2004, and January 3, 2003 | F-5 | |||
Consolidated Statements of Changes in Stockholders Equity for the years ended December 31, 2004, January 2, 2004, and January 3, 2003 | F-6 | |||
Consolidated Statements of Cash Flows for the years ended December 31, 2004, January 2, 2004, and January 3, 2003 | F-7 | |||
Notes to Consolidated Financial Statements | F-8 | |||
(2)
|
Schedules required by Regulation S-X are filed as an exhibit to this report: | |||
I. Independent Registered Public Accounting Firm Report on Schedule | F-31 | |||
II. Schedule II Valuation and Qualifying Accounts and Reserves | F-32 |
3 | .1 | Certificate of Incorporation, as amended(8) | ||
3 | .2 | By-laws, as amended(9) | ||
4 | .1 | 1991 Stock Option Plan of STAAR Surgical Company(2) | ||
4 | .2 | 1995 STAAR Surgical Company Consultant Stock Plan(3) | ||
4 | .3 | 1996 STAAR Surgical Company Non-Qualified Stock Plan(4) | ||
4 | .4 | Stockholders Rights Plan, dated effective April 20, 1995(9) | ||
4 | .5 | 1998 STAAR Surgical Company Stock Plan, adopted April 17, 1998(5) | ||
4 | .6 | Form of Certificate for Common Stock, par value $0.01 per share(14) | ||
4 | .7 | 2003 Omnibus Equity Incentive Plan and form of Option Grant and Stock Option Agreement(13) | ||
4 | .8 | Amendment No. 1 to Stockholders Rights Plan, dated April 21, 2003(15) | ||
4 | .9 | Registration Rights Agreement, dated June 4, 2004(19) | ||
10 | .1 | Joint Venture Agreement, dated May 23, 1988, among the Company, Canon Sales Co, Inc. and Canon, Inc., and Exhibit B, Technical Assistance and License Agreement, dated September 6, 1988, between the Company and Canon Staar Co., Inc.(7) | ||
10 | .2 | Settlement Agreement among the Company, Canon, Inc., Canon Sales Co., Inc., and Canon Staar Company, Inc. dated September 28, 2001(10) | ||
10 | .3 | Indenture of Lease dated September 1, 1993, between the Company and FKT Associates and First through Third Additions Thereto(9) | ||
10 | .4 | Second Amendment to Indenture of Lease dated September 21, 1998, between the Company and FKT Associates(9) | ||
10 | .5 | Third Amendment to Indenture of Lease dated October 13, 2003, by and between the Company and FKT Associates(17) | ||
10 | .6 | Indenture of Lease dated October 20, 1983, between the Company and Dale E. Turner and Francis R. Turner and First through Fifth Additions Thereto(6) |
39
10
.7
Sixth Lease Addition to Indenture of Lease dated
October 13, 2003, by and between the Company and Turner
Trust UTD Dale E. Turner March 28, 1984(17)
10
.8
Standard Industrial/ Commercial Multi-Tenant Lease-Gross dated
April 5, 2000, entered into between the Company and Kilroy
Realty, L.P.(9)
10
.9
Amendment No. 1 to Standard Industrial/ Commercial
Multi-Tenant Lease dated January 3, 2003, by and between
the Company and California Rosen(17)
10
.10
Lease Agreement dated July 12, 1994, between STAAR Surgical
AG and Calderari and Schwab AG/ SA**
10
.11
Supplement #1 dated July 10, 1995, to the Lease Agreement
of July 12, 1994, between STAAR Surgical AG and Calderari
and Schwab AG/SA**
10
.12
Supplement #2 dated August 2, 1999, to the Lease Agreement
of July 12, 1994, between STAAR Surgical AG and Calderari
and Schwab AG/SA**
10
.13
Commercial Lease Agreement dated November 29, 2000, between
Domilens GmbH and DePfa Deutsche Pfandbriefbank AG**
10
.14
Patent License Agreement, dated May 24, 1995, with Eye
Microsurgery Intersectoral Research and Technology Complex(16)
10
.15
Patent License Agreement, dated January 1, 1996, with Eye
Microsurgery Intersectoral Research and Technology Complex(9)
10
.16
Promissory Note dated June 16, 1999, from Peter J. Utrata
to the Company(8)
10
.17
Stock Pledge Agreement dated June 16, 1999, by Peter J.
Utrata in favor of the Company(8)
10
.18
Promissory Note dated June 2, 2000, from Peter J. Utrata to
the Company(9)
10
.19
Stock Pledge Agreement dated June 2, 2000, between the
Company and Peter J. Utrata(9)
10
.20
Mortgage dated July 16, 2004, between the Company and Peter
J. Utrata**
10
.21
Forbearance Agreement dated July 22, 2004, between the
Company and Peter J. Utrata**
10
.22
Employment Agreement dated December 19, 2000, between the
Company and David Bailey(9)
10
.23
Stock Option Plan and Agreement for Chief Executive Officer
dated November 13, 2001, between the Company and David
Bailey(10)
10
.24
Stock Option Certificate dated August 9, 2001, between the
Company and David Bailey**
10
.25
Stock Option Certificate dated January 2, 2002, between the
Company and David Bailey**
10
.26
Stock Option Certificate dated February 14, 2003, between
the Company and David Bailey**
10
.27
Amended and Restated Stock Option Certificate dated
February 12, 2003, between the Company and David Bailey**
10
.28
Stock Option Certificate dated May 9, 2000, between the
Company and Volker Anhaeusser**
10
.29
Stock Option Certificate dated May 31 2000, between the
Company and Volker Anhaeusser**
10
.30
Stock Option Certificate dated May 30, 2002, between the
Company and Volker Anhaeusser**
10
.31
Stock Option Agreement dated November 13, 2001, between the
Company and David R. Morrison(10)
10
.32
Stock Option Certificate dated February 13, 2003, between
the Company and Donald Duffy**
10
.33
Employment Agreement dated January 3, 2002, between the
Company and John Bily(11)
10
.34
Stock Option Certificate dated January 18, 2002, between
the Company and John C. Bily**
10
.35
Amended and Restated Stock Option Certificate dated
February 12, 2003, between the Company and John C. Bily**
10
.36
Offer of Employment dated July 12, 2002, from the Company
to Nick Curtis**
10
.37
Amendment to Offer of Employment dated February 14, 2003
from the Company to Nick Curtis**
10
.38
Stock Option Certificate dated February 14, 2003, between
the Company and Nicholas Curtis**
10
.39
Amended and Restated Stock Option Certificate dated
February 12, 2003, between the Company and Nicholas Curtis**
10
.40
Employment Agreement dated March 18, 2005, between the
Company and Tom Paul**
40
10
.41
Employment Agreement dated March 18, 2005, between the
Company and James Farnworth**
10
.42
Form of Indemnification Agreement between the Company and
certain officers and directors**
10
.43
Managing Directors Contract of Employment, dated
June 22, 1993, between Domilens and Guenther Roepstorff**
10
.44
Supplementary Agreement #1 to the Managing Directors
Contract of Employment, dated November 25, 1997, between
STAAR Surgical AG and Guenther Roepstorff**
10
.45
Supplementary Agreement #2 to the Managing Directors
Contract of Employment dated January 1, 1998, between
Domilens and Guenther Roepstorff**
10
.46
Supplementary Agreement #3 to the Managing Directors
Contract of Employment dated January 1, 2003, between
Domilens and Guenther Roepstorff**
10
.47
Employment Agreement dated May 5, 2004, between the
ConceptVision Australia Pty Limited ACN 006 391 928 and Philip
Butler Stoney(18)
10
.48
Employment Agreement dated May 5, 2004, between the
ConceptVision Australia Pty Limited ACN 006 391 928 and Robert
William Mitchell(18)
#10
.49
Assignment Agreement of the Share Capital of Domilens Vertrieb
fuer medizinische Produkte GmbH dated January 3, 2003,
between STAAR Surgical AG and Guenther Roepstorff(12)
10
.50
Assignment Agreement of the Share Capital of ConceptVision
Australia Pty Limited ACN 006 391 928, dated May 5, 2004,
between the Company and Philip Butler Stoney and Robert William
Mitchell(18)
10
.51
Addendum to the Assignment Agreement of the Share Capital of
ConceptVision Australia Pty Limited ACN 006 391 928, dated
May 5, 2004, between the Company and Philip Butler Stoney
and Robert William Mitchell(18)
10
.52
Form of Purchase Agreement dated June 11, 2003, entered
into between the Company and Crestwood Capital Partners, LP;
Crestwood Capital International, Ltd; Crestwood Capital Partners
II, LP; RS Emerging Growth Pacific Partners Master Fund Unit
Trust; RS Emerging Growth Pacific Partners LP, Prism Partners I,
LP; Prism Partners II Offshore Fund; Prism Partners Offshore
Fund; Vertical Ventures Investments, LLC; Smithfield Fiduciary,
LLC, individually(21)
10
.53
Stock Purchase Agreement dated June 4, 2004, between the
Company and Andesite Management, L.P., Colonial Fund LLC,
Domain Public Equity Partners, L.P., Fortis L Fund Equity
Pharma World, Fortis L Fund Opportunity World, Heartland
Group, Inc., ProMed Offshore Fund, Ltd., ProMed Partners, L.P.,
ProMed Partners II, L.P., Sagitta Asset Management Ltd., SF
Capital Partners, Ltd., Special Situations Cayman
Fund L.P., Special Situations Fund III, L.P., Special
Situations Private Equity Fund, L.P., Ursus Capital, L.P., Ursus
Offshore, Ltd., Zeke, LP(19)
10
.54
Master Credit Agreement dated August 2, 2004, between STAAR
Surgical AG and UBS AG(20)
10
.55
Credit Agreement effective January 13, 2003, between
Domilens Gmbh and Postbank(12)
10
.56
Promissory Note dated March 29, 2002, between the Company
and Pollet & Richardson**
#10
.57
Security Agreement dated March 29, 2002, between the
Company and Pollet & Richardson(12)
14
.1
Code of Ethics**
21
.1
List of Significant Subsidiaries**
23
.1
Consent of BDO Seidman, LLP**
31
.1
Certification Pursuant to Rule 13a-14(a) of the Securities
Exchange Act of 1934, Adopted Pursuant to Section 302 of
the Sarbanes-Oxley Act of 2002**
31
.2
Certification Pursuant to Rule 13a-14(a) of the Securities
Exchange Act of 1934, Adopted Pursuant to Section 302 of
the Sarbanes-Oxley Act of 2002**
32
.1
Certification Pursuant to 18 U.S.C. Section 1350,
Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002**
** | Filed herewith |
| Management contract or compensatory plan or arrangement |
41
# | All schedules and or exhibits have been omitted. Any omitted schedule or exhibit will be furnished supplementally to the Securities and Exchange Commission upon request |
(2) | Incorporated by reference from the Companys Registration Statement on Form S-8, File No. 033-76404, as filed on March 11, 1994. |
(3) | Incorporated by reference from the Companys Registration Statement on Form S-8, File No. 033-60241, as filed on June 15, 1995. |
(4) | Incorporated by reference from the Companys Annual Report on Form 10-K, for the year ended January 3, 1997, as filed on April 2, 1997. |
(5) | Incorporated by reference from the Companys Proxy Statement, for its Annual Meeting of Stockholders held on May 29, 1998, as filed on May 1, 1998. |
(6) | Incorporated by reference from the Companys Annual Report on Form 10-K, for the year ended January 2, 1998, as filed on April 1, 1998. |
(7) | Incorporated by reference from the Companys Annual Report on Form 10-K, for the year ended January 1, 1999, as filed on April 1, 1999. |
(8) | Incorporated by reference from the Companys Annual Report on Form 10-K, for the year ended December 31, 1999, as filed on March 30, 2000. |
(9) | Incorporated by reference from the Companys Annual Report on Form 10-K, for the year ended December 29, 2000, as filed on March 29, 2001. |
(10) | Incorporated by reference to the Companys Annual Report on Form 10-K, for the year ended December 28, 2001, as filed on March 28, 2002. |
(11) | Incorporated by reference to the Companys Quarterly Report, for the period ended June 28, 2002, as filed on August 12, 2002. |
(12) | Incorporated by reference to the Companys Annual Report on Form 10-K, for the year ended January 3, 2003, as filed on April 3, 2003. |
(13) | Incorporated by reference from the Companys Proxy Statement, for its Annual Meeting of Stockholders held on June 18, 2003, as filed on May 19, 2003. |
(14) | Incorporated by reference to Exhibit 4.1 to Amendment No. 1 to the Companys Registration Statement on Form 8-A/ A, as filed on April 18, 2003. |
(15) | Incorporated by reference to the Companys Quarterly Report, for the period ended April 4, 2003, as filed on May 19, 2003. |
(16) | Incorporated by reference from the Companys Annual Report on Form 10-K/ A, for the year ended December 29, 2000, as filed on May 9, 2001. |
(17) | Incorporated by reference to the Companys Annual Report on Form 10-K, for the year ended January 2, 2004, as filed on March 17, 2004. |
(18) | Incorporated by reference to the Companys Quarterly Report, for the period ended April 2, 2004, as filed on May 12, 2004. |
(19) | Incorporated by reference to the Companys Current Report on Form 8-K, as filed on June 9, 2004. |
(20) | Incorporated by reference to the Companys Quarterly Report, for the period ended October 1, 2004, as filed on November 10, 2004. |
(21) | Incorporated by reference to the Companys Current Report on Form 8-K, as filed on June 13, 2003. |
42
STAAR SURGICAL COMPANY |
By: | /s/ David Bailey |
|
|
David Bailey | |
President and Chief Executive Officer | |
(principal executive officer) | |
Date: March 30, 2005 |
Name | Title | Date | ||||
/s/
David Bailey
|
President, Chief Executive Officer, Chairman and Director (principal executive officer) | March 30, 2005 | ||||
/s/
John Bily
|
Chief Financial Officer (principal accounting and financial officer) | March 30, 2005 | ||||
/s/
David Schlotterbeck
|
Director | March 30, 2005 | ||||
/s/
Donald Duffy
|
Director | March 30, 2005 | ||||
/s/
David Morrison
|
Director | March 30, 2005 | ||||
/s/
Volker Anhaeusser
|
Director | March 30, 2005 |
43
F-1
/s/ BDO Seidman, LLP |
F-2
/s/ BDO Seidman, LLP |
F-3
F-4
F-5
F-6
F-7
F-8
F-9
F-10
F-11
F-12
F-13
F-14
F-15
F-16
F-17
F-18
F-19
F-20
F-21
F-22
F-23
F-24
F-25
F-26
F-27
F-28
F-29
F-30
F-31
F-32
Table of Contents
2004
2003
2002
(In thousands,
except per share amounts)
$
51,685
$
50,409
$
47,880
49
368
51,685
50,458
48,248
25,542
22,621
24,099
26,143
27,837
24,149
9,253
9,343
8,959
20,302
19,509
16,833
6,246
5,120
4,016
500
390
1,454
36,301
34,362
31,262
(10,158
)
(6,525
)
(7,113
)
(191
)
11
36
219
256
361
(215
)
(322
)
(579
)
99
(582
)
(603
)
(88
)
(637
)
(785
)
(10,246
)
(7,162
)
(7,898
)
1,057
1,127
8,805
29
68
75
$
(11,332
)
$
(8,357
)
$
(16,778
)
$
(0.58
)
$
(0.47
)
$
(0.98
)
19,602
17,704
17,142
Table of Contents
Accumulated
Common
Common
Additional
Other
Stock
Stock Par
Paid-In
Comprehensive
Accumulated
Notes
Shares
Value
Capital
Income (Loss)
(Deficit)
Receivable
Total
(In thousands)
17,158
$
172
$
75,573
$
(1,728
)
$
(24,011
)
$
(3,864
)
$
46,142
5
6
6
39
120
120
3
12
12
236
236
(243
)
(3
)
(970
)
2,129
1,156
96
96
(242
)
(242
)
(1,814
)
(1,814
)
1,617
1,617
(16,778
)
(16,778
)
16,962
169
74,977
(111
)
(40,789
)
(3,695
)
30,551
387
4
1,549
1,553
54
1
278
279
206
206
1,000
10
8,938
8,948
3,270
3,270
(118
)
(118
)
(1,796
)
(1,796
)
683
683
(8,357
)
(8,357
)
18,403
184
85,948
572
(49,146
)
(2,339
)
35,219
250
3
826
829
11
60
60
231
231
2,000
20
11,626
11,646
330
330
(95
)
(95
)
500
500
452
452
(11,332
)
(11,332
)
20,664
$
207
$
98,691
$
1,024
$
(60,478
)
$
(1,604
)
$
37,840
Table of Contents
2004
2003
2002
(In thousands)
$
(11,332
)
$
(8,357
)
$
(16,778
)
2,005
1,950
2,171
688
952
933
2,102
175
159
191
(11
)
(36
)
9,132
231
206
236
60
279
132
1,225
500
(1,364
)
(95
)
(124
)
(226
)
21
104
144
(542
)
474
1,462
(2,282
)
(1,041
)
3,108
32
380
(232
)
769
351
(966
)
775
(206
)
264
(8,804
)
(4,146
)
569
(1,705
)
(1,309
)
(874
)
(16
)
(75
)
(75
)
(8,000
)
2,875
(768
)
330
3,270
10
(91
)
189
493
81
76
40
(7,294
)
2,151
(406
)
72
(2,912
)
(2,598
)
2,000
829
1,553
6
11,646
8,948
12,547
7,589
(592
)
452
683
585
(3,099
)
6,277
156
7,286
1,009
853
$
4,187
$
7,286
$
1,009
Table of Contents
Note 1
Significant Accounting Policies
Canon Staar Joint Venture
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Fiscal Year
$
481
479
479
479
478
$
2,396
Table of Contents
2004
2003
2002
0
%
0
%
0
%
72
%
69
%
66
%
4.22
%
4.37
%
4.50
%
4.2
4.8
5.4
2004
2003
2002
$
(11,332
)
$
(8,357
)
$
(16,778
)
(739
)
(1,563
)
(1,679
)
$
(12,071
)
$
(9,920
)
$
(18,457
)
$
(0.58
)
$
(0.47
)
$
(0.98
)
$
(0.62
)
$
(0.56
)
$
(1.08
)
Table of Contents
2004
2003
2002
$
(11,332
)
$
(8,357
)
$
(16,778
)
452
683
1,617
$
(10,880
)
$
(7,674
)
$
(15,161
)
Table of Contents
Table of Contents
Note 2
Short-Term Investments
2004
2003
Market
Market
Cost
Value
Cost
Value
$
5,125
$
5,125
$
5,125
$
5,125
$
$
Note 3
Accounts Receivable
2004
2003
$
2,602
$
2,834
4,075
3,575
6,677
6,409
460
734
$
6,217
$
5,675
Note 4
Inventories
2004
2003
$
985
$
830
2,253
1,273
11,846
10,699
$
15,084
$
12,802
Note 5
Property, Plant and Equipment
2004
2003
$
12,388
$
12,791
4,378
3,808
4,826
4,608
21,592
21,207
15,429
14,569
$
6,163
$
6,638
Table of Contents
Note 6
Investment in Joint Venture
2004
2003
$
6,237
$
7,728
1,402
3,297
1,238
1,881
807
829
10,908
9,273
4,572
3,237
6,163
122
$
(304
)
$
22
2004
2003
2002
$
(382
)
$
22
$
(8
)
50
%
50
%
50
%
(191
)
11
(4
)
40
$
(191
)
$
11
$
36
Note 7
Notes Payable
Table of Contents
Note 8
Income Taxes
2004
2003
2002
$
$
$
(995
)
(74
)
1,057
1,127
742
1,057
1,127
(327
)
9,021
111
9,132
$
1,057
$
1,127
$
8,805
Table of Contents
2004
2003
2002
$
(3,484
)
34.0
%
$
(2,435
)
34.0
%
$
(2,685
)
34.0
%
715
(10.0
)
36
(0.3
)
23
(0.3
)
38
(0.5
)
(0.0
)
(0.0
)
1,305
(16.5
)
158
(1.5
)
107
(1.5
)
(1,245
)
15.8
7
(0.1
)
4,340
(42.4
)
2,717
(37.9
)
11,392
(144.3
)
$
1,057
(10.3
)%
$
1,127
(15.7
)%
$
8,805
(111.5
)%
Table of Contents
2004
2003
$
143
$
114
475
611
171
156
3
3
79
6
21
(892
)
(890
)
$
$
25,508
19,141
880
876
(54
)
194
207
450
429
267
252
246
37
32
(27,280
)
(21,185
)
$
$
2004
2003
2002
$
(12,887
)
$
(10,163
)
$
(14,066
)
2,641
3,001
6,168
$
(10,246
)
$
(7,162
)
$
(7,898
)
Table of Contents
Note 9
Business Acquisitions
Note 10
Stockholders Equity
Table of Contents
Weighted
Average
Number of
Exercise
Shares
Price
2,911
$
8.85
972
$
3.73
$
(746
)
$
10.55
3,137
$
6.86
553
$
4.52
(387
)
$
4.03
(84
)
$
5.89
3,219
$
6.84
531
$
7.76
(250
)
$
3.32
(348
)
$
8.27
3,152
$
7.12
2,535
$
7.27
Table of Contents
Table of Contents
Options
Outstanding
Number
Weighted-Average
Number
Range of
Outstanding at
Remaining
Weighted-Average
Exercisable at
Weighted-Average
Exercise Prices
12/31/04
Contractual Life
Exercise Price
12/31/04
Exercise Price
(In thousands)
(In thousands)
$ 1.70 to $ 2.15
160
3.1 years
$
1.93
160
$
1.93
$ 2.96 to $ 4.30
1,037
4.1 years
$
3.54
821
$
3.52
$ 4.62 to $ 6.25
402
0.8 years
$
5.61
365
$
5.64
$ 7.00 to $10.19
620
6.2 years
$
8.75
314
$
9.67
$10.60 to $13.88
933
3.9 years
$
11.54
875
$
11.58
$ 1.70 to $13.88
3,152
4.0 years
$
7.12
2,535
$
7.27
Note 11
Commitments and Contingencies
Operating
Capital
Fiscal Year
Leases
Leases
$
927
$
92
435
6
435
3
437
2
52
2
$
2,286
$
105
(8
)
$
2,286
$
97
$
86
11
$
97
Table of Contents
Fiscal Year
$
1,022
200
$
1,222
Table of Contents
Note 12
Other Liabilities
Table of Contents
Note 13
Related Party Transactions
Note 14
Supplemental Disclosure of Cash Flow Information
2004
2003
2002
$
$
$
(2,129
)
500
1,713
1,814
(658
)
973
(500
)
(1,713
)
$
203
$
$
426
1,107
442
(542
)
(868
)
(768
)
$
$
(2,438
)
$
336
2,102
Table of Contents
Note 15
Other Charges
Note 16
Net Loss Per Share
2004
2003
2002
19,602
17,704
17,142
19,602
17,704
17,142
Note 17
Geographic and Product Data
2004
2003
2002
$
21,643
$
23,464
$
24,082
22,128
19,840
16,081
7,914
7,105
7,717
$
51,685
$
50,409
$
47,880
Table of Contents
2004
2003
2002
(In thousands)
$
46,772
$
46,409
$
44,349
4,913
4,000
3,531
$
51,685
$
50,409
$
47,880
2004
2003
$
9,035
$
10,181
6,799
6,511
2,010
2,220
1,253
212
$
19,097
$
19,124
Note 18
Quarterly Financial Data (Unaudited)
December 31, 2004
1st Qtr.
2nd Qtr.
3rd Qtr.
4th Qtr.
$
13,569
$
12,024
$
12,140
$
13,952
7,317
6,150
6,097
6,579
(1,299
)
(3,380
)
(2,268
)
(4,385
)
(.07
)
(.18
)
(.11
)
(.21
)
Table of Contents
January 2, 2004
1st. Qtr.
2nd Qtr.
3rd Qtr.
4th Qtr.
$
12,826
$
12,951
$
11,927
$
12,754
6,979
7,056
6,587
7,215
(958
)
(1,169
)
(2,710
)
(3,520
)
(.06
)
(.07
)
(.15
)
(.19
)
Table of Contents
/s/
BDO Seidman,
LLP
Table of Contents
Column A
Column B
Column C
Column D
Column E
Balance at
Balance at
Beginning
End of
Description
of Year
Additions
Deductions
Year
(In thousands)
$
734
$
236
$
510
$
460
22,075
6,097
28,172
500
500
$
22,809
$
6,833
$
510
$
29,132
$
805
$
108
$
179
$
734
18,607
3,468
22,075
1,795
1,795
$
21,207
$
3,576
$
1,974
$
22,809
$
768
$
1,186
$
1,149
$
805
100
100
4,288
14,319
18,607
3,609
1,814
1,795
$
8,765
$
15,505
$
3,063
$
21,207
EXHIBIT 10.10
DOMENICO CALDERARI AG/SA
LEASE AGREEMENT
between
EINFACHE GESELLSCHAFT CALDERARI & SCHWAB, Schloss-Str. 10, 2560 NIDAU
- Lessor - and STARR SURGICAL AG, Junkerngasse 21, 3011 BERN - Lessee - |
1. Leased Premises
Lessee leases an area of 460 m2 on the 2nd floor of the property known as Hauptstrasse 104, 2560 Nidau, as a production site and office as well as Parking Area West on the 3rd floor.
Lessor shall also grant Lessee permission to use the free space in the "Kaminraum" [chimney space], which is located outside of the Leased Premises, where it may place a compressor, vacuum device and similar objects there.
2. Commencement of Lease:
The Lease shall commence on October 1st, 1994. For the purpose of organizing the business, Lessee may have use of the keys starting immediately. There shall be no rent payable for the period up until October 1st, 1994.
3 Term of Lease
The term of the Lease is fixed and the Lease shall expire on October 31. 1999.
3.1 Option
After expiration of the fixed-term Lease, Lessee shall have the option to extend the Lease by 5 more years. If Lessee elects to exercise this option, it must notify Lessor in writing no later than March 31, 1999. If Lessee does not exercise the option and as long as neither of the parties to the contract terminates the Lease effective October 31, 1999, after expiration of the term the Lease shall be automatically extended by one year at a time. In case of termination, notice must be given 6 months in advance.
4. Rent 4.1 Net Rent Net rent for the production and office space until 09.30.1996 shall be Sfr. 59,800.00 annually (= Sfr. 130.00 per m2 for that year) and is payable in monthly installments of Sfr. 4,983.00. After October 1st, 1996, the rent shall be increased to Sfr.150.00 per m2, which results in an annual rent of Sfr. 69,230.00 payable in monthly installments of Sfr. 5,769.00. Net rent for Parking Area "West" shall be Sfr. 4,800.00 annually and shall be payable in monthly installments of Sfr. 400.00. 4.1.1 After October 1st, 1996, the annual net rent of Sfr. 69,230.00/ 4,800.00 shall be tied to the consumer price index BIGA(1). The rent corresponds to the level of the index applicable at that point in time, i.e. August 1996. Upon request by one of the parties, the net rent may be adjusted once annually on January 1st regardless of the fixed term of the Lease, taking into account the entire percentage of change undergone by this index. The first adjustment may be done on 01.01.1998 at the earliest. 4.1.2 The net annual rent of Sfr. 69,230.00 / 4,800.00 is a base rent. Rent may not fall below this amount regardless of potential adjustments. 4.2 Utilities 4.2.1 The payments on account towards expenses for heating, electricity used for shared rooms and for the burner, water fees, possibly sewage and garbage collection fees, expenses for janitorial services which are billed by the manager on April 30th, shall amount to Sfr. 500.00 monthly. 4.2.2 In exchange for participation in covering the cost thereof, Lessee shall have the opportunity to use the service elevator. 4.3 Bank Guarantee At the time the Lease is entered into, Lessee shall deposit the sum of Sfr. 15,000.00 as an irrevocable bank guarantee. 5. Use of the Leased Premises 5.1 The Leased Premises shall be used for the production and warehousing of medical supplies and as an office and training site. ---------- (1) Bundesamt fur Industrie, Gewerbe und Arbeit (Swiss federal bureau of industry, business and work) |
5.2 The Leased Premises must to be handed over in clean condition. The carpeted floors shall be shampooed once more before Lessee moves in. 5.3 Maintenance Lessee shall maintain the Leased Premises in good and clean condition. Repairs under Sfr.1,000.00 annually shall be paid for by Lessee. If damage to the Leased Premises is evident, Lessee shall keep its extent at a minimum by either taking immediate measures at its expense or by informing Lessor without delay. Repair work, minor work to prepare the Leased Premises for occupancy, or needed alterations to the Leased Premises or to the property shall be tolerated by Lessee without claims for damages. The following work shall be paid for entirely by Lessee. - Replacement of electrical switches, sockets and fuses, light bulbs (as well as, on a pro rata basis, of the lighting fixtures belonging to the building), water faucets and door locks. |
- Unclogging of water lines, sinks, toilets and laundry equipment.
- Repair or replacement of washers on radiators and other devices.
5.4 House Rules
Lessee shall be duly considerate of the other tenants and neighbors in every respect. Lessor shall not lease space to tenants causing a trade-related nuisance (heavy dust emission, noise).
5.5 Subletting
Subletting of rooms shall only be permitted with explicit consent of Lessor.
5.6 Access to the Leased Premises
For the purpose of protecting its interests, Lessor shall have the right, having made an appointment in writing with the business management, to access the Leased Premises with a member of the management present.
6. Insurance
6.1 Lessee shall insure all machinery, equipment, as well as furniture, merchandise and all objects located within the leased space, at its own expense, adequately against theft, fire, damage caused by explosion and water, as well as against risks incidental to the business, particularly renter's liability.
Lessee shall bear the consequences in case of non-fulfillment of this obligation, with no responsibility whatsoever resting with Lessor.
7. Company Signs and Inscriptions
7.1 Installation and Execution
Lessor gives, in advance, its consent to the installation of company signs beneath the rented frontage window as well as above the main entrance.
7.2 Expenses
Expenses for new signs or changes to signs shall be the responsibility of Lessee. In case of necessary removal and re-installation due to a change in tenants, Lessee shall pay for this expense.
8. Changes to the Leased Premises
8.1 Permits
Changes to the Leased Premises which require permits shall require notification of Lessor in advance.
Lessor shall inform Lessee regarding changes to the Leased Premises.
9. Yielding of the Leased Premises
9.1 Cleaning
The Leased Premises must be yielded in a tidy and cleaned condition.
9.2 Damage
Lessee shall be liable for any damage not due to normal wear and tear. Such damage shall have been repaired by Lessee by the time the Lease terminates.
9.3 Restoration
Restorations shall be carried out according to the customs and practices of the property and homeowners association of the city of Biel and its environs.
9.4 After 5 years, the changes made to the interior do not have to be reversed and the Leased Premises do not have to be restored to their original condition after the expiration of the Lease.
10. Structural Alterations
The one-time structural alterations indicated on the attached list and/or sketch (removal and construction of non-supporting partitions, the moving of doors, installation of connecting pipes for water supply and drainage) which shall be arranged by Lessor and must be completed by October 1st, 1994, shall be paid for by Lessor. The attached and signed layout constitutes an integral part of this Lease Agreement.
Lessor guarantees that the electrical lines within the Leased Premises are of sufficient capacity to meet the needs of the machinery and devices used by Lessee. Should this not be the case, Lessor shall strengthen the electrical grid at its expense.
Lessor guarantees the completion of such work within 2 -1/2 months after Lessee's submission of the definite layout. Should it not do so, Lessor shall be required to pay a conventional penalty of Sfr. 1,000.00 per day, regardless of fault. It the layout is later altered, no conventional penalty whatsoever shall apply.
a) Both parties agree that Lessor shall do its best to carry out the alterations as quickly as possible after the definite layout has been submitted.
11. Further Options
Lessee shall have until 03.01.1995 to notify Lessor whether it wants to lease, within a period of 3 months, the space in the cellar (approx. 100 m2 at Sfr. 80.00 per m2 for that year). Lessor guarantees to make this space available within the aforementioned time period.
Lessor shall have the option to lease the space on the first floor as a whole or only one half of it. Notification of interest in the retail space "LANCIA" must be submitted at least 6 months in advance, and notification of interest in the retail space "FIAT" at least 12 months in advance. Regarding rent, it shall be agreed that it may not exceed the rent indexed by BIGA as of October 1st, 1994 on a basis of Sfr. 200.00 per m2 for that year.
Should Lessee find another tenant for the aforementioned space, it shall notify Lessee in writing. If Lessee tenant does not exercises its option to lease said space within 60 days, Lessor shall have the right to lease it to a third parties.
Lessee is assured that it shall have first option to rent any and all spaces that become available. If Lessee does not exercise this option in writing within 60 days, Lessor may rent such spaces to third parties. However, the rent charged to the third party may not be below that offered to Lessee.
Lessee is assured that, should the building be sold, it shall be given first option to lease it. If Lessee does not exercise this option in writing within 60 days, Lessor shall have the right to sell the space, subject to the right of preemption hereinafter referred to, to third parties. However, the sales price may not be below that offered to Lessee.
Lessor shall grant Lessee an unlimited right of preemption for the building known as Hauptstrasse 104, Nidau and/or for parts of the property resulting from the establishment of individual floors. This right of preemption shall exist for the entire term of the Lease.
12. Special Provisions
Lessee specifically acknowledges that it has been notified that Lessor shall insist on its right of retention guaranteed by law under Schkg(2) 283 / OR(3) 257-59 and 268. The deadline for filing a retention request is 30 days after written notification.
Lessee shall be granted the right to have this Lease Agreement noted in the public real estate register at its own expense.
Nidau, July 12, 1994 Nidau, July 12, 1994
Lessee: Lessor: [signature] [signature] STAAR SURGICAL AG EINFACHE GESELLSCHAFT CALDIERI & SCHWAB |
(3) Obligationenrecht (law of contracts)
EXHIBIT 10.11
SUPPLEMENT TO THE LEASE AGREEMENT OF JULY 12, 1994
between
EINFACHE GESELLSCHAFT CALDERARI & SCHWAB, Schloss-Str. 8 A, 2560 NIDAU
- Lessor - and STARR SURGICAL AG, Hauptstrass 104, 2560 NIDAU - Lessee - |
1. Leased Premises
Lessee leases an area of 390 m2 on the ground floor of the property known as Hauptstrasse 104, 2560 Nidau, as a production site and office as well as Parking Area North in front of the building.
2. Commencement of Lease:
The Lease shall commence on November 1st, 1995. For the purpose of organizing the business, Lessee may have use of the keys starting September 1st. immediately. There shall be no rent payable for the period up until November 1st, 1995.
3 Term of Lease
The term of the Lease is fixed and the Lease shall expire on October 31. 2000.
3.1 Option
After expiration of the fixed-term Lease, Lessee shall have the option to extend the Lease by 5 more years. If Lessee elects to exercise this option, it must notify Lessor in writing no later than March 31, 2000. If Lessee does not exercise the option and as long as neither of the parties to the contract terminates the Lease effective October 31, 2000, after expiration of the term the Lease shall be automatically extended by one year at a time. In case of termination, notice must always be given 6 months in advance.
4. Rent
4.1 Net Rent
Net rent for the production and office space shall be Sfr. 70,200.00 annually (= Sfr. 180.00 per m2 for that year) and is payable in monthly installments of Sfr.5,850.00. Net rent for Parking Area "Nord" shall be Sfr. 4,800.00 annually and shall be payable in monthly installments of Sfr. 400.00. 4.1.1 After October 1st, 1997, the annual net rent of Sfr. 70,200.00/ 5,850.00 shall be tied to the consumer price index BIGA(1). The rent corresponds to the level of the index applicable at that point in time, i.e. August 1997. Upon request by one of the parties, the net rent may be adjusted once annually on January 1st regardless of the fixed term of the Lease, taking into account the entire percentage of change undergone by this index. The first adjustment may be done on 01.01.1998 at the earliest. 4.1.2 The net annual rent of Sfr. 70,200.00 / 5,850.00 is a base rent. Rent may not fall below this amount regardless of potential adjustments. 4.2 Utilities 4.2.1 The payments on account towards expenses for heating, electricity used for shared rooms and for the burner, water fees, possibly sewage and garbage collection fees, expenses for janitorial services which are billed by the manager on April 30th, shall amount to Sfr. 400.00 monthly. 4.2.2 In exchange for participation in covering the cost thereof, Lessee shall have the opportunity to use the service elevator. 4.3 Bank Guarantee At the time the Lease is entered into, Lessee shall deposit the sum of Sfr. 15,000.00 as an irrevocable bank guarantee. 10. Structural Alterations Lessor shall carry out the following structural alterations at its expense: - Service elevator (Palette USA) to the already leased warehouse located in the basement, without transportation of persons. |
- Stairs for persons leading to the warehouse in the basement.
- Opening in the wall with door into the stairway (as big as possible).
- Construction of 2 walls with 2 doors for building a reception area by the entrance (according to layout).
- Construction of two bathrooms (3 toilets each for men / 3 each for women) and possible sewer hook-up according to layout.
(1) Bundesamt fur Industrie, Gewerbe und Arbeit (Swiss federal bureau of industry, business and work)
- Construction of a firm boundary along the store window front at a railing level.
- Construction of a sliding door in store window "North".
Lessor guarantees the completion of the aforementioned work between 07.01 - 08.30.1995 as long as the definite layout is submitted by 04.30.1995 at the latest.
Nidau, Nidau, Lessee: Lessor: [signature] ------------------------ -------------------------------- STARR SURGICAL AG Mr. E. Calderari [signature] -------------------------------- Mr. W. Schwab |
EXHIBIT 10.12
SUPPLEMENT TO THE LEASE AGREEMENT OF JULY 12, 1994
FOR THE PRODUCTION SPACE EX RUCCI
between
EINFACHE GESELLSCHAFT CALDERARI & SCHWAB, Schloss-Str. 8-A 2560 Nidau
- Lessor - and STARR SURGICAL AG, Hauptsrasse 104, 2560 NIDAU - Lessee - |
1. Leased Premises
Lessee Lessee leases an area of 259 m2 on the ground floor of the property known as Hauptstrasse 104, 2560 Nidau as a production site (240 m2) and basement (29 m2), as well as 5 parking spaces in the Parking Area North (Ex Rucci).
2. Commencement of Lease
The Lease shall commence on September 15, 1999.
3. Term of Lease
The term of the Lease is fixed and the Lease shall expire on December 3, 2006.
3.1 Option
After expiration of the fixed-term Lease, Lessee shall have the option to extend the Lease by 5 more years. If Lessee elects to exercise this option, it must notify Lessor in writing no later than 12.31.2005. If Lessee does not exercise the option and as long as neither of the parties to the contract terminates the Lease effective December 31, 2005, after expiration of the term, the Lease shall be automatically extended by one year at a time. In case of termination, notice must always be given 1 year in advance.
4. Rent 4.1 Net Rent Net rent for the production and cellar space shall be Sfr. 45,520.00 annually (= Sfr.180.00 per m2 for that year/cellar = Sfr. 80.00 per m2 for that year) and is payable in monthly installments of Sfr.3,793.00. Net rent for 5 parking spaces "Nord" shall be Sfr. 4,800.00 annually and shall be payable in monthly installments of Sfr. 400.00. 4.1.1 After September 15, 1999, the annual net rent of Sfr. 45,520.00/ 3,793.00 shall be tied to the consumer price index BIGA1. The rent corresponds to the level of the index applicable at that point in time, i.e. August 1999. Upon request by one of the parties, the net rent may be adjusted once annually on January 1st regardless of the fixed term of the Lease, taking into account the entire percentage of change undergone by this index. The first adjustment may be done on 01.01.2001 at the earliest. 4.1.2 The net annual rent of Sfr. 45,520.00 / 3,793.00 is a base rent. Rent may not fall below this amount regardless of potential adjustments. 4.2 Utilities 4.2.1 The payments on account towards expenses for heating, electricity used for shared rooms and for the burner, water fees, possibly sewage and garbage collection fees, expenses for janitorial services which are billed by the manager on April 30th, shall amount to Sfr. 400.00 monthly. 4.2.2 Possible land contamination by the body shop, such as oil, gasoline, etc., shall be the responsibility of Lessor. 10. Structural Alterations Lessor shall carry out the following structural alterations at its |
expense:
- Interior walling up of an exterior garage door with transom.
- 3 doors with an interior width of at least 1.30 m (e.g. a double door like we already have in our production area).
- 1 partition (if possible transom).
- All side walls and ceilings finished with smooth plaster and painted white.
- Floor with smooth, easy to clean covering (such as ceramic tile, anti-static linoleum).
(1) Bundesamt fur Industrie, Gewerbe und Arbeit (Swiss federal bureau of industry, business and work)
- All windows, glass brick walls and doors fitted flush so that they are dustproof.
- All no longer used pipes, cables and other objects attracting dust removed, all walls, floors and ceiling cleaned of dust.
- Division of exterior parking area into marked spaces and resurfacing of the transition from exterior wall to road surface.
- Standard lighting for production and warehouse space
11. Special Provisions
By entering into this contract, both Lease Agreements of 07.12.1994 as well as Supplement I dated 07.10.1995 are being extended. The new term of the Lease shall expire on 12.31.2006.
Nidau, Nidau, Lessee: Lessor: [signature] 08.02.99 [signature] ----------------------------- -------------------------------- STARR SURGICAL AG Mr. E. Calderari [signature] -------------------------------- Mr. W. Schwab |
EXHIBIT 10.13
COMMERCIAL LEASE AGREEMENT
Lessor: DePfa Deutsche Pfandbriefbank AG Paulinenstra(beta)e 15, 65189 WiesbADEN represented by: DePfa Bau-, Verwaltungs- und Controlling GmbH Poppenbutteler Bogen 17, 22399 Hamburg Lessee: DOMILENS GmbH Holsteiner Chaussee 303 a, 22457 Hamburg |
enter into the following Lease Agreement:
Leased Premises: Office and Business Premises Holsteiner Chaussee 303 a + b, 22457 Hamburg Area Entrance 303 a, approx. 1'454.15 m2 Entrance 303 b, 3rd floor, approx. 118.83 m2 Entrance 303 b, 4th floor, approx. 148.85 m2
Parts of the Lease Agreement
Preamble
1. Leased Premises
2. Purpose of Lease
3. Term and Termination of Lease
4. Handing over of Premises
5. Rent, Utilities, Heating Costs, Value Guarantee Payment and Accounting
6. Security Deposit
7. Joint Advertising
8. Advertising Equipment
9. Safeguarding Collective Interests
10. Electricity, Heating (Gas), and Water
11. Maintenance and Repair of Leased Premises
12. Structural Alterations by Lessee
13. Lessee's Liability
14. Improvements and Structural Alterations by Lessor
15. Yielding of Leased Premises
16. Lessor's Access to the Leased Premises
17. Assignability of Use of Leased Premises
18. Reconstruction Clause, Business Interruptions
19. Lessor's Liability, Insurance
20. House Rules
21. Miscellaneous
22. Final Provisions
Preamble
Due to the fact that Lessee has decided to lease additional space beyond the already existing Lease involving Holsteiner Chaussee 303 a and b, 22457 Hamburg, the parties agree to the following:
Through the signing of this Lease Agreement, the Lease Agreement dated July 07.07./14.1993 as well as the Supplement to the Lease Agreement dated 04.27./ 05.05.98, and the Lease Agreement of 08.20./25.1999 as well as the Supplement to the Lease Agreement dated 08.12./16.99 are void as of 12.31.2000..
The Lease of the entire space of approx. 1,721.83 m2 is subject to the following provisions:
1. Leased Premises
1.1 The Leased Premises consist of an area measuring approx. 1,721.83 m2. Unless otherwise agreed upon hereinafter, the office space leased by Lessee is referred to as Leased Space.
1.2 The space measurements in 1.1 of the Lease Agreement are axis measurements based on building plans. Provided that the deviation from the actual Leased Space is less than 5 percent, Lessee states already today that it is in agreement with such a deviation.
1.3 Lessee shall be responsible for obtaining, at its own expense, all official permits and licenses which may be required in connection with conducting business. In this effort, Lessor shall lend technical support to Lessee upon Lessee's request.
1.4 The Leased Premises may only be used for legally, officially and contractually permitted purposes. Lessee is required to comply, at its own expense, with the legal, governmental and technical regulations (e.g. DIN(1), VDS(2), VDE(3)) which apply to its business and keep Lessor free of any impositions which may be issued against it. Upon request, Lessee must provide Lessor with relevant inspection certificates issued by an accredited expert. Lessor may set a reasonable time limit within which Lessee must meet above obligations. If it is not met or Lessee's whereabouts are unknown, Lessor may have necessary measures taken at Lessee's expense.
2. Purpose of Lease
2.1 Maintaining an Office
(1) Deutsche Industrie-Normen (German industrial standards)
(2) Vertrauen durch Sicherheit, an independent, international, accredited testing and certification institution
(3) Assn. for Electrical, Electronic and Information Technologies, an independent testing and certification institute
3. Term and Termination of Lease 3.01 Commencement of Lease: 01.01.2001 3.02 Not applicable 3.03 Term of Lease: 10 years fixed 3.04 Special rights of termination: as of 12.31.2004 as of 08.30.2007 |
Notice of special termination must be given by Lessee in writing and received by Lessor at least 6 months before the agreed upon date.
3.05 Tenancy shall end with the expiration of the term agreed upon under this contract according to 3.03 if the rights to special termination are not exercised.
3.06 Not applicable
3.07 As far as the right of termination without notice is concerned, in particular termination due to non-payment of rent, the legal provisions apply. In this context, the prepaid fees for utilities as well as heating shall be treated as part of the rent. Moreover, it shall be considered an important reason for termination without notice by Lessor if Lessee, although it has received a reminder in writing, does not meet essential obligations within a reasonable period (e.g. use that constitutes a breach of contract, considerable harassment or interference with Lessor or other tenants, permitting unauthorized use by third parties).
3.08 Lessor is further entitled to terminate the lease without notice if Lessee's assets are subject to the initiation of judicial court-supervised reorganization or bankruptcy proceedings or an application for reorganization has been denied due to insufficient assets. The same applies filed for reorganization or bankruptcy, stops payments or enters into a settlement out of court.
3.09 In case of a premature termination of the Lease for which Lessee is responsible, Lessee is liable for lost rent, utilities and other payments for the term of the Lease under the Lease Agreement as well as for all additional damages suffered by Lessor due to the premature termination of the lease.
3.10 Any notice of termination must be given in writing.
3.11 If the term of the Lease expires, Section of the BGB(4) shall not apply.
4. Handing-over of Leased Premises
4.1 Lessor shall hand over the Leased Premises in the presently existing condition which Lessee observed when viewing the premises, unless other terms have been agreed upon which are explicitly set forth in this Lease Agreement. Lessor reserves the right to make insignificant changes as well as alterations required to comply with governmental regulations. Any structural or other work requested by Lessee or necessary for its intended use, particularly if it goes beyond or otherwise differs from the condition at the time the Leased Premises was handed over, shall be at the expense of Lessee. The same applies to technical equipment whose installation is required either by the authorities or under this Lease Agreement or which becomes necessary for the operation or furnishing of the Leased Premises.
4.2 Not applicable
4.3 Lessee's right to occupy Leased Space Nr. 5, 3rd floor, approx. size 118,83 m2, takes effect only after payment of the security deposit under section 6. Handing over is scheduled for January 2001, but may be delayed until 02.01.2001 due to remodeling. For this reason, the owner grants Lessee a rent reduction of DM 1'000.00 per month for November and December of 2000.
4.4 At the time of the hand-over, a hand-over protocol shall be created which shall document, in particular, which defects, if any, are pointed out by Lessee. Lessor shall have any noted defects which it has acknowledged repaired before the office is opened if possible. Lessee shall give Lessor the opportunity to carry out the repairs. The provisions in section 14.2 shall apply hereto.
4.5 Not applicable
4.6 Not applicable
5. Rent, Utilities, Heating Expenses, Payment and Accounting
5.1 Rent
(4) Bundesgesetzbuch (Swiss federal law)
For the space measuring 1,721.83 m2, Lessee shall pay Lessor a monthly net rent excluding heating of DM 34'800.00 plus VAT plus advance payments: 1. for operating expenses per Exhibit 3 to Section 27 II. Assessment Regulations (II. AR) DM 3'281.00 plus VAT 2. for heating costs per Exhibit 3 to Section 27 II AR DM 880.00 plus VAT 3. rent for reserved parking space DM 2'220.00 plus VAT --------------------- Total rent: DM 41'181.00 plus VAT --------------------- Lessor's bank account information: Name of account DePfa-BVC wg Host.Chausee Account number: 8626000001 Bank/Savings bank DePfa Bank AG BauBoden Bank code: 200 104 24 |
Lessee's bank account information:
Name of account: __________________________Account number:
Bank/Savings bank _____________________________Bank code:
5.1.1 Graduated Lease agreement
The net rent excluding heating agreed upon in 5.1 shall increase after a year at the earliest as follows:
Level m2 DM/m2 monthly rent in DM ----- -- ------ ------------------ Area 1,721.83 at the end of the 1st rental year 2002 20.57 DM 35,426.40 at the end of the 2nd rental year 2003 20.95 DM 36,064.08 at the end of the 3rd rental year 2004 21.32 DM 36,713.23 |
Rent increases during the term of the graduated lease agreement are not allowed, except for increases in advance payments for utilities.
5.1.2. All aforementioned amounts are net amounts and Lessee must pay additional VAT at the official rate applicable at the respective times, at this time 15 percent.
5.2 Rent adjustment at the end of the 4th year of lease:
New negotiations regarding rent will be initiated as of 01.01.2005
5.3 not applicable
5.4 not applicable 5.5 Utilities 5.5.1 Utilities for the office and business premises, in particular operational expenses, the cost for care, maintenance, upkeep and repairs as well as for the cleaning of shared facilities and equipment, shall be distributed evenly among all tenants according to the ratio of the area of their leased space to the total area of leased space within the office and business premises. These utilities consist of: a) reserved parking for cars (parking spaces, underground parking garages), traffic lanes, landscaping and other external improvements as well as exterior lighting; b) other shared facilities and equipment of a structural or technical nature, such as, if applicable, entrances, all toilets and sanitation, elevators, sprinkler systems, etc. which are not located within the Leased Premises; |
c) property taxes;
d) building insurance, such as fire, liability and tap water insurance;
e) fees for public street sweeping and expenses for snow and ice removal;
f) electrical power supply for shared facilities and equipment, garbage collection, water supply and sewage disposal incl. public fees, insofar as these expenses are not the responsibility of the individual tenants. Included is, in particular, water usage connected with shared installations and facilities (e.g. heating systems, sprinkler systems, etc.);
g) security, janitorial and consultation services for the office and business facilities, including the hiring of required personnel, especially the expenses for building personnel (building inspector, building technician, etc.);
h) alterations to the existing shared facilities and installations needed due to official requirements established after construction of the Leased Premises;
i) neon signs, collective sign installations, interior and exterior building signage, including signs in public traffic areas, flag poles, flags and the like, which are not related to individual tenants, but to the Leased Premises; furthermore, the installation of such equipment as well as the rental of space required for their installation; j) expenses for cleaning the area of Entrance 303 b; k) expenses for local building management, as well as all utilities according to Exhibit 3, Section 27 II AR. Lessor has the right to establish a new scale for the distribution of utilities (as a whole or as individual types of expenses) at any time - whereby the new scale may also be applied to the running accounting period - as long as it is appropriate. 5.5.2 not applicable 5.5.3 Lessor has the right to allocate the cost for further services, which may be allocated under section 5.5.1., to third parties. 5.5.4 Lessor has the right to also include those costs for utilities which have not yet been incurred at the commencement of the Lease Agreement in the utilities statement and bill the tenants proportionally. 5.6 Heating expenses 5.6.1 The costs attributable to the leased areas, such as the costs for operation (including control), care, maintenance, upkeep and repairs as well as for cleaning the heating system, shall be distributed evenly among all tenants according to the provisions regarding heating expenses at a rate determined to 50 percent by usage and to 50 percent by the size of the used space. 5.6.2 The heating expenses attributable to the shared facilities and installations of the office and business facilities shall be paid for by all tenants evenly according to each tenant's total leased space in relation to the total leased area of the commercial building. Insofar as the usage is not determined by measurements, the calculation of these costs shall be based upon the ratio between shared areas to be heated and total areas to be heated within the Leased Premises. 5.6.3 not applicable |
5.6.4 Section 5.5.1, last sentence (establishment of a new scale of distribution) applies to the expensed mentioned in sections 5.6.1 and 5.6.2 accordingly. 5.6.5 The heating period lasts from October 1st of any given year until May 31st of the following year. Furthermore, Lessee is only entitled to heating during normal business hours. Lessor reserves the right to make changes hereto. |
5.7 Sales tax
See section 5.1.2
5.8 not applicable 5.9 Rent Payments and Accounting and Cost Allocation 5.9.1 Rent is payable monthly in advance, no later than on the third business day of each month. Determination whether a payments is on time shall be based upon the day on which it is received by Lessor or credited to Lessor's account. 5.9.2 All payments must be made to Lessor or to the person or agency authorized by Lessor to receive them. Upon request by Lessor, Lessee shall make payments by method of direct debit transfer using the attached form. 5.9.3 not applicable 5.9.4 not applicable 5.9.5 Lessee shall make monthly prepayments towards the expenses described in sections 5.5.1 (utilities for the office and business facilities), 5.6.1 and 5.6.2 (heating expenses) together with the minimum rent, initially in the amount stated in 5.1. Section 5.6.1 is applied accordingly. Unless explicitly agreed upon otherwise, an annual statement regarding the prepayments will be issued to Lessee. Any differences between the final billed amount and the prepaid amount shall be either paid by Lessee within four weeks from receipt of the statement or reimbursed by Lessor, whichever may apply. Upon Lessee's request, Lessor shall grant Lessee the opportunity to review the accounting records at the administrative offices of Lessee/manager at a scheduled time within the above mentioned four week period. |
The statement is considered approved if Lessee has not contested it in writing by stating his reasons within another period of four weeks. Lessor may reassess prepayments if it is obvious that the prepayments do not cover the projected costs, and he can do so during an accounting period or at the time the tenancy commences. 5.9.6 According to section 5.5, all expenses pertaining to a particular billing period for which Lessor has been billed shall be invoiced. Invoices pertaining to past billing periods which are received after the period has ended are included in the next statement. If tenancy commences within a billing period, Lessee shall be billed on a pro- rated basis. 5.9.7. If a payment is overdue, Lessor shall have the right to charge an administrative fee of DM 10.00 per reminder to pay, plus interest for default which shall be 5 percent higher than the base interest rate of the Bundesbank [German central bank], which is 4,26 percent at this time, unless the sustained damage is verifiably less. Furthermore, in case of delinquency Lessor may demand the surrender of the property placed as a lien and dispose of such property by means of unrestricted sale. 5.9.8 If a payment made by Lessee is not sufficient to cover all of its accrued debts, Lessor shall have the right, regardless of any dissenting statement made by Lessee, to apply the payment first to the not legally enforceable and not legally pending and finally to the legally enforceable debt, first to the older and then to the newer one. 5.9.9 In regards to rent or other charges made by Lessor based upon this Lease Agreement, Lessee may neither exercise a right to withhold payment (right to withhold performance) nor offset the charges against a contested counterclaim or a counterclaim that has been determined to be not legally valid. A right to mitigate only exists if it is explicitly provided for under the Lease Agreement. 5.9.10 Lessor shall not owe interest on overpaid rent, prepayments and other billed amounts. |
5.10 The disposal of packaging materials etc. shall be the duty of Lessee. All expenses connected with the disposal shall be paid by Lessee. If Lessor arranges the disposal, the resulting expenses shall be distributed among the tenants under utilities according to section 5.5.
5.11 Should there be an increase in official charges (taxes, fees, assessments), insurance premiums and the like applicable to the property after the Lease Agreement is entered into, or an introduction of new charges levied upon the property, Lessor shall have the right to distribute the extra costs incurred during the period following the commencement of the Lease Agreement among the tenants, based upon the their area of leased space in relation to the total leased space within the office and business facilities, unless another method of allocation is mandated by law or decree.
5.12. Any increases in premiums for property insurance which my arise due to the specific commercial use by Lessee shall be paid by Lessee to Lessor. Any changes on the part of Lessee which could lead to an increase in those insurance premiums during the tenancy must be reported to Lessor.
6. Security Deposit
Upon entering into this Lease Agreement, Lessee shall pay Lessor a security deposit in the amount of DM 5,000.00. This security deposit must be in the form of a performance bond through a large German bank or financial institution governed by public law. Lessor shall be authorized to use this bond to satisfy his claims based upon this Leases Agreement if Lessee dose not fulfill his obligations or does not do so completely or in a timely manner. The bond serves as a means to cover all claims by Lessor existing in connections with or arising due to the termination of the tenancy. The bond must be surrendered after termination of the tenancy as soon as and if it has been determined that Lessor has no further claims against Lessee. Furthermore, should the bond be used by Lessor during the term of the lease, it must be replenished immediately by Lessee until it is restored to its original amount.
7. Joint Advertising
not applicable
8. Advertising Equipment
8.1 In the interest of advertising in keeping with the common character of the office and business facilities, the installation and design of equipment serving the purpose of advertising or sales promotion located outside the Leased Premises shall require prior approval in writing by the Lessor.
8.2 It shall be the responsibility of Lessee to obtain all the necessary permits which may be hereto required by law and to fulfill any imposed administrative conditions, whereby all expenses shall be the responsibility of Lessee.
8.3 Lessee shall be liable for all damage arising from the installation of such equipment and must hold Lessor harmless of all claims by third parties.
9. Safeguarding Collective Interests
Assuming that in the interest of all tenants a positive general impression of the Leased Premises must be maintained, Lessee shall promise to comply with the following provisions:
9.1 not applicable
9.2 Lessee shall be required to use the Leased Premises during the entire term of the lease without interruption according to the stated purpose; Lessee shall not leave the Leased Premises unused or empty, either as a whole or in part.
9.3 not applicable
9.4 not applicable
9.5 Lessee shall use the Leased Premises in keeping with the character of the office and business premises. It shall abstain from any actions of a nature which could be detrimental to the legitimate interests of other tenants or have a negative effect on the office building.
9.6 not applicable
9.7 not applicable
10. Electricity, Heat (Gas) and Water
10.1 The existing lines for electricity, heat (gas) and water (supply media) may be used - if available - by Lessee only to the extent that its use does not exceed their capacity. Lessee may meet excess needs by having supply lines enlarged at its own expense after obtaining Lessor's prior written consent hereto.
10.2 For its gas and/or electrical needs, Lessee shall have a meter/meters installed by firms authorized to do so at its own expense; payment for gas or electricity shall be Lessee's responsibility.
10.3 Water meters are installed for the purpose of determining water use. The cost for water supply and sewage disposal shall be carried by Lessee based on use and shall be distributed among the tenants and billed under utilities.
10.4 Meters are to be kept accessible and easily readable.
10.5 In case of disruptions or damage to the supply lines, Lessee shall be responsible for immediate shut-off. If it is unable to do so or if the disruption or damage affects other tenants, Lessee or his agent shall be require to notify Lessor immediately.
10.6 In case of changes to or interruptions in the supply of electricity, heating or water or the disposal of sewage due to circumstances not caused by Lessee, or if flooding or other events of a catastrophic nature should occur, Lessee shall have no right to withhold rent or seek damages from Lessor.
11. Maintenance and Repair of Leased Premises
11.1 Lessee shall be responsible for the care, maintenance, cosmetic repair, upkeep and repair of the leased space and/or the interior of the leased rooms as well as the doors and windows of the exterior facade at its own expense. This shall also apply to technical equipment (such as electrical and sanitary installations, etc.) to the extent that this equipment is located within the Leased Premises and is used exclusively by Lessee. Cosmetic repairs in particular shall be carried out by Lessee in a professional manner at regular intervals - sanitary installations and kitchen areas every 3 years - the remaining office spaces every 4 years.
Work on technical installations may only be done by professional companies.
11.2 If Lessee does not fulfill any of the above obligations within a reasonable grace period set by Lessor in spite of a written request by the Lessor, Lessor shall have the right to have the required work done at Lessee's expense. A warning of dismissal by Lessor shall not be required. Should a delay pose a danger, not grace period shall be necessary.
12. Structural Alterations by Lessee
12.1 Structural alterations by Lessee, especially remodeling and incorporation of fixtures and fittings, installations, as well as putting bars on windows, may only be carried out with prior written approval by Lessor. If approval is granted by Lessor, Lessee shall be responsible for obtaining all necessary permits. All expenses for structural alterations (including any official fees) shall be paid for by Lessee.
12.2 Installation of transmission devices (e.g. exterior antennae, access cables, etc.) shall require prior approval in writing by Lessor.
12.3 Lessee shall be liable for any damage arising from any construction measures taken by Lessee.
13. Lessee's Liability
13.1 Lessee shall be liable to Lessor for any damage caused to the Leased Premises by Lessee, members of its family and its employees, as well as hired craftsmen, their workers and assistants, delivery personnel, clients and other related persons. Lessee shall be liable, in particular, for any damage due to improper use of high-voltage and low-voltage power lines, bathroom and sanitary installations, sprinkler and heating systems, or failure to close doors or carry out other duties (e.g. lighting, etc.). In such cases it shall not matter whether the party causing the damage is at fault.
13.2 Lessee shall also be liable to Lessor for any damage to any and all buildings, gates, parking facilities and traffic lanes caused by delivery and pickup of merchandise, in particular by its own or other vehicles and not due to normal wear and tear. Section 13.1 sentence 3 shall apply accordingly.
13.3 Lessee shall repair any damage for which it is liable under sections 13.1 and 13.2 immediately. If it does not meet this obligation within the deadline set by Lessor even after receiving written notice, Lessor may have the necessary work done at Lessee's expense. A warning of dismissal by Lessor shall not be required. Should the damage pose a danger or the whereabouts of Lessee be unknown, a written warning and setting of a deadline shall not be required.
13.4 If Lessor is responsible for repairing damage on or in the building or Leased Premises, such damage must be reported to Lessor immediately. If Lessee fails to do so, it shall be liable for any damage due to the delay.
14. Improvements and Structural Alterations by Lessor
14.1 Lessor may carry out improvements and structural alterations for the purpose of expansion and extension of the office and business facilities, of preservation of the building or Leased Premises, of protection from impending damage or of repair of defects or damage without Lessee's consent. This shall also apply to work which, although not necessary, is useful, such as the modernization of the building and Leased Premises. Lessee shall keep the affected sections of the Leased Premises accessible; it may not impede such work being carried out; it shall be required to tolerate the inconveniences, in particular odors, dirt, and noise, caused by the above mentioned measures.
14.2 As far as Lessee's tolerance of the work is concerned, Lessee shall only be entitled to reduce the rent if the work results in substantial interference with its use of the Leased Premises.
15. Yielding of Leased Premises
15.1 The conversions, incorporation of fixtures and fittings and installations carried out by Lessee are only for temporary purposes. Therefore, they do not become part of the building (Section 95 BGB).
15.2 At the termination of the Lease, Lessee shall be required to yield the Leased Premises - subject to regulations to the contrary and irrespective of their condition at the commencement of the Lease - as follows:
a) All removable equipment as well as all fittings installed by Lessee shall be removed;
b) all exterior advertising shall be removed;
c) the leased space is to be turned over in clean and tidy condition;
d) any and all keys in Lessee's possession - even those for lockable fixtures installed by Lessee, shall be turned over to Lessor.
16. Lessor's Access to the Leased Premises
16.1 Lessor or its agents shall have the right to access the Leased Premises any time within Lessee's normal business hours.
16.2 Lessee shall ensure that rooms can also be entered in its absence. If it does not fulfill this obligation, it shall be liable for any and all damage due to undue delay, such as when entry was not possible in case of impending danger.
17. Assignability of Use of Leased Premises
17.1 Subletting or any other assignment of use to third parties by Lessee shall only be permitted with Lessor's prior consent in writing. Lessor's consent must also be obtained regarding the provisions for subletting/assignment of use proposed by Lessee. Section 549 paragraph 1, clause 2 BGB shall not be applied. In case of subletting/assignment of use, Lessee assigns, in advance, the rent it is entitled to receive from the third party, including the security deposit, up to the amount which Lessor is entitled to, as a precaution to Lessor.
17.2 For companies, a change of principal or of a general partner or a change in legal form shall constitute an assignment of use to a third party. Lessee
must immediately report such developments as well as changes in regards to business permits or other important matters affecting the Lease to Lessor in writing.
17.3 In case of the sale of Lessee's entire business or a portion of the business, this Lease Agreement shall be transferred to Lessee's legal successor, if Lessor consents to it in writing.
18. Reconstruction Clause, Business Interruptions
18.1 Should the Leased Premises or shared facilities be totally or vastly destroyed or damaged due to construction errors, fire, explosion, lightning, a storm, an act of God, the effects of war or other circumstances, this Lease Agreement shall only expire after Lessor has declared that it will not rebuild. Insofar as the use of the damaged or destroyed Leased Premises under the Lease Agreement is no longer possible, Lessee's obligation to pay rent rests commencing on the day following the event causing the damage. In case of partial destruction or damage, the obligation to pay rent shall lapse pro rata. After reconstruction has been completed, the provisions regarding handing over and payment of rent shall apply correspondingly.
18.2 Business interruptions within the office and business facilities - for whatever reason - which are beyond Lessor's control shall not affect Lessee's obligation to pay rent as long as those interruptions can be remedied within a reasonable amount of time. Lessor shall have the right to have the office and business facilities vacated during daily business hours for safety reasons and to have access to the site of the office and business facilities cordoned off.
18.3 In cases described in sections 18.1 and 18.2 above, Lessee shall only be entitled to compensation for damages under the provisions set forth in section 19.1. Lessee may only exercise other rights if Lessor is responsible for the business interruption.
19. Lessor's Liability, Insurance
19.1 Lessee shall only be entitled to compensation for damages in case of gross negligence by Lessor or its vicarious agents; such entitlements in cases of gross negligence shall be limited to the type and extent of coverage provided by an adequate liability insurance contract entered into by Lessor.
19.2 Furthermore, in case of a defect in the Leased Property, Lessee may only make a claim for damages if the damage or curtailment of use is substantial. The same shall apply to a reduction in rent, which, in addition,
shall only be permissible if it is announced in writing one month prior to the due date of the affected rent.
19.3 Lessee shall be obligated to purchase the following insurance policies at its expense and to furnish proof of such a purchase upon Lessor's request:
a) fire as well as tap water insurance including coverage for waste water damage to personal property, such as fixtures and materials;
b) liability insurance for personal injury, property and asset damage up to the limits of coverage customary for the line of business Lessee is conducting.
20. House Rules
20.1 In the interest of peaceful coexistence, any interference with the other tenants must be avoided. This shall apply in particular to noise and odors. Lessee shall be liable for any and all damages due to its non-compliance with these rules and must take immediate remedial action in case of a complaint. This shall apply even if Lessee is engaged in a line of business usually associated with noise and odor emissions.
Lessee shall take, at its own expense, all necessary structural and business measures (especially those required by law) to prevent unacceptable emissions, especially emissions of noise and odor, from Lessee's business premises to neighboring areas of the Leased Property. This shall also apply for other areas outside the business premises. If necessary, Lessee shall, upon request by Lessor, install its own exhaust system. Lessee shall be required to keep this system in good working order at all times, to make sure that it complies meets official requirements and regulations and is operating continuously.
20.2 Lessee shall be responsible for the adequate cleaning of its leased space, including, in particular, the facades and/or store window areas, and must ensure adequate ventilation, heating and lighting in its rooms, to the extent that Lessee has control over these matters. It shall be Lessee's duty to clean areas even if they are outside the Leased Property at any time if the dirt has been caused by its business.
If Lessee does not meet these responsibilities in accordance with regulations, Lessor shall have the right to have the dirt removed at Lessee's expense.
20.3 Unauthorized persons shall be prohibited from accessing the roof and the technical rooms.
20.4 Lessee must use the main traffic routes and necessary emergency exits - if need be, according to Lessor's instructions - and keep those as well as the entrances to the buildings, traffic areas, courtyards, passages, stairways, entrances to basements, etc. free of objects of any kind. Sales, presentations of merchandise and the placement of advertising media outside the Leased Property shall only be permitted after Lessor's written consent, which may be revoked at any time, has been obtained in advance.
20.5 Lessee may only park its vehicles in the spaces allocated for this purpose by Lessor. The same shall apply to the vehicles of employees, visitors, and delivery personnel. Lessee must instruct these persons to comply with these provisions. Lessee shall not be entitled to the allotment of such parking spaces; their allocation may be revoked or changed by Lessor at any time. The washing of vehicles on the property shall not be permitted.
20.6 In case of the existence of shared major equipment systems and facilities, such as central heating, elevators, other technical systems, etc., provisions regarding their usage must be complied with and the instructions of the manager or building inspectors must be followed.
20.7 Lessee may make useful changes and amendments to these house rules; it is required to notify Lessor of such changes and amendments in writing.
21. Miscellaneous
21.1 The Owner, DePfa Deutsche Pfandbriefbank AG, assumes the cost for the interior fittings of the leased space Nr. 6, 3rd Floor, approx. 118.83 m2. Owner also awards the contracts for the interior fittings of the leased space.
21.2 not applicable
21.3 Lessee is aware that not all contracts of the tenants located in the office and business facilities have the same term. Lessee may not infer any rights based upon the termination of other leases or the amount of rent payable under such leases.
21.4 Lessor reserves the right to carry out structural alterations outside the Leased Property and make changes regarding the occupancy of the leased spaces. Lessor does not guarantee that certain tenants or trades are represented in the office and business facilities.
21.5 If Lessee changes its mailing address, a statement by Lessor sent to the address last given in writing by Lessee shall be considered received on the day it is posted in the mail (date postmarked).
21.6 If Lessor consists of several persons, they assume joint liability for all debts arising from the Lease Agreement. For a statement by Lessor to be legally valid, it is sufficient if made towards one of the tenants. Statements of intent by one tenant are also binding for the other tenants. Facts leading to a change in tenancy for one tenant have to be accepted by the other tenants as having the same kind of effect on them. 21.7 Lessor shall have the right to transfer its rights and duties under this contract to another company, unless such a transfer jeopardizes the continued proper performance of the contract. Upon Lessor's announcement of such legal succession to Lessee, Lessor ceases, with all its rights and duties, to be a party in the Lease Agreement with Lessee. 21.8 Any protection of Lessee from competition is excluded. 21.9 not applicable 21.10 Lessee consents to data regarding the Lease in connection with the administration of the property being stored on electronic data carriers. When processing such data, Lessor shall comply with the provisions of the German Federal Data Protection Act. |
22. Final Provisions
22.1 The validity of this contract shall not be affected by the invalidity of individual provisions or by gaps in the provisions of the Agreement. An invalid provision or gap in the provision is to be replaced or closed, respectively, by a valid provision which conforms in its meaning and purpose with the deleted or not provided provision as closely as possible.
22.2 Agreements or assurances of any kind which affect the Lease or the Leased Premises shall only be effective if made in writing and if they bare the legally valid signatures of Lessor and Lessee, unless a different wish by the parties to the contract has been clearly expressed. The same applies to changes and amendments as well as the annulment of the contract or the clause mandating that the agreements or assurances be in
writing. Hamburg, dated: 11.30.2000 Hamburg, dated: 11.29.2000 DePfa Verwaltungs- und Controlling GmbH Poppenbutteler Bogen 17, 22399 Hamburg [signature] [signature] ------------------------------------- ----------------------------------- (Lessor) (Lessee) DOMILENS GmbH Holsteiner Chaussee 303 a, 22457 Hamburg Phone: 040/55 98 80-0 Fax: 040/56 98 80-80 |
Exhibit 10.20
After Recording Return To:
Staar Surgical Company
1911 Walker Avenue
Monrovia, California 91016
Attn: John Bily
__________________ [Space Above This Line for Recording Data] __________________
MORTGAGE
DEFINITIONS
Words used in multiple sections of this document are defined below and other words are defined in Sections 3, 11, 13, 18, 20 and 21. Certain rules regarding the usage of words used in this document are also provided in Section 16.
(A) "SECURITY INSTRUMENT" means this document, which is dated July 16, 2004, together with all Riders to this document.
(B) "BORROWER" is PETER J. UTRATA, an individual. Borrower is the mortgagor under this Security Instrument.
(C) "LENDER" is STAAR SURGICAL COMPANY, a Delaware corporation. Lender's address is 1911 Walker Avenue, Monrovia, California 91016. Lender is the mortgagee under this Security Instrument.
(D) "NOTE" means, collectively and individually (i) the promissory note ("Note A") signed by Borrower and dated June 16, 1999, in the face principal amount of $1,258,000.00, and (ii) the promissory note ("Note B") signed by Borrower and dated June 2, 2000, in the face principal amount of $272,500.00. Note A states that Borrower owes Lender One Million Two Hundred Fifty-Eight Thousand Dollars (U.S. $1,258,000.00) plus interest. Borrower has promised to pay the debt evidenced by Note A in full not later than June 15, 2004. (By a Forbearance Agreement dated June 16, 2004 (the "Forbearance Agreement") between Borrower and Lender, Lender agreed to forebear on the exercise of its rights and remedies under the Note and the Pledge Agreement (as defined in the Forbearance Agreement) until March 15, 2005. Note B states the Borrower owes Lender Two Hundred Seventy-Two Thousand Five Hundred Dollars (U.S. $272,500.00) plus interest. Borrower has promised to pay the debt evidenced by Note B in full no later than June 1, 2005.
(E) "PROPERTY" means the property that is described below under the heading "Transfer of Rights in the Property."
(F) "LOAN" means the debt evidenced by the Note, plus interest, any prepayment charges and late charges due under the Note, and all sums due under this Security Instrument, plus interest.
(G) [Intentionally omitted.]
(H) "APPLICABLE LAW" means all controlling applicable federal, state and local statutes, regulations, ordinances and administrative rules and orders (that have the effect of law) as well as all applicable final, non-appealable judicial opinions.
(I) "COMMUNITY ASSOCIATION DUES, FEES, AND ASSESSMENTS" means all dues, fees, assessments and other charges that are imposed on Borrower or the Property by a condominium association, homeowners association or similar organization.
(J) "ELECTRONIC FUNDS TRANSFER" means any transfer of funds, other than a transaction originated by check, draft, or similar paper instrument, which is initiated through an electronic terminal, telephonic instrument, computer, or magnetic tape so as to order, instruct, or authorize a financial institution to debit or credit an account. Such term includes, but is not limited to, point-of-sale transfers, automated teller machine transactions, transfers initiated by telephone, wire transfers, and automated clearinghouse transfers.
(K) [Intentionally omitted.]
(L) "MISCELLANEOUS PROCEEDS" means any compensation, settlement, award of damages, or proceeds paid by any third party (other than insurance proceeds paid under the coverages described in Section 5) for: (i) damage to, or destruction of, the Property; (ii) condemnation or other taking of all or any part of the Property; (iii) conveyance in. lieu of condemnation; or (iv) misrepresentations of, or omissions as to, the value and/or condition of the Property.
(M) "MORTGAGE INSURANCE" means insurance protecting Lender against the nonpayment of, or default on, the Loan.
(N) "PERIODIC PAYMENT" means the regularly scheduled amount due for (i)
principal and interest under the Note, plus (ii) any amounts under Section 3 of
this Security Instrument.
(O) [Intentionally omitted.]
(P) "SUCCESSOR IN INTEREST OF BORROWER" means any party that has taken title to the Property, whether or not that party has assumed Borrower's obligations under the Note and/or this Security Instrument.
TRANSFER OF RIGHTS IN THE PROPERTY
This Security Instrument secures to Lender: (i) the repayment of the Loan, and all renewals, extensions and modifications of the Note; and (ii) the performance of Borrower's covenants and agreements under this Security Instrument and the Note. For this purpose, Borrower does hereby mortgage, grant and convey to Lender, the following described property, which currently has the address of 117 NE Sewalls Road, Stuart, Florida 34995 ("Property Address"):
See Exhibit "A" attached hereto and incorporated herein by this reference.
TOGETHER WITH all the improvements now or hereafter erected on the property, and all easements, appurtenances, and fixtures now or hereafter a part of the property. All replacements and additions shall also be covered by this Security Instrument. All of the foregoing is referred to in this Security Instrument as the "Property."
BORROWER COVENANTS that Borrower is lawfully seized of the estate hereby conveyed and has the right to mortgage, grant and convey the Property and that the Property
is unencumbered, except for encumbrances of record. Borrower warrants and will defend generally the title to the Property against all claims and demands, subject to any encumbrances of record.
THIS SECURITY INSTRUMENT combines uniform covenants for national use and non-uniform covenants with limited variations by jurisdiction to constitute a uniform security instrument covering real property.
UNIFORM COVENANTS. Borrower and Lender covenant and agree as follows:
1. PAYMENT OF PRINCIPAL, INTEREST, ESCROW ITEMS, PREPAYMENT CHARGES, AND LATE CHARGES. Borrower shall pay when due the principal of, and interest on, the debt evidenced by the Note and any prepayment charges and late charges due under the Note. Borrower shall also pay funds for Escrow Items pursuant to Section 3. Payments due under the Note and this Security Instrument shall be made in U.S. currency. However, if any check or other instrument received by Lender as payment under the Note or this Security Instrument is returned to Lender unpaid, Lender may require that any or all subsequent payments due under the Note and this Security Instrument be made in one or more of the following forms, as selected by Lender: (a) cash; (b) money order; (c) certified check, bank check, treasurer's check or cashier's check, provided any such check is drawn upon an institution whose deposits are insured by a federal agency, instrumentality, or entity; or (d) Electronic Funds Transfer.
Payments are deemed received by Lender when received at the location designated in the Note or at such other location as may be designated by Lender in accordance with the notice provisions in Section 15. Lender may return any payment or partial payment if the payment or partial payments are insufficient to bring the Loan current. Lender may accept any payment or partial payment insufficient to bring the Loan current, without waiver of any rights hereunder or prejudice to its rights to refuse such payment or partial payments in the future, but Lender is not obligated to apply such payments at the time such payments are accepted. If each Periodic Payment is applied as of its scheduled due date, then Lender need not pay interest on unapplied funds. Lender may hold such unapplied funds until Borrower makes payment to bring the Loan current. If Borrower does not do so within a reasonable period of time, Lender shall either apply such funds or return them to Borrower. If not applied earlier, such funds will be applied to the outstanding principal balance under the Note immediately prior to foreclosure. No offset or claim which Borrower might have now or in the future against Lender shall relieve Borrower from making payments due under the Note and this Security Instrument or performing the covenants and agreements secured by this Security Instrument.
2. APPLICATION OF PAYMENTS OR PROCEEDS. Except as otherwise described in this Section 2, all payments accepted and applied by Lender shall be applied in the following order of priority:
(a) interest due under the Note; (b) principal due under the Note; (c) amounts due under Section 3. Such payments shall be applied to each Periodic Payment in the order in which it became due. Any remaining amounts shall be applied first to late charges, second to any other amounts due under this Security Instrument, and then to reduce the principal balance of the Note.
If Lender receives a payment from Borrower for a delinquent Periodic Payment which includes a sufficient amount to pay any late charge due, the payment may be applied
to the delinquent payment and the late charge. If more than one Periodic Payment is outstanding, Lender may apply any payment received from Borrower to the repayment of the Periodic Payments if, and to the extent that, each payment can be paid in full. To the extent that any excess exists after the payment is applied to the full payment of one or more Periodic Payments, such excess may be applied to any late charges due. Voluntary prepayments shall be applied first to any prepayment charges and then as described in the Note.
Any application of payments, insurance proceeds, or Miscellaneous Proceeds to principal due under the Note shall not extend or postpone the due date, or change the amount, of the Periodic Payments.
3. FIRST MORTGAGE. This Security Instrument is subordinate to a mortgage in favor of Virtual Bank, a Division of Lydian Private Bank, securing a note in the amount of $1,500,000.00 (the "First Mortgage"). Borrower hereby agrees that the current outstanding principal balance of the indebtedness secured by the First Mortgage does not exceed $1,500,000.00. Borrower further agrees that Borrower shall pay all amounts secured by the First Mortgage when due and perform all of its obligations under the First Mortgage. Any default under the First Mortgage shall constitute a default under this Security Instrument.
4. CHARGES; LIENS. Borrower shall pay all taxes, assessments, charges, fines, and impositions attributable to the Property which can attain priority over this Security Instrument, leasehold payments or ground rents on the Property, if any, and Community Association Dues, Fees, and Assessments, if any. To the extent that these items are Escrow Items, Borrower shall pay them in the manner provided in Section 3.
Borrower shall promptly discharge any lien which has priority over this
Security Instrument unless Borrower: (a) agrees in writing to the payment of the
obligation secured by the lien in a manner acceptable to Lender, but only so
long as Borrower is performing such agreement; (b) contests the lien in good
faith by, or defends against enforcement of the lien in, legal proceedings which
in Lender's opinion operate to prevent the enforcement of the lien while those
proceedings are pending, but only until such proceedings are concluded; or (c)
secures from the holder of the lien an agreement satisfactory to Lender
subordinating the lien to this Security Instrument. If Lender determines that
any part of the Property is subject to a lien which can attain priority over
this Security Instrument, Lender may give Borrower a notice identifying the
lien. Within 10 days of the date on which that notice is given, Borrower shall
satisfy the lien or take one or more of the actions set forth above in this
Section 4.
Lender may require Borrower to pay a one-time charge for a real estate tax verification and/or reporting service used by Lender in connection with this Loan.
5. PROPERTY INSURANCE. Borrower shall keep the improvements now existing or hereafter erected on the Property insured against loss by fire, hazards included within the term "extended coverage," and any other hazards including, but not limited to, earthquakes and floods, for which Lender requires insurance. This insurance shall be maintained in the amounts (including deductible levels) and for the periods that Lender requires. What Lender requires pursuant to the preceding sentences can change during the term of the Loan. The insurance carrier providing the insurance shall be chosen by Borrower subject to Lender's right to disapprove Borrower's choice, which right shall not be exercised unreasonably. Lender may require Borrower to pay, in connection with this Loan, either: (a) a one-time
charge for flood zone determination, certification and tracking services; or (b) a one-time charge for flood zone determination and certification services and subsequent charges each time remappings or similar changes occur which reasonably might affect such determination or certification. Borrower shall also be responsible for the payment of any fees imposed by the Federal Emergency Management Agency in connection with the review of any flood zone determination resulting from an objection by Borrower.
If Borrower fails to maintain any of the coverages described above, Lender may obtain insurance coverage, at Lender's option and Borrower's expense. Lender is under no obligation to purchase any particular type or amount of coverage. Therefore, such coverage shall cover Lender, but might or might not protect Borrower, Borrower's equity in the Property, or the contents of the Property, against any risk, hazard or liability and might provide greater or lesser coverage than was previously in effect. Borrower acknowledges that the cost of the insurance coverage so obtained might significantly exceed the cost of insurance that Borrower could have obtained. Any amounts disbursed by Lender under this Section 5 shall become additional debt of Borrower secured by this Security Instrument. These amounts shall bear interest at the Note rate from the date of disbursement and shall be payable, with such interest, upon notice from Lender to Borrower requesting payment.
All insurance policies required by Lender and renewals of such policies shall be subject to Lender's right to disapprove such policies, shall include a standard mortgage clause, and shall name Lender as mortgagee and/or as an additional loss payee. Lender shall have the right to hold the policies and renewal certificates. If Lender requires, Borrower shall promptly give to Lender all receipts of paid premiums and renewal notices. If Borrower obtains any form of insurance coverage, not otherwise required by Lender, for damage to, or destruction of, the Property, such policy shall include a standard mortgage clause and shall name Lender as mortgagee and/or as an additional loss payee.
In the event of loss, Borrower shall give prompt notice to the insurance carrier and Lender. Lender may make proof of loss if not made promptly by Borrower. Unless Lender and Borrower otherwise agree in writing, any insurance proceeds, whether or not the underlying insurance was required by Lender, shall be applied to restoration or repair of the Property, if the restoration or repair is economically feasible and Lender's security is not lessened. During such repair and restoration period, Lender shall have the right to hold such insurance proceeds until Lender has had an opportunity to inspect such Property to ensure the work has been completed to Lender's satisfaction, provided that such inspection shall be undertaken promptly. Lender may disburse proceeds for the repairs and restoration in a single payment or in a series of progress payments as the work is completed. Unless an agreement is made in writing or Applicable Law requires interest to be paid on such insurance proceeds, Lender shall not be required to pay Borrower any interest or earnings on such proceeds. Fees for public adjusters, or other third parties, retained by Borrower shall not be paid out of the insurance proceeds and shall be the sole obligation of Borrower. If the restoration or repair is not economically feasible or Lender's security would be lessened, the insurance proceeds shall be applied to the sums secured by this Security Instrument, whether or not then due, with the excess, if any, paid to Borrower. Such insurance proceeds shall be applied in the order provided for in Section 2.
If Borrower abandons the Property, Lender may file, negotiate and settle any available insurance claim and related matters. If Borrower does not respond within 30 days
to a notice from Lender that the insurance carrier has offered to settle a claim, then Lender may negotiate and settle the claim. The 30-day period will begin when the notice is given. In either event, or if Lender acquires the Property under Section 22 or otherwise, Borrower hereby assigns to Lender (a) Borrower's rights to any insurance proceeds in an amount not to exceed the amounts unpaid under the Note or this Security Instrument, and (b) any other of Borrower's rights (other than the right to any refund of unearned premiums paid by Borrower) under all insurance policies covering the Property, insofar as such rights are applicable to the coverage of the Property. Lender may use the insurance proceeds either to repair or restore the Property or to pay amounts unpaid under the Note or this Security Instrument, whether or not then due.
6. [Intentionally omitted.]
7. PRESERVATION, MAINTENANCE AND PROTECTION OF THE PROPERTY; INSPECTIONS. Borrower shall not destroy, damage or impair the Property, allow the Property to deteriorate or commit waste on the Property. Whether or not Borrower is residing in the Property, Borrower shall maintain the Property in order to prevent the Property from deteriorating or decreasing in value due to its condition. Unless it is determined pursuant to Section 5 that repair or restoration is not economically feasible, Borrower shall promptly repair the Property if damaged to avoid further deterioration or damage. If insurance or condemnation proceeds are paid in connection with damage to, or the taking of, the Property, Borrower shall be responsible for repairing or restoring the Property only if Lender has released proceeds for such purposes. Lender may disburse proceeds for the repairs and restoration in a single payment or in a series of progress payments as the work is completed. If the insurance or condemnation proceeds are not sufficient to repair or restore the Property, Borrower is not relieved of Borrower's obligation for the completion of such repair or restoration.
Lender or its agent may make reasonable entries upon and inspections of the Property. If it has reasonable cause, Lender may inspect the interior of the improvements on the Property. Lender shall give Borrower notice at the time of or prior to such an interior inspection specifying such reasonable cause.
8. [Intentionally omitted.]
9. PROTECTION OF LENDER'S INTEREST IN THE PROPERTY AND RIGHTS UNDER THIS SECURITY INSTRUMENT. If (a) Borrower fails to perform the covenants and agreements contained in this Security Instrument, (b) there is a legal proceeding that might significantly affect Lender's interest in the Property and/or rights under this Security Instrument (such as a proceeding in bankruptcy, probate, for condemnation or forfeiture, for enforcement of a lien which may attain priority over this Security Instrument or to enforce laws or regulations), or (c) Borrower has abandoned the Property, then Lender may do and pay for whatever is reasonable or appropriate to protect Lender's interest in the Property and rights under this Security Instrument, including protecting and/or assessing the value of the Property, and securing and/or repairing the Property. Lender's actions can include, but are not limited to: (a) paying any sums secured by a lien which has priority over this Security Instrument; (b) appearing in court; and (c) paying reasonable attorneys' fees to protect its interest in the Property and/or rights under this Security Instrument, including its secured position in a bankruptcy proceeding. Securing the Property includes, but is not limited to, entering the Property to make repairs, change locks, replace or board up doors and windows, drain water from pipes, eliminate building or other code violations or dangerous conditions, and have
utilities turned on or off. Although Lender may take action under this Section 9, Lender does not have to do so and is not under any duty or obligation to do so. It is agreed that Lender incurs no liability for not taking any or all actions authorized under this Section 9.
Any amounts disbursed by Lender under this Section 9 shall become additional debt of Borrower secured by this Security Instrument. These amounts shall bear interest at the Note rate from the date of disbursement and shall be payable, with such interest, upon notice from Lender to Borrower requesting payment.
If this Security Instrument is on a leasehold, Borrower shall comply with all the provisions of the lease. If Borrower acquires fee title to the Property, the leasehold and the fee title shall not merge unless Lender agrees to the merger in writing.
10. [Intentionally omitted.]
11. ASSIGNMENT OF MISCELLANEOUS PROCEEDS; FORFEITURE. All Miscellaneous Proceeds are hereby assigned to and shall be paid to Lender.
If the Property is damaged, such Miscellaneous Proceeds shall be applied to restoration or repair of the Property, if the restoration or repair is economically feasible and Lender's security is not lessened. During such repair and restoration period, Lender shall have the right to hold such Miscellaneous Proceeds until Lender has had an opportunity to inspect such Property to ensure the work has been completed to Lender's satisfaction, provided that such inspection shall be undertaken promptly. Lender may pay for the repairs and restoration in a single disbursement or in a series of progress payments as the work is completed. Unless an agreement is made in writing or Applicable Law requires interest to be paid on such Miscellaneous Proceeds, Lender shall not be required to pay Borrower any interest or earnings on such Miscellaneous Proceeds. If the restoration or repair is not economically feasible or Lender's security would be lessened, the Miscellaneous Proceeds shall be applied to the sums secured by this Security Instrument, whether or not then due, with the excess, if any, paid to Borrower. Such Miscellaneous Proceeds shall be applied in the order provided for in Section 2.
In the event of a total taking, destruction, or loss in value of the Property, the Miscellaneous Proceeds shall be applied to the sums secured by this Security Instrument, whether or not then due, with the excess, if any, paid to Borrower.
In the event of a partial taking, destruction, or loss in value of the Property in which the fair market value of the Property immediately before the partial taking, destruction, or loss in value is equal to or greater than the amount of the sums secured by this Security Instrument immediately before the partial taking, destruction, or loss in value, unless Borrower and Lender otherwise agree in writing, the sums secured by this Security Instrument shall be reduced by the amount of the Miscellaneous Proceeds multiplied by the following fraction: (a) the total amount of the sums secured immediately before the partial taking, destruction, or loss in value divided by (b) the fair market value of the Property immediately before the partial taking, destruction, or loss in value. Any balance shall be paid to Borrower.
In the event of a partial taking, destruction, or loss in value of the Property in which the fair market value of the Property immediately before the partial taking, destruction, or loss in value is less than the amount of the sums secured immediately before the partial taking, destruction, or loss in value, unless Borrower and Lender otherwise agree in writing,
the Miscellaneous Proceeds shall be applied to the sums secured by this Security Instrument whether or not the sums are then due.
If the Property is abandoned by Borrower, or if, after notice by Lender to Borrower that the Opposing Party (as defined in the next sentence) offers to make an award to settle a claim for damages, Borrower fails to respond to Lender within 30 days after the date the notice is given, Lender is authorized to collect and apply the Miscellaneous Proceeds either to restoration or repair of the Property or to the sums secured by this Security Instrument, whether or not then due. "Opposing Party" means the third party that owes Borrower Miscellaneous Proceeds or the party against whom Borrower has a right of action in regard to Miscellaneous Proceeds.
Borrower shall be in default if any action or proceeding, whether civil or criminal, is begun that, in Lender's judgment, could result in forfeiture of the Property or other material impairment of Lender's interest in the Property or rights under this Security Instrument. Borrower can cure such a default and, if acceleration has occurred, reinstate as provided in Section 19, by causing the action or proceeding to be dismissed with a ruling that, in Lender's judgment, precludes forfeiture of the Property or other material impairment of Lender's interest in the Property or rights under this Security Instrument. The proceeds of any award or claim for damages that are attributable to the impairment of Lender's interest in the Property are hereby assigned and shall be paid to Lender.
All Miscellaneous Proceeds that are not applied to restoration or repair of the Property shall be applied in the order provided for in Section 2.
12. BORROWER NOT RELEASED; FORBEARANCE BY LENDER NOT A WAIVER. Extension of the time for payment or modification of amortization of the sums secured by this Security Instrument granted by Lender to Borrower or any Successor in Interest of Borrower shall not operate to release the liability of Borrower or any Successors in Interest of Borrower. Lender shall not be required to commence proceedings against any Successor in Interest of Borrower or to refuse to extend time for payment or otherwise modify amortization of the sums secured by this Security Instrument by reason of any demand made by the original Borrower or any Successors in Interest of Borrower. Any forbearance by Lender in exercising any right or remedy including, without limitation, Lender's acceptance of payments from third persons, entities or Successors in Interest of Borrower or in amounts less than the amount then due, shall not be a waiver of or preclude the exercise of any right or remedy.
13. JOINT AND SEVERAL LIABILITY; CO-SIGNERS; SUCCESSORS AND ASSIGNS BOUND. Borrower covenants and agrees that Borrower's obligations and liability shall be joint and several. However, any Borrower who co-signs this Security Instrument but does not execute the Note (a "co-signer"):
(a) is co-signing this Security Instrument only to mortgage, grant and convey the co-signer's interest in the Property under the terms of this Security Instrument; (b) is not personally obligated to pay the sums secured by this Security Instrument; and (c) agrees that Lender and any other Borrower can agree to extend, modify, forbear or make any accommodations with regard to the terms of this Security Instrument or the Note without the co-signer's consent.
Subject to the provisions of Section 18, any Successor in Interest of Borrower who assumes Borrower's obligations under this Security Instrument in writing, and is approved by Lender, shall obtain all of Borrower's rights and benefits under this Security Instrument. Borrower shall not be released from Borrower's obligations and liability under this Security
Instrument unless Lender agrees to such release in writing. The covenants and agreements of this Security Instrument shall bind (except as provided in Section 20) and benefit the successors and assigns of Lender.
14. LOAN CHARGES. Lender may charge Borrower fees for services performed in connection with Borrower's default, for the purpose of protecting Lender's interest in the Property and rights under this Security Instrument, including, but not limited to, attorneys' fees, property inspection and valuation fees. In regard to any other fees, the absence of express authority in this Security Instrument to charge a specific fee to Borrower shall not be construed as a prohibition on the charging of such fee. Lender may not charge fees that are expressly prohibited by this Security Instrument or by Applicable Law.
If the Loan is subject to a law which sets maximum loan charges, and that law is finally interpreted so that the interest or other loan charges collected or to be collected in connection with the Loan exceed the permitted limits, then: (a) any such loan charge shall be reduced by the amount necessary to reduce the charge to the permitted limit; and (b) any sums already collected from Borrower which exceeded permitted limits will be refunded to Borrower. Lender may choose to make this refund by reducing the principal owed under the Note or by making a direct payment to Borrower. If a refund reduces principal, the reduction will be treated as a partial prepayment without any prepayment charge (whether or not a prepayment charge is provided for under the Note). Borrower's acceptance of any such refund made by direct payment to Borrower will constitute a waiver of any right of action Borrower might have arising out of such overcharge.
15. NOTICES. All notices given by Borrower or Lender in connection with this Security Instrument must be in writing. Any notice to Borrower in connection with this Security Instrument shall be deemed to have been given to Borrower when mailed by first class mail or when actually delivered to Borrower's notice address if sent by other means. Notice to any one Borrower shall constitute notice to all Borrowers unless Applicable Law expressly requires otherwise. The notice address shall be the Property Address unless Borrower has designated a substitute notice address by notice to Lender. Borrower shall promptly notify Lender of Borrower's change of address. If Lender specifies a procedure for reporting Borrower's change of address, then Borrower shall only report a change of address through that specified procedure. There may be only one designated notice address under this Security Instrument at any one time. Any notice to Lender shall be given by delivering it or by mailing it by first class mail to Lender's address stated herein unless Lender has designated another address by notice to Borrower. Any notice in connection with this Security Instrument shall not be deemed to have been given to Lender until actually received by Lender. If any notice required by this Security Instrument is also required under Applicable Law, the Applicable Law requirement will satisfy the corresponding requirement under this Security Instrument.
16. GOVERNING LAW; SEVERABILITY; RULES OF CONSTRUCTION. This Security Instrument shall be governed by federal law and the law of the jurisdiction in which the Property is located. All rights and obligations contained in this Security Instrument are subject to any requirements and limitations of Applicable Law. Applicable Law might explicitly or implicitly allow the parties to agree by contract or it might be silent, but such silence shall not be construed as a prohibition against agreement by contract. In the event that any provision or clause of this Security Instrument or the Note conflicts with Applicable
Law, such conflict shall not affect other provisions of this Security Instrument or the Note which can be given effect without the conflicting provision.
As used in this Security Instrument: (a) words of the masculine gender shall mean and include corresponding neuter words or words of the feminine gender; (b) words in the singular shall mean and include the plural and vice versa; and (c) the word "may" gives sole discretion without any obligation to take any action.
17. BORROWER'S COPY. Borrower shall be given one copy of the Note and of this Security Instrument.
18. TRANSFER OF THE PROPERTY OR A BENEFICIAL INTEREST IN BORROWER. As used in this Section 18, "Interest in the Property" means any legal or beneficial interest in the Property, including, but not limited to, those beneficial interests transferred in a bond for deed, contract for deed, installment sales contract or escrow agreement, the intent of which is the transfer of title by Borrower at a future date to a purchaser.
If all or any part of the Property or any Interest in the Property is sold or transferred (or if Borrower is not a natural person and a beneficial interest in Borrower is sold or transferred) without Lender's prior written consent, Lender may require immediate payment in full of all sums secured by this Security Instrument. However, this option shall not be exercised by Lender if such exercise is prohibited by Applicable Law.
If Lender exercises this option, Lender shall give Borrower notice of acceleration. The notice shall provide a period of not less than 30 days from the date the notice is given in accordance with Section 15 within which Borrower must pay all sums secured by this Security Instrument. If Borrower fails to pay these sums prior to the expiration of this period, Lender may invoke any remedies permitted by this Security Instrument without further notice or demand on Borrower.
19. BORROWER'S RIGHT TO REINSTATE AFTER ACCELERATION. If Borrower meets certain conditions, Borrower shall have the right to have enforcement of this Security Instrument discontinued at any time prior to the earliest of: (a) five days before sale of the Property pursuant to any power of sale contained in this Security Instrument; (b) such other period as Applicable Law might specify for the termination of Borrower's right to reinstate; or (c) entry of a judgment enforcing this Security Instrument. Those conditions are that Borrower: (a) pays Lender all sums which then would be due under this Security Instrument and the Note as if no acceleration had occurred; (b) cures any default of any other covenants or agreements; (c) pays all expenses incurred in enforcing this Security Instrument, including, but not limited to, reasonable attorneys' fees, property inspection and valuation fees, and other fees incurred for the purpose of protecting Lender's interest in the Property and rights under this Security Instrument; and (d) takes such action as Lender may reasonably require to assure that Lender's interest in the Property and rights under this Security Instrument, and Borrower's obligation to pay the sums secured by this Security Instrument, shall continue unchanged. Lender may require that Borrower pay such reinstatement sums and expenses in one or more of the following forms, as selected by Lender: (a) cash; (b) money order; (c) certified check, bank check, treasurer's check or cashier's check, provided any such check is drawn upon an institution whose deposits are insured by a federal agency, instrumentality or entity; or (d) Electronic Funds Transfer. Upon reinstatement by Borrower, this Security Instrument and obligations secured hereby shall
remain fully effective as if no acceleration had occurred. However, this right to reinstate shall not apply in the case of acceleration under Section 18.
20. SALE OF NOTE; NOTICE OF GRIEVANCE. The Note or a partial interest in the Note (together with this Security Instrument) can be sold one or more times without prior notice to Borrower.
Neither Borrower nor Lender may commence, join, or be joined to any judicial action (as either an individual litigant or the member of a class) that arises from the other party's actions pursuant to this Security Instrument or that alleges that the other party has breached any provision of, or any duty owed by reason of, this Security Instrument, until such Borrower or Lender has notified the other party (with such notice given in compliance with the requirements of Section 15) of such alleged breach and afforded the other party hereto a reasonable period after the giving of such notice to take corrective action. If Applicable Law provides a time period which must elapse before certain action can be taken, that time period will be deemed to be reasonable for purposes of this paragraph. The notice of acceleration and opportunity to cure given to Borrower pursuant to Section 22 and the notice of acceleration given to Borrower pursuant to Section 18 shall be deemed to satisfy the notice and opportunity to take corrective action provisions of this Section 20.
21. HAZARDOUS SUBSTANCES. As used in this Section 21: (a) "Hazardous
Substances" are those substances defined as toxic or hazardous substances,
pollutants, or wastes by Environmental Law and the following substances:
gasoline, kerosene, other flammable or toxic petroleum products, toxic
pesticides and herbicides, volatile solvents, materials containing asbestos or
formaldehyde, and radioactive materials; (b) "Environmental Law" means federal
laws and laws of the jurisdiction where the Property is located that relate to
health, safety or environmental protection; (c) "Environmental Cleanup" includes
any response action, remedial action, or removal action, as defined in
Environmental Law; and (d) an "Environmental Condition" means a condition that
can cause, contribute to, or otherwise trigger an Environmental Cleanup.
Borrower shall not cause or permit the presence, use, disposal, storage, or release of any Hazardous Substances, or threaten to release any Hazardous Substances, on or in the Property. Borrower shall not do, nor allow anyone else to do, anything affecting the Property (a) that is in violation of any Environmental Law, (b) which creates an Environmental Condition, or (c) which, due to the presence, use, or release of a Hazardous Substance, creates a condition that adversely affects the value of the Property. The preceding two sentences shall not apply to the presence, use, or storage on the Property of small quantities of Hazardous Substances that are generally recognized to be appropriate to normal residential uses and to maintenance of the Property (including, but not limited to, hazardous substances in consumer products).
Borrower shall promptly give Lender written notice of(a) any investigation, claim, demand, lawsuit or other action by any governmental or regulatory agency or private party involving the Property and any Hazardous Substance or Environmental Law of which Borrower has actual knowledge, (b) any Environmental Condition, including but not limited to, any spilling, leaking, discharge, release or threat of release of any Hazardous Substance, and (c) any condition caused by the presence, use or release of a Hazardous Substance which adversely affects the value of the Property. If Borrower learns, or is notified by any governmental or regulatory authority, or any private party, that any removal or other
remediation of any Hazardous Substance affecting the Property is necessary, Borrower shall promptly take all necessary remedial actions in accordance with Environmental Law. Nothing herein shall create any obligation on Lender for an Environmental Cleanup.
NON-UNIFORM COVENANTS. Borrower and Lender further covenant and agree as
follows: 22. ACCELERATION; REMEDIES. LENDER SHALL GIVE NOTICE TO BORROWER PRIOR
TO ACCELERATION FOLLOWING BORROWER'S BREACH OF ANY COVENANT OR AGREEMENT IN THIS
SECURITY INSTRUMENT (BUT NOT PRIOR TO ACCELERATION UNDER SECTION 18 UNLESS
APPLICABLE LAW PROVIDES OTHERWISE). THE NOTICE SHALL SPECIFY: (a) THE DEFAULT;
(b) THE ACTION REQUIRED TO CURE THE DEFAULT; (c) A DATE, NOT LESS THAN 30 DAYS
FROM THE DATE THE NOTICE IS GIVEN TO BORROWER, BY WHICH THE DEFAULT MUST BE
CURED; AND (d) THAT FAILURE TO CURE THE DEFAULT ON OR BEFORE THE DATE SPECIFIED
IN THE NOTICE MAY RESULT IN ACCELERATION OF THE SUMS SECURED BY THIS SECURITY
INSTRUMENT, FORECLOSURE BY JUDICIAL PROCEEDING AND SALE OF THE PROPERTY. THE
NOTICE SHALL FURTHER INFORM BORROWER OF THE RIGHT TO REINSTATE AFTER
ACCELERATION AND THE RIGHT TO ASSERT IN THE FORECLOSURE PROCEEDING THE
NONEXISTENCE OF A DEFAULT OR ANY OTHER DEFENSE OF BORROWER TO ACCELERATION AND
FORECLOSURE. IF THE DEFAULT IS NOT CURED ON OR BEFORE THE DATE SPECIFIED IN THE
NOTICE, LENDER AT ITS OPTION MAY REQUIRE IMMEDIATE PAYMENT IN FULL OF ALL SUMS
SECURED BY THIS SECURITY INSTRUMENT WITHOUT FURTHER DEMAND AND MAY FORECLOSE
THIS SECURITY INSTRUMENT BY JUDICIAL PROCEEDING. LENDER SHALL BE ENTITLED TO
COLLECT ALL EXPENSES INCURRED IN PURSUING THE REMEDIES PROVIDED IN THIS SECTION
22, INCLUDING, BUT NOT LIMITED TO, REASONABLE ATTORNEYS' FEES AND COSTS OF TITLE
EVIDENCE.
23. RELEASE. Upon payment of all sums secured by this Security Instrument, Lender shall release this Security Instrument. Borrower shall pay any recordation costs. Lender may charge Borrower a fee for releasing this Security Instrument, but only if the fee is paid to a third party for services rendered and the charging of the fee is permitted under Applicable Law.
24. ATTORNEYS' FEES. As used in this Security Instrument and the Note, attorneys' fees shall include those awarded by an appellate court and any attorneys' fees incurred in a bankruptcy proceeding.
25. JURY TRIAL WAIVER. The Borrower hereby waives any right to a trial by jury in any action, proceeding, claim, or counterclaim, whether in contract or tort, at law or in equity, arising out of or in any way related to this Security Instrument or the Note.
BY SIGNING BELOW, Borrower accepts and agrees to the terms and covenants contained in this Security Instrument and in any Rider executed by Borrower and recorded with it.
Signed, sealed and delivered in the presence of:
Borrower: Witness: /s/ Christi Murphy /s/ Peter J. Utrata ------------------ ------------------------------ Peter J. Utrata, an individual |
__________________ [SPACE BELOW THIS LINE FOR ACKNOWLEDGMENT] __________________
STATE OF CALIFORNIA ) ) ss. COUNTY OF _____________ ) |
On 7/21/04, before me, Lisa Reynolds, a Notary Public in and for said County and State, personally appeared Peter J. Utrata, personally known to me (or proved to me on the basis of satisfactory evidence) to be the person whose name is subscribed to the within instrument, and acknowledged to me that he executed the same in his authorized capacity, and that by his signature on the instrument the person, or the entity upon behalf of which the person acted, executed the instrument. WITNESS my hand and official seal.
/s/ Lisa M. Reynolds ------------------------------ Signature of Notary Public |
[SEAL]
EXHIBIT A
LEGAL DESCRIPTION OF PROPERTY
All that real property in the City of Stuart, Martin County, Florida described as follows:
Lot 6 Twin Rivers (less easterly 2" right of way per D/R1096/1064) PB 2, Page 62.
Assessor's Parcel No.: 36-37-41-007-000-00060-2.
EXHIBIT 10.21
FORBEARANCE AGREEMENT
This FORBEARANCE AGREEMENT (this "Agreement") is made and entered into as of the 22nd day of July, 2004, by and between Peter J. Utrata, M.D., an individual ("Borrower") and STAAR Surgical Company, a Delaware corporation ("Lender") with reference to the following facts:
RECITALS
A. Borrower has executed a Promissory Note (the "Note") in favor of Lender in the original principal amount of One Million Two Hundred Fifty-Eight Thousand Dollars ($1,258,000).
B. Borrower has pledged to Lender the interest of Borrower in certain common stock pursuant to the Pledge Agreement (the "Pledge Agreement") dated as of June 16, 1999, for the purpose of securing payment of the Note.
C. Under the Note, the entire unpaid principal balance plus accrued interest was due on June 15, 2004.
D. Borrower failed to pay the amounts due under the Note when due.
E. Lender and Borrower are willing to enter into this Agreement on the terms and conditions set forth herein.
AGREEMENT
1. Defined Terms. Capitalized terms used but not defined herein shall have the meanings set forth in the Pledge Agreement.
2. Agreement of Forbearance. Subject to all of the terms and provisions contained in this Agreement, the Lender agrees to forbear in the exercise of any rights or remedies it may have under the Note and the Pledge Agreement until March 15, 2005 (the "Forbearance Period").
3. Initial Repayment. Borrower agrees that, in consideration of Lender's agreement to enter into this Forbearance Agreement, on or before July 30, 2004 Borrower shall pay to Lender $150,000 (the "Initial Repayment"), to be applied first to repayment of unpaid interest, and second to reduction of the principal balance of the Note.
4. Payment of Principal and Interest. All obligations of Borrower to Lender under the Note shall become immediately due and payable, and Borrower shall pay the Principal Amount and all accrued and unpaid interest on the Principal Amount and all
other indebtedness due under the Note, on the earlier to occur of (a) July 1, 2004, if Borrower has not prior to that date delivered to Lender the Initial Repayment, (b) the first date after the date of the execution of this Forbearance Agreement on which the closing bid price for STAAR common stock on the Nasdaq National Market (or on such other stock exchange or quotation system where STAAR's common stock principally trades at the time) (the "Closing Price") is, and has been for twenty (20) consecutive trading days, [$13.00] or greater (the "Market Settlement Date"), or (c) the end of the Forbearance Period. If the date set for payment under this Note falls on a Saturday, Sunday, or holiday recognized by either the United States of America or the State of California, payment of this Note shall be due on the next business day.
5. Company Right of Redemption. The Lender may at any time request that on the Market Settlement Date the Borrower surrender some or all of its pledged shares to the Lender in lieu of some or all of the cash repayment of Borrower's obligation under the Note. If so requested, the Borrower shall surrender the requested shares on the Market Settlement Date (or an earlier date at the election of the Borrower) and the Borrower's indebtedness under the Note shall be reduced in an amount equal to the number of shares so surrendered multiplied by the Closing Price on the date of surrender. The maximum number of shares of Common Stock that the Borrower may be required to surrender shall be the quotient resulting when the total amount of the Borrower's obligations under the Note is divided by the closing Price on the Market Settlement Date.
6. Reaffirmation and Ratification. Borrower hereby reaffirms, ratifies and confirms its obligations under the Note and Pledge Agreement and acknowledges that all of the terms and provisions of the Pledge Agreement and Note remain in full force and effect.
7. Further Assurances. Each of the parties hereto shall, at the request of the other party hereto, deliver to the requesting party all further documents or other assurances as may reasonably be necessary or desirable in connection with this Agreement.
8. Integration. This Agreement constitutes the entire agreement of the parties in connection with the subject matter hereof and cannot be changed or terminated orally. All prior agreements, understandings, representations, warranties and negotiations regarding the subject matter hereof, if any, are merged into this Agreement.
9. Counterparts. This Agreement may be executed in multiple counterparts, each of which when so executed and delivered shall be deemed an original, and all of which, taken together, shall constitute but one and the same agreement.
10. Attorney's Fees. Borrower acknowledges and agrees that all
attorney's fees and expenses incurred in connection with the negotiation and
preparation of this Agreement shall be the responsibility of Borrower under
Section 10 of the Note and that such fees and expenses shall be added to the
obligations of Borrower to Lender under the Note.
11. Governing Law. This Agreement shall be governed by and construed to be in accordance with the internal laws of the State of California.
WHEREFORE, the parties hereto have executed this Forbearance Agreement as of the date first set forth above.
Borrower:
/s/ Peter J. Utrata, M.D. ----------------------------------- Peter J. Utrata, M.D. |
Lender:
STAAR SURGICAL COMPANY
1911 Walker Avenue Monrovia,
California 91016
By: /s/ John Bily ------------------------------- Name: John Bily ------------------------------ Title: CFO ----------------------------- |
EXHIBIT 10.24
STOCK OPTION CERTIFICATE
This Stock Option Certificate is entered into between STAAR Surgical Company, a Delaware corporation (the "Company"), whose principal executive office is located at 1911 Walker Avenue, Monrovia, California 91016, and DAVID BAILEY (the "Recipient") whose address is 1911 Walker Avenue, Monrovia, California 91016, pursuant to that certain 1998 STAAR Surgical Company Stock Plan (the "Plan") adopted by the Board of Directors on April 17, 1998 and approved by the shareholders on May 29, 1998.
1. GRANT OF OPTION. This Stock Option Certificate certifies that the Company has granted to the Recipient, pursuant to the terms of the Plan, an option (the "Option") to purchase, in whole or in part, one hundred and fifty thousand (150,000) shares of the Company's voting common stock, par value $.01 (the "Common Stock") (collectively and severally, the "Option Shares"), at the price of three dollars and thirty-five cents ($3.35) per Option Share (the "Option Price"), subject to the following terms and conditions. The date of this grant is August 9, 2001 (the "Grant Date").
2. PLAN; PLAN SUMMARY. Subject to the terms of this Stock Option Certificate, the Recipient's rights to purchase the Option Shares are governed by the Plan, the terms of which are incorporated herein by this reference. Capitalized terms used in this Stock Option Certificate but not defined herein shall have the meanings ascribed to them in the Plan.
3. CHARACTER OF OPTION. This Option (i) is [__] a Non-Qualified Option or
(ii) is [X] an Incentive Option.
4. CAPACITY OF RECIPIENT. This Option is granted to the Recipient in the Recipient's capacity as (i) [X] an employee, (ii) [__] a director, or (iii) [__] a consultant.
5. EXPIRATION OF OPTION. The right to exercise the Options granted by this Stock Option Certificate shall expire and be null and void and of no further force or effect to the extent not exercised by 5:00 p.m. Pacific Time, on the 8th day of August, 2011 (the "Option Expiration Date"). Nothwithstanding the foregoing, to the extent the Option is not fully vested, the right to exercise the Option shall be subject to earlier expiration as provided in Article X of the Plan.
6. EXERCISE VESTING CONDITIONS. The Option Shares are subject to Article V, Section 5.05 of the Plan and to the following vesting schedule:
Cumulative Vested Percentage of Date Shares -------------- ----------------- August 9, 2001 16.67% August 9, 2002 33.33% August 9, 2003 50% August 9, 2004 66.67% August 9, 2005 100% |
The above vesting schedule will be accelerated according to the Recipient's achievement of certain goals and objectives as stated below:
(i) the right to purchase twenty-five thousand (25,000) Option Shares shall vest immediately upon completion of the implant of four hundred (400) implantable contact lenses (ICLs) in Canada, so long as such implants are completed by March 31, 2002;
(ii) the right to purchase twenty-five thousand (25,000) Option Shares shall vest immediately upon completion of the implant of three thousand (3,000) AquaFlow glaucoma devices worldwide, so long as such implants are completed by March 31, 2002;
(iii) the right to purchase twenty-five thousand (25,000) Option Shares shall vest immediately upon agreement with banks, funds or other lenders to refinance the business to the satisfaction of the Board of Directors;
(iv) the right to purchase twenty-five thousand (25,000) Option Shares shall vest immediately upon execution of a license agreement between the Corporation and a third party in respect of current technology of STAAR (such as the WAVE(TM) Phacoemulsification System or between the Corporation and a third party for production of the Corporation's silicone IOL); and
(v) the right to purchase twenty-five thousand (25,000) Option Shares shall vest immediately upon resolution of the dispute pending on August 9, 2001 between the Corporation and Canon-STAAR Company, Inc.
7. MANNER OF EXERCISE AND PAYMENT. This Option shall be exercised by delivery of this Option Certificate to the Secretary of the Company, together with:
(a) A Consent of Spouse (as such consent is defined in the Plan) from the spouse of the Recipient, if any, duly signed by such spouse; and
(b) Full payment for the Option Shares to be purchased in goods funds (in U.S. dollars) by cash or check or through a "same day sale" commitment from the Recipient and a broker-dealer that is a member of the National Association of Securities Dealers (an "NASD Dealer") whereby the Recipient irrevocably elects to exercise the Option and to sell a portion of the Option Shares so purchased to pay for the Option Price, and whereby the NASD Dealer irrevocably commits upon receipt of such Option Shares to forward the Option Price directly to the Company.
8. FORFEITURE; VESTING CONDITIONS. The Option Shares Subject to Article V,
Section 5.05 of the Plan and to the vesting schedule set forth above are subject
to Article X of the Plan and to the forfeiture provisions included therein
relating to the Recipient's continued performance of services in the capacity
indicated above; provided, however, that the vesting schedule and forfeiture
provisions of that certain Employment Agreement entered into by and between the
Recipient and the Company on December 20,
2000.
9. VESTING ON CHANGE OF CONTROL. Any unvested Option Shares shall immediately vest upon the occurrence of a Change In Control or an Approved Corporate Transaction.
10. MISCELLANEOUS.
(a) PREPARATION OF STOCK OPTION CERTIFICATE. This Stock Option Certificate was prepared by the Company or its legal counsel solely on behalf of the Company. It is acknowledged by the Recipient that he or she was not represented by the Company or any of its officers, directors, employees or agents (including the Company's legal counsel) in connection with the transaction contemplated by this Stock Option Certificate, and that the Recipient had separate and independent advice of counsel. In light of the foregoing it is acknowledged by the Recipient that the Company shall not be construed to be solely responsible for the drafting hereof, and that any ambiguity in the Plan or this Stock Option Certificate, or the interpretation thereof or hereof, shall not be construed against the Company as the alleged draftsman of this Stock Option Certificate.
(b) INTERPRETATION.
(i) Entire Agreement/No Collateral Representations. The Recipient acknowledges and agrees that this Stock Option Certificate, together with and subject to the Plan: (1) is the final, complete and exclusive statement of the agreement of the parties with respect to the subject matter hereof; (2) supersedes any prior or contemporaneous agreements or understandings of any kind, oral or written (collectively and severally, the "prior agreements"), and that any such prior agreements are of no force or effect except as expressly set forth herein; and (3) may not be varied, supplemented or contradicted by evidence of prior agreements, or by evidence of subsequent oral agreements.
(ii) Amendment; Waiver. Except as expressly otherwise provided herein, neither this Stock Option Certificate nor any of its terms may be amended, supplemented, discharged or terminated (other than by performance), except as provided in the Plan or by a written instrument or instruments signed by all of the parties to this Stock Option Certificate. No waiver of any acts or obligations hereunder shall be effective unless such waiver shall be in a written instrument or instruments signed by each party claimed to have given or consented to such waiver and each party affected by such waiver.
(iii) Severability. If any term or provision of this Stock Option Certificate or the application thereof to any person or circumstance shall, to any extent, be determined to be invalid, illegal or unenforceable under present or future laws effective during the term of this Stock Option Certificate, then, and in that event: (A) the performance of the offending term or provision (but only to the extent its application is invalid, illegal or unenforceable) shall be excused as if it had never been incorporated into this Stock Option Certificate, and, in lieu of such excused provision, there shall be added a provision as similar in terms and amount to such excused provision as may be possible and be legal, valid and enforceable, and (B) the remaining part of this Stock Option Certificate (including the application of the offending term or provision to persons or circumstances other than those as to which it is held invalid, illegal or unenforceable) shall not be affected thereby and shall continue in full force and effect to the fullest extent
provided by law.
(iv) No Reliance Upon Prior Representation. The Recipient acknowledges that neither the Company nor any of its officers, directors, employees or agents have made any oral representation or promise which would induce the Recipient prior to executing this Stock Option Certificate to change the Recipient's position to the Recipient's detriment, partially perform, or part with value in reliance upon such representation or promise; the Recipient acknowledges that he or she has taken such action at its own risk; and the Recipient represents that he or she has not so changed his or her position, performed or parted with value prior to the time of his or her execution of this Stock Option Certificate.
(c) ENFORCEMENT. This Stock Option Certificate and the rights and remedies of each party arising out of or relating to this Stock Option Certificate shall be solely governed in accordance with the laws (without regard to the conflicts of law principles thereof) of the state of Delaware.
(d) SUCCESSORS AND ASSIGNS. The Recipient may not assign his rights or benefits or delegate any of his duties or obligations under this Stock Option Certificate, in whole or in part, without the prior written consent of the Company, except pursuant to the terms of the Plan. Subject to the foregoing, all of the representations, warranties, covenants, conditions and provisions of this Stock Option Certificate shall be binding upon and shall inure to the benefit of each party and such party's respective successors and permitted assigns, spouses, heirs, executors, administrators, and personal and legal representatives.
(e) NOTICES. Unless otherwise specifically provided in this Stock Option Certificate, all notices, demands, requests, consents, approvals or other communications (collectively and severally called "notices") required or permitted to be given hereunder, or which are given with respect to this Stock Option Certificate, shall be in writing, and shall be given by: (A) personal delivery (which form of notice shall be deemed to have been given upon delivery), (B) by telegraph or by private airborne/overnight delivery service (which forms of notice shall be deemed to have been given upon confirmed delivery by the delivery agency), (C) by electronic or facsimile or telephonic transmission, provided the receiving party has a compatible device or confirms receipt thereof (which forms of notice shall be deemed delivered upon confirmed transmission or confirmation of receipt), or (D) by mailing in the United States mail by registered or certified mail, return receipt requested, postage prepaid (which forms of notice shall be deemed to have been given upon the fifth {5th} business day following the date mailed).
WHEREFORE, the parties hereto have for purposes of this Stock Option Certificate executed this Stock Option Certificate in the City of Monrovia, County of Los Angeles, State of California, effective as of the 9th day of August 2001.
COMPANY:
STAAR Surgical Company,
a Delaware corporation
By: /s/ John Bily ------------------------- John C. Bily, Secretary ATTEST: [SEAL] RECIPIENT: /s/ David Bailey ----------------------------- David Bailey |
EXHIBIT A
TO
STOCK OPTION CERTIFICATE
NOTICE OF EXERCISE OF STOCK OPTION
NOTICE OF EXERCISE OF STOCK OPTION
[To be signed by the Recipient only upon exercise of Option]
TO: Secretary
STAAR Surgical Company
1911 Walker Avenue
Monrovia, California 91016
The undersigned, the holder of an Option under that certain Stock Option Certificate dated effective the 9th day of August, 2001 (the "Option Certificate"), between STAAR Surgical Company, a Delaware corporation (the "Company") and the undersigned (the "Recipient"), hereby irrevocably elects, in accordance with the terms and conditions of that certain 1998 STAAR Surgical Company Stock Plan (the "Plan") adopted by the Board of Directors on April 17, 1998 and approved by the shareholders on May 29, 1998, under which the Option Certificate was granted, to exercise the undersigned's Option to purchase ____________________ (______)(1) shares of the Company's voting common stock, $.01 per share par value ("Common Stock") (collectively and severally, the "Option Shares"), for the aggregate purchase price of __________________ ($_________)(2).
(1) Insert number of Option Shares as specified in the Option Certificate which are vested Option Shares (as defined by the Plan) which the Recipient is exercising the Option to purchase.
(2) Number of Option Shares to be exercised as hereinabove specified multiplied by the Option Price per share.
Signature:_________________________________
Print Name:________________________________
Address:___________________________________
Date:________________
EXHIBIT 10.25
STOCK OPTION CERTIFICATE
This Stock Option Certificate is entered into between STAAR Surgical Company, a Delaware corporation (the "Company"), whose principal executive office is located at 1911 Walker Avenue, Monrovia, California 91016, and DAVID BAILEY (the "Recipient") whose address is 1911 Walker Avenue, Monrovia, California 91016, pursuant to that certain 1998 STAAR Surgical Company Stock Plan (the "Plan") adopted by the Board of Directors on April 17, 1998 and approved by the shareholders on May 29, 1998.
1. GRANT OF OPTION. This Stock Option Certificate certifies that the Company has granted to the Recipient, pursuant to the terms of the Plan, a stock option (the "Option") to purchase, in whole or in part, one hundred and fifty thousand (150,000) shares of the Company's voting common stock, par value $.01 (the "Common Stock") (collectively and severally, the "Option Shares"), at the price of three dollars and eighty-one cents ($3.81) per Option Share (the "Option Price"), subject to the following terms and conditions. The date of this grant January 2, 2002 (the "Grant Date").
2. PLAN; PLAN SUMMARY. Subject to the terms of this Stock Option Certificate, the Recipient's rights to purchase the Option Shares are governed by the Plan, the terms of which are incorporated herein by this reference. Capitalized terms used in this Stock Option Certificate but not defined herein shall have the meanings ascribed to them in the Plan.
3. CHARACTER OF OPTION. This Option (i) is [__] a Non-Qualified Option or
(ii) is [X] an Incentive Option.
4. CAPACITY OF RECIPIENT. This Option is granted to the Recipient in the Recipient's capacity as (i) [X] an employee, (ii) [__] a director, or (iii) [__] a consultant.
5. EXPIRATION OF OPTION. The right to exercise the Options granted by this Stock Option Certificate shall expire and be null and void and of no further force or effect to the extent not exercised by 5:00 p.m. Pacific Time, on the 2nd day of January, 2012 (the "Option Expiration Date"). Nothwithstanding the foregoing, to the extent the Option is not fully vested, the right to exercise the Option shall be subject to earlier expiration as provided in Article X of the Plan.
6. EXERCISE VESTING CONDITIONS. The Option Shares are subject to Article V, Section 5.05 of the Plan and to the following vesting schedule:
Cumulative Vested Percentage of Date Shares --------------- ----------------- January 2, 2003 33 1/3% January 2, 2004 33 1/3% January 2, 2005 33 1/3% |
The above vesting schedule will be accelerated according to the Recipient's achievement of certain goals
and objectives as stated below:
(i) the right to purchase thirty thousand (30,000) Option Shares shall vest immediately upon the Company's receipt of approval from the United States Food and Drug Administration for use of the Toric ICL as an investigational device, so long as such approval is received by March 31, 2002;
(ii) the right to purchase thirty thousand (30,000) Option Shares shall vest immediately when the Company's product, Visacryl 2, is launched in Germany and four additional key markets outside the United States, so long as the product is launched in all five markets by June 30, 2002;
(iii) the right to purchase thirty thousand (30,000) Option Shares shall vest on the date that the Company executes an original equipment manufacturer supply agreement for the Company's existing products yielding revenues in the first year of not less than $1,500,000, so long as such agreement is signed by September 30, 2002;
(iv) the right to purchase thirty thousand (30,000) Option Shares shall vest immediately once the Company hires a qualified Chief Financial Officer and qualified Vice President in charge of research and development, clinical affairs and regulatory affairs, so long as both positions are filled by June 30, 2002; and
(v) the right to purchase thirty thousand (30,000) Option Shares shall vest on April 1, 2002, so long as the Company has achieved and maintained a positive cash flow during the period from October 1 through December 31, 2001 and January 1 through March 31, 2002.
7. MANNER OF EXERCISE AND PAYMENT. This Option shall be exercised by delivery of the Notice of Exercise of Stock Option, in the form attached hereto as Exhibit A, to the Secretary of the Company, together with:
(a) A Consent of Spouse (as such consent is defined in the Plan) from the spouse of the Recipient, if any, duly signed by such spouse; and
(b) Full payment for the Option Shares to be purchased in goods funds (in U.S. dollars) by cash or check or through a "same day sale" commitment from the Recipient and a broker-dealer that is a member of the National Association of Securities Dealers (an "NASD Dealer") whereby the Recipient irrevocably elects to exercise the Option and to sell a portion of the Option Shares so purchased to pay for the Option Price, and whereby the NASD Dealer irrevocably commits upon receipt of such Option Shares to forward the Option Price directly to the Company.
8. FORFEITURE; VESTING CONDITIONS. The Option Shares Subject to Article V,
Section 5.05 of the Plan and to the vesting schedule set forth above are subject
to Article X of the Plan and to the forfeiture provisions included therein
relating to the Recipient's continued performance of services in the capacity
indicated above; provided, however, that the vesting schedule and forfeiture
provisions of that certain Employment Agreement entered into by and between the
Recipient and the Company on December 20, 2000.
9. VESTING ON CHANGE OF CONTROL. Any unvested Option Shares shall immediately vest upon the occurrence of a Change In Control or an Approved Corporate Transaction.
10. MISCELLANEOUS.
(a) PREPARATION OF STOCK OPTION CERTIFICATE. This Stock Option Certificate was prepared by the Company or its legal counsel solely on behalf of the Company. It is acknowledged by the Recipient that he or she was not represented by the Company or any of its officers, directors, employees or agents (including the Company's legal counsel) in connection with the transaction contemplated by this Stock Option Certificate, and that the Recipient had separate and independent advice of counsel. In light of the foregoing it is acknowledged by the Recipient that the Company shall not be construed to be solely responsible for the drafting hereof, and that any ambiguity in the Plan or this Stock Option Certificate, or the interpretation thereof or hereof, shall not be construed against the Company as the alleged draftsman of this Stock Option Certificate.
(b) INTERPRETATION.
(i) Entire Agreement/No Collateral Representations. The Recipient acknowledges and agrees that this Stock Option Certificate, together with and subject to the Plan: (1) is the final, complete and exclusive statement of the agreement of the parties with respect to the subject matter hereof; (2) supersedes any prior or contemporaneous agreements or understandings of any kind, oral or written (collectively and severally, the "prior agreements"), and that any such prior agreements are of no force or effect except as expressly set forth herein; and (3) may not be varied, supplemented or contradicted by evidence of prior agreements, or by evidence of subsequent oral agreements.
(ii) Amendment; Waiver. Except as expressly otherwise provided herein, neither this Stock Option Certificate nor any of its terms may be amended, supplemented, discharged or terminated (other than by performance), except as provided in the Plan or by a written instrument or instruments signed by all of the parties to this Stock Option Certificate. No waiver of any acts or obligations hereunder shall be effective unless such waiver shall be in a written instrument or instruments signed by each party claimed to have given or consented to such waiver and each party affected by such waiver.
(iii) Severability. If any term or provision of this Stock Option Certificate or the application thereof to any person or circumstance shall, to any extent, be determined to be invalid, illegal or unenforceable under present or future laws effective during the term of this Stock Option Certificate, then, and in that event: (A) the performance of the offending term or provision (but only to the extent its application is invalid, illegal or unenforceable) shall be excused as if it had never been incorporated into this Stock Option Certificate, and, in lieu of such excused provision, there shall be added a provision as similar in terms and amount to such excused provision as may be possible and be legal, valid and enforceable, and (B) the remaining part of this Stock Option Certificate (including the application of the offending term or provision to persons or circumstances other than those as to which it is held invalid, illegal or unenforceable) shall not be affected thereby and shall continue in full force and effect to the fullest extent provided by law.
(iv) No Reliance Upon Prior Representation. The Recipient acknowledges that neither the Company nor any of its officers, directors, employees or agents have made any oral representation or promise which would induce the Recipient prior to executing this Stock Option Certificate
to change the Recipient's position to the Recipient's detriment, partially perform, or part with value in reliance upon such representation or promise; the Recipient acknowledges that he or she has taken such action at its own risk; and the Recipient represents that he or she has not so changed his or her position, performed or parted with value prior to the time of his or her execution of this Stock Option Certificate.
(c) ENFORCEMENT. This Stock Option Certificate and the rights and remedies of each party arising out of or relating to this Stock Option Certificate shall be solely governed in accordance with the laws (without regard to the conflicts of law principles thereof) of the state of Delaware.
(d) SUCCESSORS AND ASSIGNS. The Recipient may not assign his rights or benefits or delegate any of his duties or obligations under this Stock Option Certificate, in whole or in part, without the prior written consent of the Company, except pursuant to the terms of the Plan. Subject to the foregoing, all of the representations, warranties, covenants, conditions and provisions of this Stock Option Certificate shall be binding upon and shall inure to the benefit of each party and such party's respective successors and permitted assigns, spouses, heirs, executors, administrators, and personal and legal representatives.
(e) NOTICES. Unless otherwise specifically provided in this Stock Option Certificate, all notices, demands, requests, consents, approvals or other communications (collectively and severally called "notices") required or permitted to be given hereunder, or which are given with respect to this Stock Option Certificate, shall be in writing, and shall be given by: (A) personal delivery (which form of notice shall be deemed to have been given upon delivery), (B) by telegraph or by private airborne/overnight delivery service (which forms of notice shall be deemed to have been given upon confirmed delivery by the delivery agency), (C) by electronic or facsimile or telephonic transmission, provided the receiving party has a compatible device or confirms receipt thereof (which forms of notice shall be deemed delivered upon confirmed transmission or confirmation of receipt), or (D) by mailing in the United States mail by registered or certified mail, return receipt requested, postage prepaid (which forms of notice shall be deemed to have been given upon the fifth {5th} business day following the date mailed).
WHEREFORE, the parties hereto have for purposes of this Stock Option Certificate executed this Stock Option Certificate in the City of Monrovia, County of Los Angeles, State of California, effective as of the 2nd day of January 2002.
COMPANY:
STAAR Surgical Company,
a Delaware corporation
By: /s/ John Bily ------------------- John C. Bily, Secretary ATTEST: |
RECIPIENT:
/s/ David Bailey ----------------------- David Bailey |
EXHIBIT A
TO
STOCK OPTION CERTIFICATE
NOTICE OF EXERCISE OF STOCK OPTION
NOTICE OF EXERCISE OF STOCK OPTION
[To be signed by the Recipient only upon exercise of Option]
TO: Secretary
STAAR Surgical Company
1911 Walker Avenue
Monrovia, California 91016
The undersigned, the holder of an Option under that certain Stock Option Certificate dated effective the 2nd day of January , 2002 (the "Option Certificate"), between STAAR Surgical Company, a Delaware corporation (the "Company") and the undersigned (the "Recipient"), hereby irrevocably elects, in accordance with the terms and conditions of that certain 1998 STAAR Surgical Company Stock Plan (the "Plan") adopted by the Board of Directors on April 17, 1998 and approved by the shareholders on May 29, 1998, under which the Option Certificate was granted, to exercise the undersigned's Option to purchase (_______)(1) shares of the Company's voting common stock, $ .01 per share par value ("Common Stock") (collectively and severally, the "Option Shares"), for the aggregate purchase price of ($________)(2).
(1) Insert number of Option Shares as specified in the Option Certificate which are vested Option Shares (as defined by the Plan) which the Recipient is exercising the Option to purchase.
(2) Number of Option Shares to be exercised as hereinabove specified multiplied by the Option Price per share.
Signature:________________________________
Print Name:_______________________________
Address:__________________________________
Date:_____________________
EXHIBIT 10.26
STOCK OPTION CERTIFICATE
This Stock Option Certificate is entered into between STAAR Surgical Company, a Delaware corporation (the "Company"), whose principal executive office is located at 1911 Walker Avenue, Monrovia, California 91016, and DAVID BAILEY (the "Recipient") whose address is 1911 Walker Avenue, Monrovia, California 91016, pursuant to that certain 1998 STAAR Surgical Company Stock Plan (the "Plan") adopted by the Board of Directors on April 17, 1998 and approved by the shareholders on May 29, 1998.
1. GRANT OF OPTION. This Stock Option Certificate certifies that the Company has granted to the Recipient, pursuant to the terms of the Plan, a stock option (the "Option") to purchase, in whole or in part, sixty thousand (60,000) shares of the Company's voting common stock, par value $.01 (the "Common Stock") (collectively and severally, the "Option Shares"), at the price of five dollars and nineteen cents ($5.19) per Option Share (the "Option Price"), subject to the following terms and conditions. The date of this grant May 30, 2002 (the "Grant Date").
2. PLAN; PLAN SUMMARY. The Recipient's rights to purchase the Option Shares are governed by the Plan, the terms of which are incorporated herein by this reference.
3. CHARACTER OF OPTION. This Option is [__] a Non-Qualified Option or is
[X] an Incentive Option.
4. CAPACITY OF RECIPIENT. This Option is granted to the Recipient in the Recipient's capacity as (i) [__] an employee, (ii) [X] a director, or (iii) [__] a consultant.
5. EXPIRATION OF OPTION. The right to exercise the Options granted by this Stock Option Certificate shall expire and be null and void and of no further force or effect to the extent not exercised by 5:00 p.m. Pacific Time, on the 30th day of May, 2007 (the "Option Expiration Date").
6. EXERCISE VESTING CONDITIONS. The Option is (i) [__] fully vested upon date of grant, or (ii) [X] subject to the following vesting schedule as well as based upon Recipient's continued performance of services in the capacity hereinabove indicated:
Cumulative Vested Percentage of Date Shares ------------ ----------------- May 30, 2002 33 1/3% May 30, 2003 66 2/3% May 30, 2004 100.0% |
7. MANNER OF EXERCISE AND PAYMENT. This Option shall be exercised by delivery of this Option Certificate to the Secretary of the Company, together with:
(a) A Consent of Spouse (as such consent is defined in the Plan) from the spouse of the Recipient, if any, duly signed by such spouse; and
(b) Full payment for the Option Shares to be purchased in goods funds (in U.S. dollars) by cash or check or through a "same day sale" commitment from the Recipient and a broker-dealer that is a member of the National Association of Securities Dealers (an "NASD Dealer") whereby the Recipient irrevocably elects to exercise the Option and to sell a portion of the Option Shares so purchased to pay for the Option Price, and whereby the NASD Dealer irrevocably commits upon receipt of such Option Shares to forward the Option Price directly to the Company.
8. FORFEITURE; VESTING CONDITIONS. This Option (i) [__] will be fully vested on date of grant, or (ii) [X] will be subject to Article V, Section 5.05 and Article X of the Plan, inasmuch as the Option will be subject to: (A) the vesting schedule set forth above and (B) the special rules regulating vesting and forfeiture on Termination of Recipient.
9. RECIPIENTS REPRESENTATIONS. The Recipient represents that the Recipient has received a Section 10(a) Prospectus, which explains the administration and operation of the Plan, and has received a copy of the Plan.
10. MISCELLANEOUS.
(a) PREPARATION OF STOCK OPTION CERTIFICATE. This Stock Option Certificate was prepared by the Company or its legal counsel solely on behalf of the Company. It is acknowledged by the Recipient that he or she was not represented by the Company or any of its officers, directors, employees or agents (including the Company's legal counsel) in connection with the transaction contemplated by this Stock Option Certificate, and that the Recipient had separate and independent advice of counsel. In light of the foregoing it is acknowledged by the Recipient that the Company shall not be construed to be solely responsible for the drafting hereof, and that any ambiguity in the Plan or this Stock Option Certificate, or the interpretation thereof or hereof, shall not be construed against the Company as the alleged draftsman of this Stock Option Certificate.
(b) INTERPRETATION.
(i) Entire Agreement/No Collateral Representations. The Recipient acknowledges and agrees that this Stock Option Certificate, together with and subject to the Plan: (1) is the final, complete and exclusive statement of the agreement of the parties with respect to the subject matter hereof; (2) supersedes any prior or contemporaneous agreements or understandings of any kind, oral or written (collectively and severally, the "prior agreements"), and that any such prior agreements are of no force or effect except as expressly set forth herein; and (3) may not be varied, supplemented or contradicted by evidence of prior agreements, or by evidence of subsequent oral agreements.
(ii) Amendment; Waiver. Except as expressly otherwise provided herein, neither this Stock Option Certificate nor any of its terms may be amended, supplemented,
discharged or terminated (other than by performance), except as provided in the Plan or by a written instrument or instruments signed by all of the parties to this Stock Option Certificate. No waiver of any acts or obligations hereunder shall be effective unless such waiver shall be in a written instrument or instruments signed by each party claimed to have given or consented to such waiver and each party affected by such waiver.
(iii) Severability. If any term or provision of this Stock Option Certificate or the application thereof to any person or circumstance shall, to any extent, be determined to be invalid, illegal or unenforceable under present or future laws effective during the term of this Stock Option Certificate, then, and in that event: (A) the performance of the offending term or provision (but only to the extent its application is invalid, illegal or unenforceable) shall be excused as if it had never been incorporated into this Stock Option Certificate, and, in lieu of such excused provision, there shall be added a provision as similar in terms and amount to such excused provision as may be possible and be legal, valid and enforceable, and (B) the remaining part of this Stock Option Certificate (including the application of the offending term or provision to persons or circumstances other than those as to which it is held invalid, illegal or unenforceable) shall not be affected thereby and shall continue in full force and effect to the fullest extent provided by law.
(c) ENFORCEMENT. This Stock Option Certificate and the rights and remedies of each party arising out of or relating to this Stock Option Certificate shall be solely governed in accordance with the laws (without regard to the conflicts of law principles thereof) of the state of Delaware.
(d) SUCCESSORS AND ASSIGNS. The Recipient may not assign his rights or benefits or delegate any of his duties or obligations under this Stock Option Certificate, in whole or in part, without the prior written consent of the Company, except pursuant to the terms of the Plan. Subject to the foregoing, all of the representations, warranties, covenants, conditions and provisions of this Stock Option Certificate shall be binding upon and shall inure to the benefit of each party and such party's respective successors and permitted assigns, spouses, heirs, executors, administrators, and personal and legal representatives.
(e) NOTICES. Unless otherwise specifically provided in this Stock Option Certificate, all notices, demands, requests, consents, approvals or other communications (collectively and severally called "notices") required or permitted to be given hereunder, or which are given with respect to this Stock Option Certificate, shall be in writing, and shall be given by: (A) personal delivery (which form of notice shall be deemed to have been given upon delivery), (B) by telegraph or by private airborne/overnight delivery service (which forms of notice shall be deemed to have been given upon confirmed delivery by the delivery agency), (C) by electronic or facsimile or telephonic transmission, provided the receiving party has a compatible device or confirms receipt thereof (which forms of notice shall be deemed delivered upon confirmed transmission or confirmation of receipt), or (D) by mailing in the United States mail by registered or certified mail, return receipt requested, postage prepaid (which forms of notice shall be deemed to have been given upon the fifth {5th} business day following the date mailed).
WHEREFORE, the parties hereto have for purposes of this Stock Option Certificate
executed this Stock Option Certificate in the City of Monrovia, County of Los Angeles, State of California, effective as of the 14th day of February 2003.
COMPANY:
STAAR Surgical Company,
a Delaware corporation
By: /s/ John Bily ------------------------ John C. Bily, Secretary ATTEST: |
[SEAL]
RECIPIENT:
/s/ David Bailey ------------------------ |
EXHIBIT A
TO
STOCK OPTION CERTIFICATE
NOTICE OF EXERCISE OF STOCK OPTION
NOTICE OF EXERCISE OF STOCK OPTION
[To be signed by the Recipient only upon exercise of Option] TO: Secretary STAAR Surgical Company 1911 Walker Avenue Monrovia, California 91016 The undersigned, the holder of an Option under that certain Stock Option |
Certificate dated effective the ___ day of _____, ______ (the "Option Certificate"), between STAAR Surgical Company, a Delaware corporation (the "Company") and the undersigned (the "Recipient"), hereby irrevocably elects, in accordance with the terms and conditions of that certain 1998 STAAR Surgical Company Stock Plan (the "Plan") adopted by the Board of Directors on April 17, 1998 and approved by the shareholders on May 29, 1998, under which the Option Certificate was granted, to exercise the undersigned's Option to purchase_____ ( )(1) shares of the Company's voting common stock, $ .01 per share par value ("Common Stock") (collectively and severally, the "Option Shares"), for the aggregate purchase price of ($____)(2).
(1) Insert number of Option Shares as specified in the Option Certificate which are vested Option Shares (as defined by the Plan) which the Recipient is exercising the Option to purchase.
(2) Number of Option Shares to be exercised as hereinabove specified multiplied by the Option Price per share.
Signature:_________________________________
Print Name:________________________________
Address:___________________________________
Date:________________
EXHIBIT 10.27
AMENDED AND RESTATED STOCK OPTION CERTIFICATE
This Amended and Restated Stock Option Certificate dated February 12, 2003 amends in its entirety the Amended and Restated Stock Option Certificate dated February 12, 2003, and is entered into between STAAR Surgical Company, a Delaware corporation (the "Company"), whose principal executive office is located at 1911 Walker Avenue, Monrovia, California 91016, and DAVID BAILEY (the "Recipient") whose address is 1911 Walker Avenue, Monrovia, California 91016, pursuant to that certain 1998 STAAR Surgical Company Stock Plan (the "Plan") adopted by the Board of Directors on April 17, 1998 and approved by the shareholders on May 29, 1998.
1. GRANT OF OPTION. Subject to the terms and conditions included herein, this Amended and Restated Stock Option Certificate certifies that the Company has granted to the Recipient, pursuant to the terms of the Plan, an option (the "Option") to purchase, in whole or in part, one hundred and forty thousand (140,000) shares of the Company's voting common stock, par value $.01 (the "Common Stock") (collectively and severally, the "Option Shares"), at the price of three dollars and sixty cents ($3.60) per Option Share (the "Option Price"). The date of this grant is February 13, 2003 (the "Grant Date").
2. PLAN; PLAN SUMMARY. The Recipient's rights to purchase the Option Shares are governed by the Plan, the terms of which are incorporated herein by this reference.
3. CHARACTER OF OPTION. This Option is [__] a Non-Qualified Option or [X] an Incentive Option.
4. CAPACITY OF RECIPIENT. This Option is granted to the Recipient in the Recipient's capacity as (i) [X] an employee, (ii) [__] a director, or (iii) [__] a consultant.
5. EXPIRATION OF OPTION. Subject to the terms and conditions set forth in this Amended and Restated Stock Option Certificate and in the Plan, the right to exercise the Options granted by this Amended and Restated Stock Option Certificate shall expire and be null and void and of no further force or effect to the extent not exercised by 5:00 p.m. Pacific Time, on the 12th day of February, 2008 (the "Option Expiration Date").
6. EXERCISE VESTING CONDITIONS. The Option is (i) [__] fully vested upon date of grant, or (ii) [X] subject to the following vesting schedule as well as based upon Recipient's continued performance of services in the capacity hereinabove indicated:
Cumulative Vested Percentage of Date Shares ----------------- ----------------- February 13, 2004 33 1/3% February 13, 2005 66 2/3% February 13, 2006 100.0% |
The above vesting schedule will be accelerated according to the Recipient's achievement of certain goals and objectives as stated below:
(i) the right to purchase fifty thousand (50,000) Option Shares shall vest immediately upon the Company's filing its submission for approval of the ICL to the United States Food and Drug Administration, so long as such filing is made by March 4, 2003; and
(ii) the right to purchase fifty thousand (50,000) Option Shares shall vest on April 1, 2004, so long as the Company has achieved sales and profit forecast for fiscal year 2003.
7. MANNER OF EXERCISE AND PAYMENT. This Option shall be exercised by delivery of this Option Certificate to the Secretary of the Company, together with:
(a) A Consent of Spouse (as such consent is defined in the Plan) from the spouse of the Recipient, if any, duly signed by such spouse; and
(b) Full payment for the Option Shares to be purchased in goods funds (in U.S. dollars) by cash or check or through a "same day sale" commitment from the Recipient and a broker-dealer that is a member of the National Association of Securities Dealers (an "NASD Dealer") whereby the Recipient irrevocably elects to exercise the Option and to sell a portion of the Option Shares so purchased to pay for the Option Price, and whereby the NASD Dealer irrevocably commits upon receipt of such Option Shares to forward the Option Price directly to the Company.
8. FORFEITURE; VESTING CONDITIONS. This Option (i) [__] will be fully vested upon date of grant, or (ii) [X] will be subject to Article V, Section 5.05 and Article X of the Plan, inasmuch as the Option will be subject to: (A) the vesting schedule set forth above and (B) the special rules regulating vesting and forfeiture on Termination of Recipient.
9. RECIPIENT'S REPRESENTATIONS. The Recipient represents that the Recipient has received a Section 10(a) Prospectus, which explains the administration and operation of the Plan, and has received a copy of the Plan.
10. MISCELLANEOUS.
(a) PREPARATION OF STOCK OPTION CERTIFICATE. This Amended and Restated Stock Option Certificate was prepared by the Company or its legal counsel solely on behalf of the Company. It is acknowledged by the Recipient that he or she was not represented by the Company or any of its officers, directors, employees or agents (including the Company's legal counsel) in connection with the transaction contemplated by this Amended and Restated Stock Option Certificate, and that the Recipient had separate and independent advice of counsel. In light of the foregoing it is acknowledged by the Recipient that the Company shall not be construed to be solely responsible for the drafting hereof, and that any ambiguity in the Plan or this Amended and Restated Stock Option Certificate, or the interpretation thereof or hereof, shall not be construed against the Company as the alleged draftsman of this Amended and Restated Stock Option Certificate.
(b) INTERPRETATION.
(i) Entire Agreement/No Collateral Representations. The Recipient acknowledges and agrees that this Amended and Restated Stock Option Certificate, together with and subject to the Plan: (1) is the final, complete and exclusive statement of the agreement of the parties with respect to the subject matter hereof; (2) supersedes any prior or contemporaneous agreements or understandings of any kind, oral or written (collectively and severally, the "prior agreements"), and that any such prior agreements are of no force or effect except as expressly set forth herein; and (3) may not be varied, supplemented or contradicted by evidence of prior agreements, or by evidence of subsequent oral agreements.
(ii) Amendment; Waiver. Except as expressly otherwise provided herein, neither this Amended and Restated Stock Option Certificate nor any of its terms may be amended, supplemented, discharged or terminated (other than by performance), except as provided in the Plan or by a written instrument or instruments signed by all of the parties to this Amended and Restated Stock Option Certificate. No waiver of any acts or obligations hereunder shall be effective unless such waiver shall be in a written instrument or instruments signed by each party claimed to have given or consented to such waiver and each party affected by such waiver.
(iii) Severability. If any term or provision of this Amended and Restated Stock Option Certificate or the application thereof to any person or circumstance shall, to any extent, be determined to be invalid, illegal or unenforceable under present or future laws effective during the term of this Amended and Restated Stock Option Certificate, then, and in that event: (A) the performance of the offending term or provision (but only to the extent its application is invalid, illegal or unenforceable) shall be excused as if it had never been incorporated into this Amended and Restated Stock Option Certificate, and, in lieu of such excused provision, there shall be added a provision as similar in terms and amount to such excused provision as may be possible and be legal, valid and enforceable, and (B) the remaining part of this Amended and Restated Stock Option Certificate (including the application of the offending term or provision to persons or circumstances other than those as to which it is held invalid, illegal or unenforceable) shall not be affected thereby and shall continue in full force and effect to the fullest extent provided by law.
(c) ENFORCEMENT. This Amended and Restated Stock Option Certificate and the rights and remedies of each party arising out of or relating to this Amended and Restated Stock Option Certificate shall be solely governed in accordance with the laws (without regard to the conflicts of law principles thereof) of the state of Delaware.
(d) SUCCESSORS AND ASSIGNS. The Recipient may not assign his rights or benefits or delegate any of his duties or obligations under this Amended and Restated Stock Option Certificate, in whole or in part, without the prior written consent of the Company, except pursuant to the terms of the Plan. Subject to the foregoing, all of the representations, warranties, covenants, conditions and provisions of this Amended and Restated Stock Option Certificate shall be binding upon and shall inure to the benefit of each party and such party's respective successors and permitted assigns, spouses, heirs, executors, administrators, and personal and legal representatives.
(e) NOTICES. Unless otherwise specifically provided in this Amended and Restated Stock Option Certificate, all notices, demands, requests, consents, approvals or other communications (collectively and severally called "notices") required or permitted to be given hereunder, or which are given with respect to this Amended and Restated Stock Option Certificate, shall be in writing, and shall be given by: (A) personal delivery (which form of notice shall be deemed to have been given upon delivery), (B) by telegraph or by private airborne/overnight delivery service (which forms of notice shall be deemed to have been given upon confirmed delivery by the delivery agency), (C) by electronic or facsimile or telephonic transmission, provided the receiving party has a compatible device or confirms receipt thereof (which forms of notice shall be deemed delivered upon confirmed transmission or confirmation of receipt), or (D) by mailing in the United States mail by registered or certified mail, return receipt requested, postage prepaid (which forms of notice shall be deemed to have been given upon the fifth {5th} business day following the date mailed).
WHEREFORE, the parties hereto have for purposes of this Amended and Restated Stock Option Certificate executed this Amended and Restated Stock Option Certificate in the City of Monrovia, County of Los Angeles, State of California, effective as of the 13th day of February, 2003.
COMPANY:
STAAR Surgical Company,
a Delaware corporation
By: /s/ John Bily --------------------------- John C. Bily, Secretary ATTEST: |
[SEAL]
RECIPIENT:
/s/ David Bailey ------------------------------ David Bailey |
ATTACHMENT
TO
STOCK OPTION CERTIFICATE
NOTICE OF EXERCISE OF STOCK OPTION
NOTICE OF EXERCISE OF STOCK OPTION
[To be signed by the Recipient only upon exercise of Option]
TO: Secretary
STAAR Surgical Company
1911 Walker Avenue
Monrovia, California 91016
The undersigned, the holder of an Option under that certain Amended and Restated Stock Option Certificate dated effective the ________ day of _______________, ___ (the "Option Certificate"), between STAAR Surgical Company, a Delaware corporation (the "Company") and the undersigned (the "Recipient"), hereby irrevocably elects, in accordance with the terms and conditions of that certain 1998 STAAR Surgical Company Stock Plan (the "Plan") adopted by the Board of Directors on April 17, 1998 and approved by the shareholders on May 29, 1998, under which the Option Certificate was granted, to exercise the undersigned's Option to purchase (_________)(1) shares of the Company's voting common stock, $ .01 per share par value ("Common Stock") (collectively and severally, the "Option Shares"), for the aggregate purchase price of ($_________)(2).
(1) Insert number of Option Shares as specified in the Option Certificate which are vested Option Shares (as defined by the Plan) which the Recipient is exercising the Option to purchase.
(2) Number of Option Shares to be exercised as hereinabove specified multiplied by the Option Price per share.
Signature:________________________________________
Print Name:_______________________________________
Address:__________________________________________
Date:_____________________________________________
EXHIBIT 10.28
STOCK OPTION CERTIFICATE
THE OPTION RIGHTS REPRESENTED BY THIS STOCK OPTION CERTIFICATE DO NOT CONSTITUTE A SECURITY WHICH IS REQUIRED TO BE REGISTERED UPON THE GRANT OF THESE OPTION RIGHTS (AND THEREFORE HAVE NOT BEEN REGISTERED) WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION UNDER THE SECURITIES ACT OF 1933, AS AMENDED, INSOFAR AS THE RECIPIENT OF THIS OPTION HAS NOT AND WILL NOT BE REQUIRED TO PAY OR GIVE ANY CONSIDERATION WITH RESPECT TO THE GRANT OF THESE OPTION RIGHTS, NOR HAS THE SECURITIES AND EXCHANGE COMMISSION REVIEWED OR PASSED UPON THE ACCURACY OR ADEQUACY OF THE RECIPIENT'S STOCK OPTION CERTIFICATE. THE OPTION RIGHTS REPRESENTED BY THIS STOCK OPTION CERTIFICATE CONSTITUTE A SECURITY WHICH HAS NOT BEEN REGISTERED OR QUALIFIED, AS THE CASE MAY BE, UNDER THE SECURITIES LAWS OF ANY STATE OR TERRITORY OF THE UNITED STATES WHICH MAY BE APPLICABLE, IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION OR QUALIFICATION, AS THE CASE MAY BE, AFFORDED BY SUCH STATE OR TERRITORIAL SECURITIES LAWS INCLUDING, WITHOUT LIMITATION, WITH THE CALIFORNIA DEPARTMENT OF CORPORATIONS, IN RELIANCE UPON THE EXEMPTION FROM REGISTATION AFFORDED BY SECTION 25102(o) OF THE CALIFORNIA BLUE SKY LAW, AS AMENDED, NOR HAS NAY SUCH SECURITIES REGULATORY AGENCY REVIEWED OR PASSED UPON THE ACCURACY OR ADEQUACY OF THIS STOCK OPTION CERTIFICATE.
This Stock Option Certificate is entered into between STAAR Surgical Company, a Delaware corporation (the "Company"), whose principal executive office is located at 1911 Walker Avenue, Monrovia, California 91016, and VOLKER D. ANHAEUSSER (the "Recipient") whose address is c/o 10900 Wilshire Boulevard, Suite 500, Los Angeles, California 90024, pursuant to that certain 1998 STAAR Surgical Company Stock Plan (the "Plan") adopted by the Board of Directors on April 17, 1998 and approved by the shareholders on May 29, 1998.
1. GRANT OF OPTION. This Stock Option Certificate certifies that the Company has granted to the Recipient, pursuant to the terms of the Plan, an option (the "Option") to purchase, in whole or in part, twenty thousand (20,000) shares of the Company's voting common stock, par value $.01 (the "Common Stock") (collectively and severally, the "Option Shares"), at the price of ten dollars and 18.8 cents ($10.188) per Option Share (the "Option Price"), subject to the following terms and conditions.
2. PLAN; PLAN SUMMARY. Subject to the terms of this Stock Option Certificate, the Recipient's rights to purchase the Option Shares are governed by the Plan, the terms of which are incorporated herein by this reference.
3. CHARACTER OF OPTION. This Option (i) is [X] a Non-Qualified Option or
(ii) is [____]
an Incentive Option.
4. CAPACITY OF RECIPIENT. This Option is granted to the Recipient in the Recipient's capacity as (i) [__] an employee, (ii) [X] a director, or (iii) [__] a consultant.
5. EXPIRATION OF OPTION. The right to exercise the Options granted by this Stock Option Certificate shall expire and be null and void and of no further force or effect to the extent not exercised by 5:00 p.m. Pacific Time, on the 8th day of May 2010 (the "Option Expiration Date"). Notwithstanding the foregoing, to the extent the Option is not fully vested, the right to exercise the Option shall be subject to earlier expiration as provided in Article X of the Plan.
6. EXERCISE VESTING CONDITIONS. The Option Shares are subject to Article V, Section 5.05 of the Plan and to the following vesting schedule:
Cumulative Vested Percentage of Date Shares ------------ ----------------- May 31, 2000 10,000 May 31, 2001 10,000 |
7. MANNER OF EXERCISE AND PAYMENT. This Option shall be exercised by delivery of this Option Certificate to the Secretary of the Company, together with:
(a) A Consent of Spouse (as such consent is defined in the Plan) from the spouse of the Recipient, if any, duly signed by such spouse; and
(b) Full payment for the Option Shares to be purchased in goods
funds (in U.S. dollars) by cash or check, and/or the following items (if
checked by the Company); (i) [X] shares of Common Stock pursuant to
Article VIII of the Plan, (ii) [__] surrender of relinquishment of rights
to acquire Common Stock as more particularly described below, or (iii)
[X] a full-recourse promissory note as more particularly described
below.
8. FORFEITURE; VESTING CONDITIONS. The Option Shares: (i) [__] will be fully vested upon date of grant, or (ii) [X] are subject to Article V, Section 5.05 of the Plan and to the vesting schedule set forth above , and are subject to Article X of the Plan and to the forfeiture provisions included therein relating to the Recipient's continued performance of services in the capacity indicated above.
9. VESTING ON CHANGE OF CONTROL. Any unvested Option Shares shall immediately vest upon the occurrence of a Change In Control or an Approved Corporate Transaction.
10. REPRESENTATIONS, WARRANTIES AND COVENANTS. The Recipient hereby represents, warrants and covenants to the Company, each of which is deemed to be a separate representation, warranty or covenant, whichever the case may be, that:
(a) The Recipient's legal permanent residence and domicile is in the State of
California.
(b) The Recipient, if a natural person, is eighteen (18) or over.
(c) The Recipient has received a copy of the Plan which explains the administration and operation of the Plan and certain other relevant matters pertaining to the Plan, and has read and understood the Plan.
(d) By reason of the Recipient's business or financial experience, the Recipient can be reasonably assumed to have the capacity to protect the Recipient's own interests in connection with the transaction contemplated by this Stock Option Certificate.
(e) Before purchasing the Option Shares, the Recipient has had the opportunity, to the extent the Recipient has determined to be necessary, to be provided with financial and other written information about the Company; to ask questions and receive answers concerning the terms and conditions of this Stock Option Certificate, an investment in the Option Shares, and the business of the Company and its finances; and that the Recipient has, to the extent he has availed himself of this opportunity, received satisfactory information and answers.
(f) Prior to exercising the Option, the Recipient had the opportunity to consult with Recipient's investment advisors who are independent of the Company, including, without limitation, investment, tax, accounting and legal advisors relative to (i) the investment merits of a proposed investment in the Option Shares and (ii) the tax consequences of the grant and exercise of the Option and the subsequent disposition of the Option Shares and the effect of same upon the Recipient's personal financial circumstances, and that the Recipient has, to the extent he has availed himself of this opportunity, received satisfactory information and answers from such investment advisors.
(g) The Recipient has been informed and understands and agrees as follows: there are substantial restrictions on the transferability of the Option Shares as are more particularly described in Article XI, Section 11.02 of the plan and, as a result of such restrictions, it may not be possible for the Recipient to sell or otherwise liquidate the Option Shares in the case of emergency and/or other need, and the Recipient must therefore be able to hold the Option Shares until the lapse of said restrictions; the Recipient must have adequate means of providing for the Recipient's current needs and personal contingencies; the Recipient must have not need for liquidity in an investment in the Option Shares; and the Recipient has evaluated the Recipient's financial resources and investment position in view of the foregoing; and that the Recipient is able to bear the economic risk of an investment in the Option Shares.
(h) The Option Shares are being purchased by the Recipient as principal and not by any other person, with the Recipient's own funds and not with the funds of any other person, and for the account of the Recipient and not as nominee or agent and not for the account of any other person. The Recipient is purchasing the Option Shares for investment for an indefinite period and not with a view to the sale of distribution of any part or all thereof by public or private sale or other disposition. Nor person other than the Recipient will have an interest, beneficial or otherwise, in the Option Shares, and the Recipient is not obligated to transfer the Option Shares to any other person nor does the Recipient have any agreement or understanding to do so.
(i) To the best of the Recipient's knowledge and belief the offer and sale of the Option Shares was not accomplished by the publication of any advertisement, article, notice or other communication published in any newspaper, magazine, or similar media or broadcast over television or radio; nor was the offer and sale of the Option Shares accomplished through any seminar or meeting to which the Recipient was invited by any such publication or advertisement.
Each representation, warranty and covenant of the Recipient shall be deemed made as of the time of grant of this Option, shall be deemed remade at any time the Recipient exercises this Option, and shall survive the date closing with respect to the exercise of the last Option hereunder.
11. MISCELLANEOUS
(a) PREPARATION OF STOCK OPTION CERTIFICATE. This Stock Option Certificate was prepared by the Company or its legal counsel solely on behalf of the Company. It is acknowledged by the Recipient that he or she was not represented by the Company or any of its officers, directors, employees or agents (including the Company's legal counsel) in connection with the transaction contemplated by this Stock Option Certificate, and that the Recipient had separate and independent advice of counsel. In light of the foregoing it is acknowledged by the Recipient that the Company shall not be construed to be solely responsible for the drafting hereof, and that any ambiguity in the Plan or this Stock Option Certificate, or the interpretation thereof or hereof, shall not be construed against the Company as the alleged draftsman of this Stock Option Certificate.
(b) INTERPRETATION.
(i) Entire Agreement/No Collateral Representations. The Recipient acknowledges and agrees that this Stock Option Certificate, together with and subject to the Plan: (1) is the final, complete and exclusive statement of the agreement of the parties with respect to the subject matter hereof; (2) supersedes any prior or contemporaneous agreements or understandings of any kind, oral or written (collectively and severally, the "prior agreements"), and that any such prior agreements are of no force or effect except as expressly set forth herein; and (3) may not be varied, supplemented or contradicted by evidence of prior agreements, or by evidence of subsequent oral agreements.
(ii) Amendment; Waiver. Except as expressly otherwise provided herein, neither this Stock Option Certificate nor any of its terms may be amended, supplemented, discharged or terminated (other than by performance), except as provided in the Plan or by a written instrument or instruments signed by all of the parties to this Stock Option Certificate. No waiver of any acts or obligations hereunder shall be effective unless such waiver shall be in a written instrument or instruments signed by each party claimed to have given or consented to such waiver and each party affected by such waiver.
(iii) Severability. If any term or provision of this Stock Option Certificate or the application thereof to any person or circumstance shall, to any extent, be determined to be invalid, illegal or unenforceable under present or future laws effective during the term of this Stock Option Certificate, then, and in that event: (A) the performance of the offending term or provision (but only to the extent its
application is invalid, illegal or unenforceable) shall be excused as if it had never been incorporated into this Stock Option Certificate, and, in lieu of such excused provision, there shall be added a provision as similar in terms and amount to such excused provision as may be possible and be legal, valid and enforceable, and (B) the remaining part of this Stock Option Certificate (including the application of the offending term or provision to persons or circumstances other than those as to which it is held invalid, illegal or unenforceable) shall not be affected thereby and shall continue in full force and effect to the fullest extent provided by law.
(iv) No Reliance Upon Prior Representation. The Recipient acknowledges that neither the Company nor any of its officers, directors, employees or agents have made any oral representation or promise which would induce the Recipient prior to executing this Stock Option Certificate to change the Recipient's position to the Recipient's detriment, partially perform, or part with value in reliance upon such representation or promise; the Recipient acknowledges that he or she has taken such action at its own risk; and the Recipient represents that he or she has not so changed his or her position, performed or parted with value prior to the time of his or her execution of this Stock Option Certificate.
(c) ENFORCEMENT. This Stock Option Certificate and the rights and remedies of each party arising out of or relating to this Stock Option Certificate shall be solely governed in accordance with the laws (without regard to the conflicts of law principles thereof) of the state of Delaware.
(d) SUCCESSORS AND ASSIGNS. The Recipient may not assign his rights or benefits or delegate any of his duties or obligations under this Stock Option Certificate, in whole or in part, without the prior written consent of the Company, except pursuant to the terms of the Plan. Subject to the foregoing, all of the representations, warranties, covenants, conditions and provisions of this Stock Option Certificate shall be binding upon and shall inure to the benefit of each party and such party's respective successors and permitted assigns, spouses, heirs, executors, administrators, and personal and legal representatives.
(e) NOTICES. Unless otherwise specifically provided in this Stock Option Certificate, all notices, demands, requests, consents, approvals or other communications (collectively and severally called "notices") required or permitted to be given hereunder, or which are given with respect to this Stock Option Certificate, shall be in writing, and shall be given by: (A) personal delivery (which form of notice shall be deemed to have been given upon delivery), (B) by telegraph or by private airborne/overnight delivery service (which forms of notice shall be deemed to have been given upon confirmed delivery by the delivery agency), (C) by electronic or facsimile or telephonic transmission, provided the receiving party has a compatible device or confirms receipt thereof (which forms of notice shall be deemed delivered upon confirmed transmission or confirmation of receipt), or (D) by mailing in the United States mail by registered or certified mail, return receipt requested, postage prepaid (which forms of notice shall be deemed to have been given upon the fifth {5th} business day following the date mailed).
WHEREFORE, the parties hereto have for purposes of this Stock Option Certificate executed this Stock Option Certificate in the City of Monrovia, County of Los Angeles, State of California, effective as of the 9st day of May 2000.
COMPANY:
STAAR Surgical Company,
a Delaware corporation
By: ________________________________
William C. Huddleston, President
ATTEST:
By: ________________________________
John Santos, Chief Financial Officer
RECIPIENT:
/s/ Volker D. Anhaeusser ------------------------------------ Volker D. Anhaeusser |
NOTICE OF EXERCISE OF STOCK OPTION
[To be signed by the Recipient only upon exercise of Option] TO: Secretary STAAR Surgical Company 1911 Walker Avenue Monrovia, California 91016 The undersigned, the holder of an Option under that certain Stock Option |
Certificate dated effective the 31st day of May 2000 (the "Option Certificate"), between STAAR Surgical Company, a Delaware corporation (the "Company") and the undersigned (the "Recipient"), hereby irrevocably elects, in accordance with the terms and conditions of that certain 1998 STAAR Surgical Company Stock Plan (the "Plan") adopted by the Board of Directors on April 17, 1998 and approved by the shareholders on May 29, 1998, under which the Option Certificate was granted, to exercise the undersigned's Option to purchase _________________________________ (_____)(1) shares of the Company's voting common stock, $ .01 per share par value ("Common Stock") (collectively and severally, the "Option Shares"), for the aggregate purchase price of _____________________ ($_________)(2).
(1) Insert number of Option Shares as specified in the Option Certificate which are vested Option Shares (as defined by the Plan) which the Recipient is exercising the Option to purchase.
(2) Number of Option Shares to be exercised as hereinabove specified multiplied by the Option Price per share.
The Recipient hereby remakes, reaffirms and reacknowledges all agreements, representations, warranties and covenants set forth in the Option Certificate as of the date of the Recipient's notice, all of which shall survive the Closing with respect to the shares of Common Stock purchased hereby.
The Recipient hereby acknowledges that the following legend (or any variation thereof determined appropriate by the Company) will be placed on the share certificate or certificates for the Option Shares to comply with applicable federal and state securities laws:
THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN (1) REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION AFFORDED BY SUCH ACT, OR (2) REGISTERED OR QUALIFIED UNDER THE SECURITIES LAWS OF ANY STATE OR TERRITORY OF THE UNITED STATES WHICH MAY BE APPLICABLE, IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION OR QUALIFICATION AFFORDED BY SUCH STATE OR TERRITORIAL SECURITIES LAWS. THESE SECURITIES HAVE BEEN ACQUIRED FOR THE HOLDER'S OWN ACCOUNT FOR INVESTMENT PURPOSES AND NOT WITH A VIEW FOR RESALE OR DISTRIBUTION. THESE SECURITIES MAY NOT BE SOLD OR TRANSFERRED UNLESS (A) THEY HAVE BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933 AS WELL AS UNDER THE SECURITIES LAWS OF ANY STATE OR TERRITORY OF THE UNITED STATES AS MAY THEN BE APPLICABLE, OR (B) THE TRANSFER AGENT (OR THE COMPANY IF THEN ACTING
AS ITS TRANSFER AGENT) IS PRESENTED WITH EITHER A WRITTEN OPINION SATISFACTORY TO COUNSEL FOR THE COMPANY OR A NO-ACTION OR INTERPRETIVE LETTER FROM THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION AND ANY APPLICABLE STATE OR TERRITORIAL SECURITIES REGULATORY AGENCY TO THE EFFECT THAT SUCH REGISTRATION OR QUALIFICATION IS NOT REQUIRED UNDER THE CIRCUMSTANCES OF SUCH SALE OR TRANSFER.
(Signature must conform in all respects to name of the Recipient as specified in the Plan, unless the undersigned is the Recipient's Successor, in which case the undersigned must submit appropriate proof of the right of the undersigned to exercise the Option.)
Signature:________________________________________
Print Name:_______________________________________
Address:__________________________________________
Date:________________
EXHIBIT 10.29
STOCK OPTION CERTIFICATE
THE OPTION RIGHTS REPRESENTED BY THIS STOCK OPTION CERTIFICATE DO NOT CONSTITUTE A SECURITY WHICH IS REQUIRED TO BE REGISTERED UPON THE GRANT OF THESE OPTION RIGHTS (AND THEREFORE HAVE NOT BEEN REGISTERED) WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION UNDER THE SECURITIES ACT OF 1933, AS AMENDED, INSOFAR AS THE RECIPIENT OF THIS OPTION HAS NOT AND WILL NOT BE REQUIRED TO PAY OR GIVE ANY CONSIDERATION WITH RESPECT TO THE GRANT OF THESE OPTION RIGHTS, NOR HAS THE SECURITIES AND EXCHANGE COMMISSION REVIEWED OR PASSED UPON THE ACCURACY OR ADEQUACY OF THE RECIPIENT'S STOCK OPTION CERTIFICATE. THE OPTION RIGHTS REPRESENTED BY THIS STOCK OPTION CERTIFICATE CONSTITUTE A SECURITY WHICH HAS NOT BEEN REGISTERED OR QUALIFIED, AS THE CASE MAY BE, UNDER THE SECURITIES LAWS OF ANY STATE OR TERRITORY OF THE UNITED STATES WHICH MAY BE APPLICABLE, IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION OR QUALIFICATION, AS THE CASE MAY BE, AFFORDED BY SUCH STATE OR TERRITORIAL SECURITIES LAWS INCLUDING, WITHOUT LIMITATION, WITH THE CALIFORNIA DEPARTMENT OF CORPORATIONS, IN RELIANCE UPON THE EXEMPTION FROM REGISTRATION AFFORDED BY SECTION 25102(o) OF THE CALIFORNIA BLUE SKY LAW, AS AMENDED, NOR HAS NAY SUCH SECURITIES REGULATORY AGENCY REVIEWED OR PASSED UPON THE ACCURACY OR ADEQUACY OF THIS STOCK OPTION CERTIFICATE.
This Stock Option Certificate is entered into between STAAR Surgical Company, a Delaware corporation (the "Company"), whose principal executive office is located at 1911 Walker Avenue, Monrovia, California 91016, and VOLKER D. ANHAEUSSER (the "Recipient") whose address is c/o 10900 Wilshire Boulevard, Suite 500, Los Angeles, California 90024, pursuant to that certain 1998 STAAR Surgical Company Stock Plan (the "Plan") adopted by the Board of Directors on April 17, 1998 and approved by the shareholders on May 29, 1998.
1. GRANT OF OPTION. This Stock Option Certificate certifies that the Company has granted to the Recipient, pursuant to the terms of the Plan, an option (the "Option") to purchase, in whole or in part, forty thousand (40,000) shares of the Company's voting common stock, par value $.01 (the "Common Stock") (collectively and severally, the "Option Shares"), at the price of thirteen dollars and sixty-two and one-half cents ($13.625) per Option Share (the "Option Price"), subject to the following terms and conditions.
2. PLAN; PLAN SUMMARY. Subject to the terms of this Stock Option Certificate, the Recipient's rights to purchase the Option Shares are governed by the Plan, the terms of which are incorporated herein by this reference.
3. CHARACTER OF OPTION. This Option (i) is [X] a Non-Qualified Option or
(ii) is [___]
an Incentive Option.
4. CAPACITY OF RECIPIENT. This Option is granted to the Recipient in the
Recipient's capacity as (i) [_____] an employee, (ii) [X] a director, or (iii)
[_____] a consultant.
5. EXPIRATION OF OPTION. The right to exercise the Options granted by this Stock Option Certificate shall expire and be null and void and of no further force or effect to the extent not exercised by 5:00 p.m. Pacific Time, on the 30th day of May 2010 (the "Option Expiration Date"). Notwithstanding the foregoing, to the extent the Option is not fully vested, the right to exercise the Option shall be subject to earlier expiration as provided in Article X of the Plan.
6. EXERCISE VESTING CONDITIONS. The Option Shares are subject to Article V, Section 5.05 of the Plan and to the following vesting schedule:
Cumulative Vested Percentage of Date Shares ------------ ----------------- May 31, 2000 20,000 May 31, 2001 20,000 |
7. MANNER OF EXERCISE AND PAYMENT. This Option shall be exercised by delivery of this Option Certificate to the Secretary of the Company, together with:
(a) A Consent of Spouse (as such consent is defined in the Plan) from the spouse of the Recipient, if any, duly signed by such spouse; and
(b) Full payment for the Option Shares to be purchased in goods
funds (in U.S. dollars) by cash or check, and/or the following items (if
checked by the Company); (i) [X] shares of Common Stock pursuant to
Article VIII of the Plan, (ii) [__] surrender of relinquishment of rights
to acquire Common Stock as more particularly described below, or (iii)
[X] a full-recourse promissory note as more particularly described
below.
8. FORFEITURE; VESTING CONDITIONS. The Option Shares: (i) [__] will be fully vested upon date of grant, or (ii) [X] are subject to Article V, Section 5.05 of the Plan and to the vesting schedule set forth above , and are subject to Article X of the Plan and to the forfeiture provisions included therein relating to the Recipient's continued performance of services in the capacity indicated above.
9. VESTING ON CHANGE OF CONTROL. Any unvested Option Shares shall immediately vest upon the occurrence of a Change In Control or an Approved Corporate Transaction.
10. REPRESENTATIONS, WARRANTIES AND COVENANTS. The Recipient hereby represents, warrants and covenants to the Company, each of which is deemed to be a separate representation, warranty or covenant, whichever the case may be, that:
(a) The Recipient's legal permanent residence and domicile is in the State of
California.
(b) The Recipient, if a natural person, is eighteen (18) or over.
(c) The Recipient has received a copy of the Plan which explains the administration and operation of the Plan and certain other relevant matters pertaining to the Plan, and has read and understood the Plan.
(d) By reason of the Recipient's business or financial experience, the Recipient can be reasonably assumed to have the capacity to protect the Recipient's own interests in connection with the transaction contemplated by this Stock Option Certificate.
(e) Before purchasing the Option Shares, the Recipient has had the opportunity, to the extent the Recipient has determined to be necessary, to be provided with financial and other written information about the Company; to ask questions and receive answers concerning the terms and conditions of this Stock Option Certificate, an investment in the Option Shares, and the business of the Company and its finances; and that the Recipient has, to the extent he has availed himself of this opportunity, received satisfactory information and answers.
(f) Prior to exercising the Option, the Recipient had the opportunity to consult with Recipient's investment advisors who are independent of the Company, including, without limitation, investment, tax, accounting and legal advisors relative to (i) the investment merits of a proposed investment in the Option Shares and (ii) the tax consequences of the grant and exercise of the Option and the subsequent disposition of the Option Shares and the effect of same upon the Recipient's personal financial circumstances, and that the Recipient has, to the extent he has availed himself of this opportunity, received satisfactory information and answers from such investment advisors.
(g) The Recipient has been informed and understands and agrees as follows: there are substantial restrictions on the transferability of the Option Shares as are more particularly described in Article XI, Section 11.02 of the plan and, as a result of such restrictions, it may not be possible for the Recipient to sell or otherwise liquidate the Option Shares in the case of emergency and/or other need, and the Recipient must therefore be able to hold the Option Shares until the lapse of said restrictions; the Recipient must have adequate means of providing for the Recipient's current needs and personal contingencies; the Recipient must have not need for liquidity in an investment in the Option Shares; and the Recipient has evaluated the Recipient's financial resources and investment position in view of the foregoing; and that the Recipient is able to bear the economic risk of an investment in the Option Shares.
(h) The Option Shares are being purchased by the Recipient as principal and not by any other person, with the Recipient's own funds and not with the funds of any other person, and for the account of the Recipient and not as nominee or agent and not for the account of any other person. The Recipient is purchasing the Option Shares for investment for an indefinite period and not with a view to the sale of distribution of any part or all thereof by public or private sale or other disposition. Nor person other than the Recipient will have an interest, beneficial or otherwise, in the Option Shares, and the Recipient is not obligated to transfer the Option Shares to any other person nor does the Recipient have any agreement or understanding to do so.
(i) To the best of the Recipient's knowledge and belief the offer and sale of the Option Shares was not accomplished by the publication of any advertisement, article, notice or other communication published in any newspaper, magazine, or similar media or broadcast over television or radio; nor was the offer and sale of the Option Shares accomplished through any seminar or meeting to which the Recipient was invited by any such publication or advertisement.
Each representation, warranty and covenant of the Recipient shall be deemed made as of the time of grant of this Option, shall be deemed remade at any time the Recipient exercises this Option, and shall survive the date closing with respect to the exercise of the last Option hereunder.
11. MISCELLANEOUS
(a) PREPARATION OF STOCK OPTION CERTIFICATE. This Stock Option Certificate was prepared by the Company or its legal counsel solely on behalf of the Company. It is acknowledged by the Recipient that he or she was not represented by the Company or any of its officers, directors, employees or agents (including the Company's legal counsel) in connection with the transaction contemplated by this Stock Option Certificate, and that the Recipient had separate and independent advice of counsel. In light of the foregoing it is acknowledged by the Recipient that the Company shall not be construed to be solely responsible for the drafting hereof, and that any ambiguity in the Plan or this Stock Option Certificate, or the interpretation thereof or hereof, shall not be construed against the Company as the alleged draftsman of this Stock Option Certificate.
(b) INTERPRETATION.
(i) Entire Agreement/No Collateral Representations. The Recipient acknowledges and agrees that this Stock Option Certificate, together with and subject to the Plan: (1) is the final, complete and exclusive statement of the agreement of the parties with respect to the subject matter hereof; (2) supersedes any prior or contemporaneous agreements or understandings of any kind, oral or written (collectively and severally, the "prior agreements"), and that any such prior agreements are of no force or effect except as expressly set forth herein; and (3) may not be varied, supplemented or contradicted by evidence of prior agreements, or by evidence of subsequent oral agreements.
(ii) Amendment; Waiver. Except as expressly otherwise provided herein, neither this Stock Option Certificate nor any of its terms may be amended, supplemented, discharged or terminated (other than by performance), except as provided in the Plan or by a written instrument or instruments signed by all of the parties to this Stock Option Certificate. No waiver of any acts or obligations hereunder shall be effective unless such waiver shall be in a written instrument or instruments signed by each party claimed to have given or consented to such waiver and each party affected by such waiver.
(iii) Severability. If any term or provision of this Stock Option Certificate or the application thereof to any person or circumstance shall, to any extent, be determined to be invalid, illegal or unenforceable under present or future laws effective during the term of this Stock Option Certificate, then, and in that event: (A) the performance of the offending term or provision (but only to the extent its
application is invalid, illegal or unenforceable) shall be excused as if it had never been incorporated into this Stock Option Certificate, and, in lieu of such excused provision, there shall be added a provision as similar in terms and amount to such excused provision as may be possible and be legal, valid and enforceable, and (B) the remaining part of this Stock Option Certificate (including the application of the offending term or provision to persons or circumstances other than those as to which it is held invalid, illegal or unenforceable) shall not be affected thereby and shall continue in full force and effect to the fullest extent provided by law.
(iv) No Reliance Upon Prior Representation. The Recipient acknowledges that neither the Company nor any of its officers, directors, employees or agents have made any oral representation or promise which would induce the Recipient prior to executing this Stock Option Certificate to change the Recipient's position to the Recipient's detriment, partially perform, or part with value in reliance upon such representation or promise; the Recipient acknowledges that he or she has taken such action at its own risk; and the Recipient represents that he or she has not so changed his or her position, performed or parted with value prior to the time of his or her execution of this Stock Option Certificate.
(c) ENFORCEMENT. This Stock Option Certificate and the rights and remedies of each party arising out of or relating to this Stock Option Certificate shall be solely governed in accordance with the laws (without regard to the conflicts of law principles thereof) of the state of Delaware.
(d) SUCCESSORS AND ASSIGNS. The Recipient may not assign his rights or benefits or delegate any of his duties or obligations under this Stock Option Certificate, in whole or in part, without the prior written consent of the Company, except pursuant to the terms of the Plan. Subject to the foregoing, all of the representations, warranties, covenants, conditions and provisions of this Stock Option Certificate shall be binding upon and shall inure to the benefit of each party and such party's respective successors and permitted assigns, spouses, heirs, executors, administrators, and personal and legal representatives.
(e) NOTICES. Unless otherwise specifically provided in this Stock Option Certificate, all notices, demands, requests, consents, approvals or other communications (collectively and severally called "notices") required or permitted to be given hereunder, or which are given with respect to this Stock Option Certificate, shall be in writing, and shall be given by: (A) personal delivery (which form of notice shall be deemed to have been given upon delivery), (B) by telegraph or by private airborne/overnight delivery service (which forms of notice shall be deemed to have been given upon confirmed delivery by the delivery agency), (C) by electronic or facsimile or telephonic transmission, provided the receiving party has a compatible device or confirms receipt thereof (which forms of notice shall be deemed delivered upon confirmed transmission or confirmation of receipt), or (D) by mailing in the United States mail by registered or certified mail, return receipt requested, postage prepaid (which forms of notice shall be deemed to have been given upon the fifth {5th} business day following the date mailed).
WHEREFORE, the parties hereto have for purposes of this Stock Option Certificate executed this Stock Option Certificate in the City of Monrovia, County of Los Angeles, State of California, effective as of the 31st day of May 2000.
COMPANY:
STAAR Surgical Company,
a Delaware corporation
By: ________________________________
William C. Huddleston, President
ATTEST:
By: ________________________________
John Santos, Chief Financial Officer
RECIPIENT:
/s/ Volker D. Anhaeusser ------------------------------------ Volker D. Anhaeusser |
NOTICE OF EXERCISE OF STOCK OPTION
[To be signed by the Recipient only upon exercise of Option] TO: Secretary STAAR Surgical Company 1911 Walker Avenue Monrovia, California 91016 The undersigned, the holder of an Option under that certain Stock Option |
Certificate dated effective the 31st day of May 2000 (the "Option Certificate"), between STAAR Surgical Company, a Delaware corporation (the "Company") and the undersigned (the "Recipient"), hereby irrevocably elects, in accordance with the terms and conditions of that certain 1998 STAAR Surgical Company Stock Plan (the "Plan") adopted by the Board of Directors on April 17, 1998 and approved by the shareholders on May 29, 1998, under which the Option Certificate was granted, to exercise the undersigned's Option to purchase ____________________________ (______)(1) shares of the Company's voting common stock, $ .01 per share par value ("Common Stock") (collectively and severally, the "Option Shares"), for the aggregate purchase price of _____________________ ($______)(2).
(1) Insert number of Option Shares as specified in the Option Certificate which are vested Option Shares (as defined by the Plan) which the Recipient is exercising the Option to purchase.
(2) Number of Option Shares to be exercised as hereinabove specified multiplied by the Option Price per share.
The Recipient hereby remakes, reaffirms and reacknowledges all agreements, representations, warranties and covenants set forth in the Option Certificate as of the date of the Recipient's notice, all of which shall survive the Closing with respect to the shares of Common Stock purchased hereby.
The Recipient hereby acknowledges that the following legend (or any variation thereof determined appropriate by the Company) will be placed on the share certificate or certificates for the Option Shares to comply with applicable federal and state securities laws:
THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN (1) REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION AFFORDED BY SUCH ACT, OR (2) REGISTERED OR QUALIFIED UNDER THE SECURITIES LAWS OF ANY STATE OR TERRITORY OF THE UNITED STATES WHICH MAY BE APPLICABLE, IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION OR QUALIFICATION AFFORDED BY SUCH STATE OR TERRITORIAL SECURITIES LAWS. THESE SECURITIES HAVE BEEN ACQUIRED FOR THE HOLDER'S OWN ACCOUNT FOR INVESTMENT PURPOSES AND NOT WITH A VIEW FOR RESALE OR DISTRIBUTION. THESE SECURITIES MAY NOT BE SOLD OR TRANSFERRED UNLESS (A) THEY HAVE BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933 AS WELL AS UNDER THE SECURITIES LAWS OF ANY STATE OR TERRITORY OF THE UNITED STATES AS MAY THEN BE APPLICABLE, OR (B) THE TRANSFER AGENT (OR THE COMPANY IF THEN ACTING
AS ITS TRANSFER AGENT) IS PRESENTED WITH EITHER A WRITTEN OPINION SATISFACTORY TO COUNSEL FOR THE COMPANY OR A NO-ACTION OR INTERPRETIVE LETTER FROM THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION AND ANY APPLICABLE STATE OR TERRITORIAL SECURITIES REGULATORY AGENCY TO THE EFFECT THAT SUCH REGISTRATION OR QUALIFICATION IS NOT REQUIRED UNDER THE CIRCUMSTANCES OF SUCH SALE OR TRANSFER.
(Signature must conform in all respects to name of the Recipient as specified in the Plan, unless the undersigned is the Recipient's Successor, in which case the undersigned must submit appropriate proof of the right of the undersigned to exercise the Option.)
Signature:________________________________________
Print Name:_______________________________________
Address:__________________________________________
Date:________________
EXHIBIT 10.30
STOCK OPTION CERTIFICATE
This Stock Option Certificate is entered into between STAAR Surgical Company, a Delaware corporation (the "Company"), whose principal executive office is located at 1911 Walker Avenue, Monrovia, California 91016, and VOLKER ANHAEUSSER (the "Recipient") whose address is Anhausser Unger Eckle & Bergien, Kriegstrasse 85, D-76133 Karlsruhe, Germany, pursuant to that certain 1998 STAAR Surgical Company Stock Plan (the "Plan") adopted by the Board of Directors on April 17, 1998 and approved by the shareholders on May 29, 1998.
1. GRANT OF OPTION. Subject to the terms and conditions included herein, this Stock Option Certificate certifies that the Company has granted to the Recipient, pursuant to the terms of the Plan, an option (the "Option") to purchase, in whole or in part, Forty-Five Thousand (45,000) shares of the Company's voting common stock, par value $.01 (the "Common Stock") (collectively and severally, the "Option Shares"), at the price of Three dollars and Eighty-one cents ($3.81) per Option Share (the "Option Price"). The date of this grant is: January 2, 2002 (the "Grant Date").
2. PLAN; PLAN SUMMARY. The Recipient's rights to purchase the Option Shares are governed by the Plan, the terms of which are incorporated herein by this reference.
3. CHARACTER OF OPTION. This Option is [X] a Non-Qualified Option or [__] an Incentive Option.
4. CAPACITY OF RECIPIENT. This Option is granted to the Recipient in the Recipient's capacity as (i) [__] an employee, (ii) [X] a director, or (iii) [__] a consultant.
5. EXPIRATION OF OPTION. Subject to the terms and conditions set forth in this Stock Option Certificate and in the Plan, the right to exercise the Options granted by this Stock Option Certificate shall expire and be null and void and of no further force or effect to the extent not exercised by 5:00 p.m. Pacific Time, on the 1st day of January, 2007 (the "Option Expiration Date").
6. EXERCISE VESTING CONDITIONS. The Option is (i) [__] fully vested upon date of grant, or (ii) [X] subject to the following vesting schedule as well as based upon Recipient's continued performance of services in the capacity hereinabove indicated:
Cumulative Vested Percentage of Date Shares --------------- ----------------- January 2, 2002 33 1/3% January 2, 2003 66 2/3% January 2, 2004 100.0% |
7. MANNER OF EXERCISE AND PAYMENT. This Option shall be exercised by delivery of this Option Certificate to the Secretary of the Company, together with:
(a) A Consent of Spouse (as such consent is defined in the Plan) from the spouse of the Recipient, if any, duly signed by such spouse; and
(b) Full payment for the Option Shares to be purchased in goods funds (in U.S. dollars) by cash or check or through a "same day sale" commitment from the Recipient and a broker-dealer that is a member of the National Association of Securities Dealers (an "NASD Dealer") whereby the Recipient irrevocably elects to exercise the Option and to sell a portion of the Option Shares so purchased to pay for the Option Price, and whereby the NASD Dealer irrevocably commits upon receipt of such Option Shares to forward the Option Price directly to the Company.
8. FORFEITURE; VESTING CONDITIONS. This Option (i) [__] will be fully vested upon date of grant, or (ii) [X] will be subject to Article V, Section 5.05 and Article X of the Plan, inasmuch as the Option will be subject to: (A) the vesting schedule set forth above and (B) the special rules regulating vesting and forfeiture on Termination of Recipient.
9. RECIPIENT'S REPRESENTATIONS. The Recipient represents that the Recipient has received a Section 10(a) Prospectus, which explains the administration and operation of the Plan, and has received a copy of the Plan.
10. MISCELLANEOUS.
(a) PREPARATION OF STOCK OPTION CERTIFICATE. This Stock Option Certificate was prepared by the Company or its legal counsel solely on behalf of the Company. It is acknowledged by the Recipient that he or she was not represented by the Company or any of its officers, directors, employees or agents (including the Company's legal counsel) in connection with the transaction contemplated by this Stock Option Certificate, and that the Recipient had separate and independent advice of counsel. In light of the foregoing it is acknowledged by the Recipient that the Company shall not be construed to be solely responsible for the drafting hereof, and that any ambiguity in the Plan or this Stock Option Certificate, or the interpretation thereof or hereof, shall not be construed against the Company as the alleged draftsman of this Stock Option Certificate.
(b) INTERPRETATION.
(i) Entire Agreement/No Collateral Representations. The Recipient acknowledges and agrees that this Stock Option Certificate, together with and subject to the Plan: (1) is the final, complete and exclusive statement of the agreement of the parties with respect to the subject matter hereof; (2) supersedes any prior or contemporaneous agreements or understandings of any kind, oral or
written (collectively and severally, the "prior agreements"), and that any such prior agreements are of no force or effect except as expressly set forth herein; and (3) may not be varied, supplemented or contradicted by evidence of prior agreements, or by evidence of subsequent oral agreements.
(ii) Amendment; Waiver. Except as expressly otherwise provided herein, neither this Stock Option Certificate nor any of its terms may be amended, supplemented, discharged or terminated (other than by performance), except as provided in the Plan or by a written instrument or instruments signed by all of the parties to this Stock Option Certificate. No waiver of any acts or obligations hereunder shall be effective unless such waiver shall be in a written instrument or instruments signed by each party claimed to have given or consented to such waiver and each party affected by such waiver.
(iii) Severability. If any term or provision of this Stock Option Certificate or the application thereof to any person or circumstance shall, to any extent, be determined to be invalid, illegal or unenforceable under present or future laws effective during the term of this Stock Option Certificate, then, and in that event: (A) the performance of the offending term or provision (but only to the extent its application is invalid, illegal or unenforceable) shall be excused as if it had never been incorporated into this Stock Option Certificate, and, in lieu of such excused provision, there shall be added a provision as similar in terms and amount to such excused provision as may be possible and be legal, valid and enforceable, and (B) the remaining part of this Stock Option Certificate (including the application of the offending term or provision to persons or circumstances other than those as to which it is held invalid, illegal or unenforceable) shall not be affected thereby and shall continue in full force and effect to the fullest extent provided by law.
(c) ENFORCEMENT. This Stock Option Certificate and the rights and remedies of each party arising out of or relating to this Stock Option Certificate shall be solely governed in accordance with the laws (without regard to the conflicts of law principles thereof) of the state of Delaware.
(d) SUCCESSORS AND ASSIGNS. The Recipient may not assign his rights or benefits or delegate any of his duties or obligations under this Stock Option Certificate, in whole or in part, without the prior written consent of the Company, except pursuant to the terms of the Plan. Subject to the foregoing, all of the representations, warranties, covenants, conditions and provisions of this Stock Option Certificate shall be binding upon and shall inure to the benefit of each party and such party's respective successors and permitted assigns, spouses, heirs, executors, administrators, and personal and legal representatives.
(e) NOTICES. Unless otherwise specifically provided in this Stock Option Certificate, all notices, demands, requests, consents, approvals or other communications (collectively and severally called "notices") required or permitted to be given hereunder, or which are given with respect to this Stock Option Certificate, shall be in writing, and shall be given by: (A) personal delivery (which form of notice shall be deemed to have been given upon delivery), (B) by telegraph or by private airborne/overnight delivery service (which forms of notice shall be deemed to have been given upon confirmed delivery by the delivery agency), (C) by electronic or facsimile or telephonic transmission, provided the receiving party has a compatible device or confirms receipt thereof (which forms of notice shall be deemed delivered upon
confirmed transmission or confirmation of receipt), or (D) by mailing in the United States mail by registered or certified mail, return receipt requested, postage prepaid (which forms of notice shall be deemed to have been given upon the fifth {5th} business day following the date mailed).
WHEREFORE, the parties hereto have for purposes of this Stock Option Certificate executed this Stock Option Certificate in the City of Monrovia, County of Los Angeles, State of California, effective as of the 30th day of May 2002.
COMPANY:
STAAR Surgical Company,
a Delaware corporation
ATTACHMENT
TO
STOCK OPTION CERTIFICATE
NOTICE OF EXERCISE OF STOCK OPTION
NOTICE OF EXERCISE OF STOCK OPTION
[To be signed by the Recipient only upon exercise of Option] TO: Secretary STAAR Surgical Company 1911 Walker Avenue Monrovia, California 91016 The undersigned, the holder of an Option under that certain Stock Option |
Certificate dated effective the __________ day of _________, _____ (the "Option Certificate"), between STAAR Surgical Company, a Delaware corporation (the "Company") and the undersigned (the "Recipient"), hereby irrevocably elects, in accordance with the terms and conditions of that certain 1998 STAAR Surgical Company Stock Plan (the "Plan") adopted by the Board of Directors on April 17, 1998 and approved by the shareholders on May 29, 1998, under which the Option Certificate was granted, to exercise the undersigned's Option to purchase ______________________ (______)(1) shares of the Company's voting common stock, $ .01 per share par value ("Common Stock") (collectively and severally, the "Option Shares"), for the aggregate purchase price of __________________________ __________ ($_______)(2).
(1) Insert number of Option Shares as specified in the Option Certificate which are vested Option Shares (as defined by the Plan) which the Recipient is exercising the Option to purchase.
(2) Number of Option Shares to be exercised as hereinabove specified multiplied by the Option Price per share.
Signature:________________________________________
Print Name:_______________________________________
Address:__________________________________________
Date:_____________________________________________
EXHIBIT 10.32
STOCK OPTION CERTIFICATE
This Stock Option Certificate is entered into between STAAR Surgical Company, a Delaware corporation (the "Company"), whose principal executive office is located at 1911 Walker Avenue, Monrovia, California 91016, and Donald Duffy (the "Recipient") whose address is 1911 Walker Avenue, Monrovia, CA 91016 pursuant to that certain 1998 STAAR Surgical Company Stock Plan (the "Plan") adopted by the Board of Directors on April 17, 1998 and approved by the shareholders on May 29, 1998.
1. GRANT OF OPTION. Subject to the terms and conditions included herein, this Stock Option Certificate certifies that the Company has granted to the Recipient, pursuant to the terms of the Plan, an option (the "Option") to purchase, in whole or in part, sixty thousand (60,000) shares of the Company's voting common stock, par value $.01 (the "Common Stock") (collectively and severally, the "Option Shares"), at the price of three dollars and sixty-one cents ($3.61) per Option Share (the "Option Price"). The date of this grant is January 30, 2003 (the "Grant Date").
2. PLAN; PLAN SUMMARY. The Recipient's rights to purchase the Option Shares are governed by the Plan, the terms of which are incorporated herein by this reference.
3. CHARACTER OF OPTION. This Option is [X] a Non-Qualified Option or [__] an Incentive Option.
4. CAPACITY OF RECIPIENT. This Option is granted to the Recipient in the Recipient's capacity as (i) [__] an employee, (ii) [X] a director, or (iii) [__] a consultant.
5. EXPIRATION OF OPTION. Subject to the terms and conditions set forth in this Stock Option Certificate and in the Plan, the right to exercise the Options granted by this Stock Option Certificate shall expire and be null and void and of no further force or effect to the extent not exercised by 5:00 p.m. Pacific Time, on the 29th day of January, 2008 (the "Option Expiration Date").
6. EXERCISE VESTING CONDITIONS. The Option is (i) [__] fully vested upon date of grant, or (ii) [__] subject to the following vesting schedule as well as based upon Recipient's continued performance of services in the capacity hereinabove indicated:
Cumulative Vested Percentage of Date Shares ---- ----------------- 100.0% |
7. MANNER OF EXERCISE AND PAYMENT. This Option shall be exercised by delivery of this Option Certificate to the Secretary of the Company, together with:
(a) A Consent of Spouse (as such consent is defined in the Plan) from the spouse of the Recipient, if any, duly signed by such spouse; and
(b) Full payment for the Option Shares to be purchased in goods funds (in U.S. dollars) by cash or check or through a "same day sale" commitment from the Recipient and a broker-dealer that is a member of the National Association of Securities Dealers (an "NASD Dealer") whereby the Recipient irrevocably elects to exercise the Option and to sell a portion of the Option Shares so purchased to pay for the Option Price, and whereby the NASD Dealer irrevocably commits upon receipt of such Option Shares to forward the Option Price directly to the Company.
8. FORFEITURE; VESTING CONDITIONS. This Option (i) [__] will be fully vested upon date of grant, or (ii) [__] will be subject to Article V, Section 5.05 and Article X of the Plan, inasmuch as the Option will be subject to: (A) the vesting schedule set forth above and (B) the special rules regulating vesting and forfeiture on Termination of Recipient.
9. RECIPIENT'S REPRESENTATIONS. The Recipient represents that the Recipient has received a Section 10(a) Prospectus, which explains the administration and operation of the Plan, and has received a copy of the Plan.
10. MISCELLANEOUS.
(a) PREPARATION OF STOCK OPTION CERTIFICATE. This Stock Option Certificate was prepared by the Company or its legal counsel solely on behalf of the Company. It is acknowledged by the Recipient that he or she was not represented by the Company or any of its officers, directors, employees or agents (including the Company's legal counsel) in connection with the transaction contemplated by this Stock Option Certificate, and that the Recipient had separate and independent advice of counsel. In light of the foregoing it is acknowledged by the Recipient that the Company shall not be construed to be solely responsible for the drafting hereof, and that any ambiguity in the Plan or this Stock Option Certificate, or the interpretation thereof or hereof, shall not be construed against the Company as the alleged draftsman of this Stock Option Certificate.
(b) INTERPRETATION.
(i) Entire Agreement/No Collateral Representations. The Recipient acknowledges and agrees that this Stock Option Certificate, together with and subject to the Plan: (1) is the final, complete and exclusive statement of the agreement of the parties with respect to the subject matter hereof; (2) supersedes any prior or contemporaneous agreements or understandings of any kind, oral or written (collectively and severally, the "prior agreements"), and that any such prior agreements are of no force or effect except as expressly set forth herein; and (3) may not be varied, supplemented or contradicted by evidence of prior agreements, or by evidence of subsequent oral agreements.
(ii) Amendment; Waiver. Except as expressly otherwise provided herein, neither this Stock Option Certificate nor any of its terms may be amended, supplemented, discharged or
terminated (other than by performance), except as provided in the Plan or by a written instrument or instruments signed by all of the parties to this Stock Option Certificate. No waiver of any acts or obligations hereunder shall be effective unless such waiver shall be in a written instrument or instruments signed by each party claimed to have given or consented to such waiver and each party affected by such waiver.
(iii) Severability. If any term or provision of this Stock Option Certificate or the application thereof to any person or circumstance shall, to any extent, be determined to be invalid, illegal or unenforceable under present or future laws effective during the term of this Stock Option Certificate, then, and in that event: (A) the performance of the offending term or provision (but only to the extent its application is invalid, illegal or unenforceable) shall be excused as if it had never been incorporated into this Stock Option Certificate, and, in lieu of such excused provision, there shall be added a provision as similar in terms and amount to such excused provision as may be possible and be legal, valid and enforceable, and (B) the remaining part of this Stock Option Certificate (including the application of the offending term or provision to persons or circumstances other than those as to which it is held invalid, illegal or unenforceable) shall not be affected thereby and shall continue in full force and effect to the fullest extent provided by law.
(c) ENFORCEMENT. This Stock Option Certificate and the rights and remedies of each party arising out of or relating to this Stock Option Certificate shall be solely governed in accordance with the laws (without regard to the conflicts of law principles thereof) of the state of Delaware.
(d) SUCCESSORS AND ASSIGNS. The Recipient may not assign his rights or benefits or delegate any of his duties or obligations under this Stock Option Certificate, in whole or in part, without the prior written consent of the Company, except pursuant to the terms of the Plan. Subject to the foregoing, all of the representations, warranties, covenants, conditions and provisions of this Stock Option Certificate shall be binding upon and shall inure to the benefit of each party and such party's respective successors and permitted assigns, spouses, heirs, executors, administrators, and personal and legal representatives.
(e) NOTICES. Unless otherwise specifically provided in this Stock Option Certificate, all notices, demands, requests, consents, approvals or other communications (collectively and severally called "notices") required or permitted to be given hereunder, or which are given with respect to this Stock Option Certificate, shall be in writing, and shall be given by: (A) personal delivery (which form of notice shall be deemed to have been given upon delivery), (B) by telegraph or by private airborne/overnight delivery service (which forms of notice shall be deemed to have been given upon confirmed delivery by the delivery agency), (C) by electronic or facsimile or telephonic transmission, provided the receiving party has a compatible device or confirms receipt thereof (which forms of notice shall be deemed delivered upon confirmed transmission or confirmation of receipt), or (D) by mailing in the United States mail by registered or certified mail, return receipt requested, postage prepaid (which forms of notice shall be deemed to have been given upon the fifth {5th} business day following the date mailed).
WHEREFORE, the parties hereto have for purposes of this Stock Option Certificate executed this Stock Option Certificate in the City of Monrovia, County of Los Angeles, State of California, effective as of the _______ day of __________________ 2001.
COMPANY:
STAAR Surgical Company,
a Delaware corporation
By: /s/ John C. Bily ------------------------------------- John C. Bily, Chief Financial Officer ATTEST: |
[SEAL]
RECIPIENT:
/s/ Donald Duffy ----------------------------------------- |
ATTACHMENT
TO
STOCK OPTION CERTIFICATE
NOTICE OF EXERCISE OF STOCK OPTION
NOTICE OF EXERCISE OF STOCK OPTION
[To be signed by the Recipient only upon exercise of Option]
TO: Secretary
STAAR Surgical Company
1911 Walker Avenue
Monrovia, California 91016
The undersigned, the holder of an Option under that certain Stock Option Certificate dated effective the _________ day of ____________, _________ (the "Option Certificate"), between STAAR Surgical Company, a Delaware corporation (the "Company") and the undersigned (the "Recipient"), hereby irrevocably elects, in accordance with the terms and conditions of that certain 1998 STAAR Surgical Company Stock Plan (the "Plan") adopted by the Board of Directors on April 17, 1998 and approved by the shareholders on May 29, 1998, under which the Option Certificate was granted, to exercise the undersigned's Option to purchase _________________ (______)(1) shares of the Company's voting common stock, $ .01 per share par value ("Common Stock") (collectively and severally, the "Option Shares"), for the aggregate purchase price of _____________________ ($_____)(2).
(1) Insert number of Option Shares as specified in the Option Certificate which are vested Option Shares (as defined by the Plan) which the Recipient is exercising the Option to purchase.
(2) Number of Option Shares to be exercised as hereinabove specified multiplied by the Option Price per share.
Signature:________________________________________
Print Name:_______________________________________
Address:__________________________________________
Date:_____________________________________________
EXHIBIT 10.34
STOCK OPTION CERTIFICATE
This Stock Option Certificate is entered into between STAAR Surgical Company, a Delaware corporation (the "Company"), whose principal executive office is located at 1911 Walker Avenue, Monrovia, California 91016, and JOHN C. BILY (the "Recipient") whose address is 1911 Walker Avenue, Monrovia, California 91016, pursuant to that certain 1998 STAAR Surgical Company Stock Plan (the "Plan") adopted by the Board of Directors on April 17, 1998 and approved by the shareholders on May 29, 1998.
1. GRANT OF OPTION. Subject to the terms and conditions included herein, this Stock Option Certificate certifies that the Company has granted to the Recipient, pursuant to the terms of the Plan, an option (the "Option") to purchase, in whole or in part, One Hundred Thousand (100,000) shares of the Company's voting common stock, par value $.01 (the "Common Stock") (collectively and severally, the "Option Shares"), at the price of Three dollars and Twenty-nine cents ($3.29) per Option Share (the "Option Price"). The date of this grant is: December 12, 2001 (the "Grant Date").
2. PLAN; PLAN SUMMARY. The Recipient's rights to purchase the Option Shares are governed by the Plan, the terms of which are incorporated herein by this reference.
3. CHARACTER OF OPTION. This Option is [__] a Non-Qualified Option or [X] an Incentive Option.
4. CAPACITY OF RECIPIENT. This Option is granted to the Recipient in the Recipient's capacity as (i) [X] an employee, (ii) [__] a director, or (iii) [__] a consultant.
5. EXPIRATION OF OPTION. Subject to the terms and conditions set forth in this Amended and Restated Stock Option Certificate and in the Plan, the right to exercise the Options granted by this Amended and Restated Stock Option Certificate shall expire and be null and void and of no further force or effect to the extent not exercised by 5:00 p.m. Pacific Time, on the 11th day of December, 2006 (the "Option Expiration Date").
6. EXERCISE VESTING CONDITIONS. The Option is (i) [__] fully vested upon date of grant, or (ii) [X] subject to the following vesting schedule as well as based upon Recipient's continued performance of services in the capacity hereinabove indicated:
Cumulative Vested Percentage of Date Shares ----------------- ----------------- December 12, 2002 33 1/3% December 12, 2003 66 2/3% December 12, 2004 100.0% |
The above vesting schedule will be accelerated according to the Recipient's achievement of certain goals and objectives to be determined at a later date. A summary of the milestones will be attached
to this agreement and will have the same force and effect as if the milestones were stated herein.
7. MANNER OF EXERCISE AND PAYMENT. This Option shall be exercised by delivery of this Option Certificate to the Secretary of the Company, together with:
(a) A Consent of Spouse (as such consent is defined in the Plan) from the spouse of the Recipient, if any, duly signed by such spouse; and
(b) Full payment for the Option Shares to be purchased in goods funds (in U.S. dollars) by cash or check or through a "same day sale" commitment from the Recipient and a broker-dealer that is a member of the National Association of Securities Dealers (an "NASD Dealer") whereby the Recipient irrevocably elects to exercise the Option and to sell a portion of the Option Shares so purchased to pay for the Option Price, and whereby the NASD Dealer irrevocably commits upon receipt of such Option Shares to forward the Option Price directly to the Company.
8. FORFEITURE; VESTING CONDITIONS. This Option (i) [__] will be fully vested upon date of grant, or (ii) [X] will be subject to Article V, Section 5.05 and Article X of the Plan, inasmuch as the Option will be subject to: (A) the vesting schedule set forth above and (B) the special rules regulating vesting and forfeiture on Termination of Recipient.
9. RECIPIENT'S REPRESENTATIONS. The Recipient represents that the Recipient has received a Section 10(a) Prospectus, which explains the administration and operation of the Plan, and has received a copy of the Plan.
10. MISCELLANEOUS.
(a) PREPARATION OF STOCK OPTION CERTIFICATE. This Amended and Restated Stock Option Certificate was prepared by the Company or its legal counsel solely on behalf of the Company. It is acknowledged by the Recipient that he or she was not represented by the Company or any of its officers, directors, employees or agents (including the Company's legal counsel) in connection with the transaction contemplated by this Amended and Restated Stock Option Certificate, and that the Recipient had separate and independent advice of counsel. In light of the foregoing it is acknowledged by the Recipient that the Company shall not be construed to be solely responsible for the drafting hereof, and that any ambiguity in the Plan or this Amended and Restated Stock Option Certificate, or the interpretation thereof or hereof, shall not be construed against the Company as the alleged draftsman of this Amended and Restated Stock Option Certificate.
(b) INTERPRETATION.
(i) Entire Agreement/No Collateral Representations. The Recipient acknowledges and agrees that this Amended and Restated Stock Option Certificate, together with and subject to the Plan: (1) is the final, complete and exclusive statement of the agreement of the parties with respect to the subject matter hereof; (2) supersedes any prior or contemporaneous agreements or understandings of any kind, oral or written (collectively and severally, the "prior
agreements"), and that any such prior agreements are of no force or effect except as expressly set forth herein; and (3) may not be varied, supplemented or contradicted by evidence of prior agreements, or by evidence of subsequent oral agreements.
(ii) Amendment; Waiver. Except as expressly otherwise provided herein, neither this Amended and Restated Stock Option Certificate nor any of its terms may be amended, supplemented, discharged or terminated (other than by performance), except as provided in the Plan or by a written instrument or instruments signed by all of the parties to this Amended and Restated Stock Option Certificate. No waiver of any acts or obligations hereunder shall be effective unless such waiver shall be in a written instrument or instruments signed by each party claimed to have given or consented to such waiver and each party affected by such waiver.
(iii) Severability. If any term or provision of this Amended and Restated Stock Option Certificate or the application thereof to any person or circumstance shall, to any extent, be determined to be invalid, illegal or unenforceable under present or future laws effective during the term of this Amended and Restated Stock Option Certificate, then, and in that event: (A) the performance of the offending term or provision (but only to the extent its application is invalid, illegal or unenforceable) shall be excused as if it had never been incorporated into this Amended and Restated Stock Option Certificate, and, in lieu of such excused provision, there shall be added a provision as similar in terms and amount to such excused provision as may be possible and be legal, valid and enforceable, and (B) the remaining part of this Amended and Restated Stock Option Certificate (including the application of the offending term or provision to persons or circumstances other than those as to which it is held invalid, illegal or unenforceable) shall not be affected thereby and shall continue in full force and effect to the fullest extent provided by law.
(c) ENFORCEMENT. This Amended and Restated Stock Option Certificate and the rights and remedies of each party arising out of or relating to this Amended and Restated Stock Option Certificate shall be solely governed in accordance with the laws (without regard to the conflicts of law principles thereof) of the state of Delaware.
(d) SUCCESSORS AND ASSIGNS. The Recipient may not assign his rights or benefits or delegate any of his duties or obligations under this Amended and Restated Stock Option Certificate, in whole or in part, without the prior written consent of the Company, except pursuant to the terms of the Plan. Subject to the foregoing, all of the representations, warranties, covenants, conditions and provisions of this Amended and Restated Stock Option Certificate shall be binding upon and shall inure to the benefit of each party and such party's respective successors and permitted assigns, spouses, heirs, executors, administrators, and personal and legal representatives.
(e) NOTICES. Unless otherwise specifically provided in this Amended and Restated Stock Option Certificate, all notices, demands, requests, consents, approvals or other communications (collectively and severally called "notices") required or permitted to be given hereunder, or which are given with respect to this Amended and Restated Stock Option Certificate, shall be in writing, and shall be given by: (A) personal delivery (which form of notice shall be deemed to have been given upon delivery), (B) by telegraph or by private airborne/overnight delivery service (which forms of notice shall be deemed to have been given upon confirmed delivery by the delivery agency), (C) by electronic or facsimile or telephonic transmission, provided
the receiving party has a compatible device or confirms receipt thereof (which forms of notice shall be deemed delivered upon confirmed transmission or confirmation of receipt), or (D) by mailing in the United States mail by registered or certified mail, return receipt requested, postage prepaid (which forms of notice shall be deemed to have been given upon the fifth {5th} business day following the date mailed).
WHEREFORE, the parties hereto have for purposes of this Amended and Restated Stock Option Certificate executed this Amended and Restated Stock Option Certificate in the City of Monrovia, County of Los Angeles, State of California, effective as of the 18 January 2002.
COMPANY:
STAAR Surgical Company,
a Delaware corporation
By: /s/ David Bailey -------------------------- David Bailey ATTEST: By: /s/ John Santos -------------------------- John Santos, Secretary |
[SEAL]
RECIPIENT:
/s/ John Bily -------------------------- |
ATTACHMENT
TO
STOCK OPTION CERTIFICATE
NOTICE OF EXERCISE OF STOCK OPTION
NOTICE OF EXERCISE OF STOCK OPTION
[To be signed by the Recipient only upon exercise of Option] TO: Secretary STAAR Surgical Company 1911 Walker Avenue Monrovia, California 91016 The undersigned, the holder of an Option under that certain Amended and |
Restated Stock Option Certificate dated effective the _____ day of ___________, ______ (the "Option Certificate"), between STAAR Surgical Company, a Delaware corporation (the "Company") and the undersigned (the "Recipient"), hereby irrevocably elects, in accordance with the terms and conditions of that certain 1998 STAAR Surgical Company Stock Plan (the "Plan") adopted by the Board of Directors on April 17, 1998 and approved by the shareholders on May 29, 1998, under which the Option Certificate was granted, to exercise the undersigned's Option to purchase (___)(1) shares of the Company's voting common stock, $ .01 per share par value ("Common Stock") (collectively and severally, the "Option Shares"), for the aggregate purchase price of ($______)(2).
(1) Insert number of Option Shares as specified in the Option Certificate which are vested Option Shares (as defined by the Plan) which the Recipient is exercising the Option to purchase.
(2) Number of Option Shares to be exercised as hereinabove specified multiplied by the Option Price per share.
Signature:________________________________________
Print Name:_______________________________________
Address:__________________________________________
Date:_____________________________________________
EXHIBIT 10.35
AMENDED AND RESTATED STOCK OPTION CERTIFICATE
This Amended and Restated Stock Option Certificate dated February 12, 2003 replaces in its entirety the Amended and Restated Stock Option Certificate dated February 12, 2003 and is entered into between STAAR Surgical Company, a Delaware corporation (the "Company"), whose principal executive office is located at 1911 Walker Avenue, Monrovia, California 91016, and JOHN C. BILY (the "Recipient") whose address is 1911 Walker Avenue, Monrovia, CA 91016, pursuant to that certain 1998 STAAR Surgical Company Stock Plan (the "Plan") adopted by the Board of Directors on April 17, 1998 and approved by the shareholders on May 29, 1998.
1. GRANT OF OPTION. Subject to the terms and conditions included herein, this Amended and Restated Stock Option Certificate certifies that the Company has granted to the Recipient, pursuant to the terms of the Plan, an option (the "Option") to purchase, in whole or in part, fifty thousand (50,000) shares of the Company's voting common stock, par value $.01 (the "Common Stock") (collectively and severally, the "Option Shares"), at the price of three dollars and sixty cents ($3.60) per Option Share (the "Option Price"). The date of this grant is February 13, 2003 (the "Grant Date").
2. PLAN; PLAN SUMMARY. The Recipient's rights to purchase the Option Shares are governed by the Plan, the terms of which are incorporated herein by this reference.
3. CHARACTER OF OPTION. This Option is [__] a Non-Qualified Option or [X] an Incentive Option.
4. CAPACITY OF RECIPIENT. This Option is granted to the Recipient in the Recipient's capacity as (i) [X] an employee, (ii) [__] a director, or (iii) [__] a consultant.
5. EXPIRATION OF OPTION. Subject to the terms and conditions set forth in this Stock Option Certificate and in the Plan, the right to exercise the Options granted by this Stock Option Certificate shall expire and be null and void and of no further force or effect to the extent not exercised by 5:00 p.m. Pacific Time, on the 12th day of February, 2008 (the "Option Expiration Date").
6. EXERCISE VESTING CONDITIONS. The Option is (i) [__] fully vested upon date of grant, or (ii) [X] subject to the following vesting schedule as well as based upon Recipient's continued performance of services in the capacity hereinabove indicated:
Cumulative Vested Percentage of Date Shares ----------------- ----------------- February 13, 2004 33 1/3% February 13, 2005 66 2/3% February 13, 2006 100.0% |
The above vesting schedule will be accelerated according to the Recipient's achievement of certain
goals and objectives as stated below:
(i) the right to purchase twenty-five thousand (25,000) Option Shares shall vest on April 1, 2004, so long as the Company has generated cash from operating activities exceeding two million dollars ($2,000,000) in fiscal year 2003; and
(ii) the right to purchase twenty-five thousand (25,000) Option Shares shall vest on April 1, 2004, so long as the Company achieves or exceeds its planned cost of goods on manufactured product for fiscal year 2003.
7. MANNER OF EXERCISE AND PAYMENT. This Option shall be exercised by delivery of this Option Certificate to the Secretary of the Company, together with:
(a) A Consent of Spouse (as such consent is defined in the Plan) from the spouse of the Recipient, if any, duly signed by such spouse; and
(b) Full payment for the Option Shares to be purchased in goods funds (in U.S. dollars) by cash or check or through a "same day sale" commitment from the Recipient and a broker-dealer that is a member of the National Association of Securities Dealers (an "NASD Dealer") whereby the Recipient irrevocably elects to exercise the Option and to sell a portion of the Option Shares so purchased to pay for the Option Price, and whereby the NASD Dealer irrevocably commits upon receipt of such Option Shares to forward the Option Price directly to the Company.
8. FORFEITURE; VESTING CONDITIONS. This Option (i) [__] will be fully vested upon date of grant, or (ii) [X] will be subject to Article V, Section 5.05 and Article X of the Plan, inasmuch as the Option will be subject to: (A) the vesting schedule set forth above and (B) the special rules regulating vesting and forfeiture on Termination of Recipient.
9. RECIPIENT'S REPRESENTATIONS. The Recipient represents that the Recipient has received a Section 10(a) Prospectus, which explains the administration and operation of the Plan, and has received a copy of the Plan.
10. MISCELLANEOUS.
(a) PREPARATION OF STOCK OPTION CERTIFICATE. This Amended and Restated Stock Option Certificate was prepared by the Company or its legal counsel solely on behalf of the Company. It is acknowledged by the Recipient that he or she was not represented by the Company or any of its officers, directors, employees or agents (including the Company's legal counsel) in connection with the transaction contemplated by this Amended and Restated Stock Option Certificate, and that the Recipient had separate and independent advice of counsel. In light of the foregoing it is acknowledged by the Recipient that the Company shall not be construed to be solely responsible for the drafting hereof, and that any ambiguity in the Plan or this Amended and Restated Stock Option Certificate, or the interpretation thereof or hereof, shall not be construed against the Company as the alleged draftsman of this Amended and Restated Stock Option Certificate.
(b) INTERPRETATION.
(i) Entire Agreement/No Collateral Representations. The Recipient acknowledges and agrees that this Amended and Restated Stock Option Certificate, together with and subject to the Plan: (1) is the final, complete and exclusive statement of the agreement of the parties with respect to the subject matter hereof; (2) supersedes any prior or contemporaneous agreements or understandings of any kind, oral or written (collectively and severally, the "prior agreements"), and that any such prior agreements are of no force or effect except as expressly set forth herein; and (3) may not be varied, supplemented or contradicted by evidence of prior agreements, or by evidence of subsequent oral agreements.
(ii) Amendment; Waiver. Except as expressly otherwise provided herein, neither this Amended and Restated Stock Option Certificate nor any of its terms may be amended, supplemented, discharged or terminated (other than by performance), except as provided in the Plan or by a written instrument or instruments signed by all of the parties to this Amended and Restated Stock Option Certificate. No waiver of any acts or obligations hereunder shall be effective unless such waiver shall be in a written instrument or instruments signed by each party claimed to have given or consented to such waiver and each party affected by such waiver.
(iii) Severability. If any term or provision of this Amended and Restated Stock Option Certificate or the application thereof to any person or circumstance shall, to any extent, be determined to be invalid, illegal or unenforceable under present or future laws effective during the term of this Amended and Restated Stock Option Certificate, then, and in that event: (A) the performance of the offending term or provision (but only to the extent its application is invalid, illegal or unenforceable) shall be excused as if it had never been incorporated into this Amended and Restated Stock Option Certificate, and, in lieu of such excused provision, there shall be added a provision as similar in terms and amount to such excused provision as may be possible and be legal, valid and enforceable, and (B) the remaining part of this Amended and Restated Stock Option Certificate (including the application of the offending term or provision to persons or circumstances other than those as to which it is held invalid, illegal or unenforceable) shall not be affected thereby and shall continue in full force and effect to the fullest extent provided by law.
(c) ENFORCEMENT. This Amended and Restated Stock Option Certificate and the rights and remedies of each party arising out of or relating to this Amended and Restated Stock Option Certificate shall be solely governed in accordance with the laws (without regard to the conflicts of law principles thereof) of the state of Delaware.
(d) SUCCESSORS AND ASSIGNS. The Recipient may not assign his rights or benefits or delegate any of his duties or obligations under this Amended and Restated Stock Option Certificate, in whole or in part, without the prior written consent of the Company, except pursuant to the terms of the Plan. Subject to the foregoing, all of the representations, warranties, covenants, conditions and provisions of this Amended and Restated Stock Option Certificate shall be binding upon and shall inure to the benefit of each party and such party's respective successors and permitted assigns, spouses, heirs, executors, administrators, and personal and legal representatives.
(e) NOTICES. Unless otherwise specifically provided in this Amended and Restated Stock Option Certificate, all notices, demands, requests, consents, approvals or other communications (collectively and severally called "notices") required or permitted to be given hereunder, or which are given with respect to this Amended and Restated Stock Option Certificate, shall be in writing, and shall be given by: (A) personal delivery (which form of notice shall be deemed to have been given upon delivery), (B) by telegraph or by private airborne/overnight delivery service (which forms of notice shall be deemed to have been given upon confirmed delivery by the delivery agency), (C) by electronic or facsimile or telephonic transmission, provided the receiving party has a compatible device or confirms receipt thereof (which forms of notice shall be deemed delivered upon confirmed transmission or confirmation of receipt), or (D) by mailing in the United States mail by registered or certified mail, return receipt requested, postage prepaid (which forms of notice shall be deemed to have been given upon the fifth {5th} business day following the date mailed).
WHEREFORE, the parties hereto have for purposes of this Amended and Restated Stock Option Certificate executed this Amended and Restated Stock Option Certificate in the City of Monrovia, County of Los Angeles, State of California, effective as of the 13th day of February, 2003.
COMPANY:
STAAR Surgical Company,
a Delaware corporation
By: /s/ John Bily ---------------------------- John C. Bily, Secretary ATTEST: |
[SEAL]
RECIPIENT:
/s/ John Bily ---------------------------- John Bily |
ATTACHMENT
TO
STOCK OPTION CERTIFICATE
NOTICE OF EXERCISE OF STOCK OPTION
NOTICE OF EXERCISE OF STOCK OPTION
[To be signed by the Recipient only upon exercise of Option] TO: Secretary STAAR Surgical Company 1911 Walker Avenue Monrovia, California 91016 The undersigned, the holder of an Option under that certain Amended and |
Restated Stock Option Certificate dated effective the ______ day of ___________, _____ (the "Option Certificate"), between STAAR Surgical Company, a Delaware corporation (the "Company") and the undersigned (the "Recipient"), hereby irrevocably elects, in accordance with the terms and conditions of that certain 1998 STAAR Surgical Company Stock Plan (the "Plan") adopted by the Board of Directors on April 17, 1998 and approved by the shareholders on May 29, 1998, under which the Option Certificate was granted, to exercise the undersigned's Option to purchase (___)(1) shares of the Company's voting common stock, $ .01 per share par value ("Common Stock") (collectively and severally, the "Option Shares"), for the aggregate purchase price of ($_____)(2).
(1) Insert number of Option Shares as specified in the Option Certificate which are vested Option Shares (as defined by the Plan) which the Recipient is exercising the Option to purchase.
(2) Number of Option Shares to be exercised as hereinabove specified multiplied by the Option Price per share.
Signature:________________________________________
Print Name:_______________________________________
Address:__________________________________________
Date:_____________________________________________
EXHIBIT 10.36
July 12, 2002
Mr. Nick Curtis
Dear Mr. Curtis:
STAAR Surgical Company is pleased to offer you the position of Sr. Vice President Sales and Marketing (U.S. and Canada), reporting directly to me. Your beginning wage will be $7,692.31 per bi-weekly payroll, in addition to all the benefits offered in our current policy.
Also included in your compensation package is an annual bonus, which will be targeted to pay up to 50% of your base salary, based on the achievement of specific objectives of which the major component - 80% of the total for the first two years - will be linked to market share growth and sales increase within the U.S. and Canadian market. Should sales growth targets be exceeded, there will be no cap on the percentage bonus that may be earned. The 2002 bonus payment will be pro-rated according to the actual number of months worked.
To further solidify our offer and subject to approval by the compensation committee, we are awarding you 75,000 STAAR Surgical Company stock options, priced at the market value on the date of acceptance of this offer, and vested in equal increments over a three year period. Additionally, 50,000 STAAR Surgical Company stock options will be available at the end of 2002 fiscal year and may be awarded based on the achievement of sales growth in the second half of 2002 versus the first half of 2002, and will be priced at the close of business on the last day of fiscal 2002, vested over a three year period. The compensation committee will review and decide on the exact size of the second award based on your performance.
STAAR Surgical will pay relocation costs from Illinois to California as outlined below:
1. Full move services. Household goods only.
2. Storage of items up to 60 days.
3. One car transported. Mileage reimbursed for second car.
4. Two days plus reasonable number of travel days expense to include lodging, meals and mileage reimbursed.
5. Two trips homefinding assistance - not to exceed four days each.
6. Temporary living expense up to 60 days.
7. Incidental expense allowance up to $1,000.
8. Closing costs on primary residence. Excludes mobile homes, excess acreage, resort homes, houseboats.
9. Traditional closing costs on home purchase up to $2,000.
Additionally, upon relocation to California, your salary and eligibility to an additional stock option grant will be reviewed. A change of control provision will be added to your terms of employment upon relocation whereby if the company is acquired and if the essential duties and responsibilities as set forth in your job description are significantly changed resulting in a loss of employment or if your employment is terminated without cause, all stock options issued to you will immediately vest and you will be entitled to payment of one year base salary.
Upon acceptance of this offer and the successful completion of a pre-employment physical, you may begin work on or before September 3, 2002. Please note that a drug test is included in the physical. Employment is at the mutual consent of the employee and STAAR and can be terminated "at will" with or without cause, by the employee or by STAAR in its sole discretion at any time.
On your first day of employment you will need to bring with you identification in order to complete all necessary paperwork, including your Employment Eligibility Verification (form I-9).
You will be asked to do your best to accomplish the mission working as part of our team and in return, STAAR offers many great opportunities. This offer is valid until July 16, 2002.
Sincerely,
/s/ David Bailey -------------------------------------- David Bailey President and Chief Executive Officer /s/ Nicholas T. Curtis 7/15/02 --------------------------------------- --------- Accepted By Date |
EXHIBIT 10.37
February 14, 2003
Mr. Nick Curtis
Dear Nick:
I am writing to confirm the changes that will take place in your compensation package related to your relocation to California. Effective July 1, 2003, your base salary will increase to $225,000 or $8,653.80 per bi-weekly pay period.
In addition, you agree to make the arrangements for bridge financing for the move to California and STAAR agrees to pay the cost of financing for a maximum six month period from the date of closing on the new property in California. In addition to paying for bridge financing, STAAR will also pay the mortgage on the new property for a maximum six-month period. If you house in Chicago is sold within this six-month period, this funding will immediately cease.
STAAR is adding to the terms of your employment a change of control provision effective immediately, with the compensation being equal to the revised base salary, plus 50% of the base as bonus reverting after two years to the average bonus actually earned over the prior two-year period.
If your employment is terminated for any reason without cause within the first two years of your relocation, you will receive 18 months of base salary. After the first two years, this figure will drop to one-year base salary and the average of the prior two years' bonus.
The abovementioned changes to your compensation package will be memorialized in an employment agreement that will be provided to you under separate cover.
Sincerely,
/s/ David Bailey ------------------------------------- David Bailey President and Chief Executive Officer |
EXHIBIT 10.38
STOCK OPTION CERTIFICATE
This Stock Option Certificate is entered into between STAAR Surgical Company, a Delaware corporation (the "Company"), whose principal executive office is located at 1911 Walker Avenue, Monrovia, California 91016, and Nick Curtis (the "Recipient") whose address is 1911 Walker Avenue, Monrovia, California 91016, pursuant to that certain 1998 STAAR Surgical Company Stock Plan (the "Plan") adopted by the Board of Directors on April 17, 1998 and approved by the shareholders on May 29, 1998.
1. GRANT OF OPTION. Subject to the terms and conditions included herein, this Stock Option Certificate certifies that the Company has granted to the Recipient, pursuant to the terms of the Plan, an option (the "Option") to purchase, in whole or in part, seventy-five thousand (75,000) shares of the Company's voting common stock, par value $.01 (the "Common Stock") (collectively and severally, the "Option Shares"), at the price of three dollars and forty-five cents ($3.45) per Option Share (the "Option Price"). The date of this grant is July 15, 2002 (the "Grant Date").
2. PLAN; PLAN SUMMARY. The Recipient's rights to purchase the Option Shares are governed by the Plan, the terms of which are incorporated herein by this reference.
3. CHARACTER OF OPTION. This Option is [__] a Non-Qualified Option or [X] an Incentive Option.
4. CAPACITY OF RECIPIENT. This Option is granted to the Recipient in the Recipient's capacity as (i) [X] an employee, (ii) [__] a director, or (iii) [__] a consultant.
5. EXPIRATION OF OPTION. Subject to the terms and conditions set forth in this Amended and Restated Stock Option Certificate and in the Plan, the right to exercise the Options granted by this Amended and Restated Stock Option Certificate shall expire and be null and void and of no further force or effect to the extent not exercised by 5:00 p.m. Pacific Time, on the 15th day of July, 2007 (the "Option Expiration Date").
6. EXERCISE VESTING CONDITIONS. The Option is (i) [__] fully vested upon date of grant, or (ii) [X] subject to the following vesting schedule as well as based upon Recipient's continued performance of services in the capacity hereinabove indicated:
Cumulative Vested Percentage of Date Shares ------------- ----------------- July 15, 2003 33 1/3% July 15, 2004 66 2/3% July 15, 2005 100.0% |
7. MANNER OF EXERCISE AND PAYMENT. This Option shall be exercised by delivery of this Option Certificate to the Secretary of the Company, together with:
(a) A Consent of Spouse (as such consent is defined in the Plan) from the spouse of the Recipient, if any, duly signed by such spouse; and
(b) Full payment for the Option Shares to be purchased in goods funds (in U.S. dollars) by cash or check or through a "same day sale" commitment from the Recipient and a broker-dealer that is a member of the National Association of Securities Dealers (an "NASD Dealer") whereby the Recipient irrevocably elects to exercise the Option and to sell a portion of the Option Shares so purchased to pay for the Option Price, and whereby the NASD Dealer irrevocably commits upon receipt of such Option Shares to forward the Option Price directly to the Company.
8. FORFEITURE; VESTING CONDITIONS. This Option (i) [__] will be fully vested upon date of grant, or (ii) [X] will be subject to Article V, Section 5.05 and Article X of the Plan, inasmuch as the Option will be subject to: (A) the vesting schedule set forth above and (B) the special rules regulating vesting and forfeiture on Termination of Recipient.
9. RECIPIENT'S REPRESENTATIONS. The Recipient represents that the Recipient has received a Section 10(a) Prospectus, which explains the administration and operation of the Plan, and has received a copy of the Plan.
10. MISCELLANEOUS.
(a) PREPARATION OF STOCK OPTION CERTIFICATE. This Amended and Restated Stock Option Certificate was prepared by the Company or its legal counsel solely on behalf of the Company. It is acknowledged by the Recipient that he or she was not represented by the Company or any of its officers, directors, employees or agents (including the Company's legal counsel) in connection with the transaction contemplated by this Amended and Restated Stock Option Certificate, and that the Recipient had separate and independent advice of counsel. In light of the foregoing it is acknowledged by the Recipient that the Company shall not be construed to be solely responsible for the drafting hereof, and that any ambiguity in the Plan or this Amended and Restated Stock Option Certificate, or the interpretation thereof or hereof, shall not be construed against the Company as the alleged draftsman of this Amended and Restated Stock Option Certificate.
(b) INTERPRETATION.
(i) Entire Agreement/No Collateral Representations. The Recipient acknowledges and agrees that this Amended and Restated Stock Option Certificate, together with and subject to the Plan: (1) is the final, complete and exclusive statement of the agreement of the parties with respect to the subject matter hereof; (2) supersedes any prior or contemporaneous agreements or understandings of any kind, oral or written (collectively and severally, the "prior agreements"), and that any such prior agreements are of no force or effect except as expressly set forth herein; and (3) may not be varied, supplemented or contradicted by evidence of prior agreements, or by evidence of subsequent oral agreements.
(ii) Amendment; Waiver. Except as expressly otherwise provided herein, neither this Amended and Restated Stock Option Certificate nor any of its terms may be amended, supplemented, discharged or terminated (other than by performance), except as provided in the Plan or by a written instrument or instruments signed by all of the parties to this Amended and Restated Stock Option Certificate. No waiver of any acts or obligations hereunder shall be effective unless such waiver shall be in a written instrument or instruments signed by each party claimed to have given or consented to such waiver and each party affected by such waiver.
(iii) Severability. If any term or provision of this Amended and Restated Stock Option Certificate or the application thereof to any person or circumstance shall, to any extent, be determined to be invalid, illegal or unenforceable under present or future laws effective during the term of this Amended and Restated Stock Option Certificate, then, and in that event: (A) the performance of the offending term or provision (but only to the extent its application is invalid, illegal or unenforceable) shall be excused as if it had never been incorporated into this Amended and Restated Stock Option Certificate, and, in lieu of such excused provision, there shall be added a provision as similar in terms and amount to such excused provision as may be possible and be legal, valid and enforceable, and (B) the remaining part of this Amended and Restated Stock Option Certificate (including the application of the offending term or provision to persons or circumstances other than those as to which it is held invalid, illegal or unenforceable) shall not be affected thereby and shall continue in full force and effect to the fullest extent provided by law.
(c) ENFORCEMENT. This Amended and Restated Stock Option Certificate and the rights and remedies of each party arising out of or relating to this Amended and Restated Stock Option Certificate shall be solely governed in accordance with the laws (without regard to the conflicts of law principles thereof) of the state of Delaware.
(d) SUCCESSORS AND ASSIGNS. The Recipient may not assign his rights or benefits or delegate any of his duties or obligations under this Amended and Restated Stock Option Certificate, in whole or in part, without the prior written consent of the Company, except pursuant to the terms of the Plan. Subject to the foregoing, all of the representations, warranties, covenants, conditions and provisions of this Amended and Restated Stock Option Certificate shall be binding upon and shall inure to the benefit of each party and such party's respective successors and permitted assigns, spouses, heirs, executors, administrators, and personal and legal representatives.
(e) NOTICES. Unless otherwise specifically provided in this Amended and Restated Stock Option Certificate, all notices, demands, requests, consents, approvals or other communications (collectively and severally called "notices") required or permitted to be given hereunder, or which are given with respect to this Amended and Restated Stock Option Certificate, shall be in writing, and shall be given by: (A) personal delivery (which form of notice shall be deemed to have been given upon delivery), (B) by telegraph or by private airborne/overnight delivery service (which forms of notice shall be deemed to have been given upon confirmed delivery by the delivery agency), (C) by electronic or facsimile or telephonic transmission, provided the receiving party has a compatible device or confirms receipt thereof (which forms of notice shall be deemed delivered upon confirmed transmission or confirmation of receipt), or (D) by mailing in the United States mail by registered or certified mail, return receipt requested, postage prepaid (which forms of notice shall be deemed to have been given upon the fifth {5th} business day
following the date mailed).
WHEREFORE, the parties hereto have for purposes of this Amended and Restated Stock Option Certificate executed this Amended and Restated Stock Option Certificate in the City of Monrovia, County of Los Angeles, State of California, effective as of the 14th day of February, 2003.
COMPANY:
STAAR Surgical Company,
a Delaware corporation
By: /s/ John Bily ---------------------------------- John C. Bily, Chief Financial Officer |
[SEAL]
RECIPIENT:
/s/ Nick Curtis ------------------------------------- Nick Curtis |
ATTACHMENT
TO
STOCK OPTION CERTIFICATE
NOTICE OF EXERCISE OF STOCK OPTION
NOTICE OF EXERCISE OF STOCK OPTION
[To be signed by the Recipient only upon exercise of Option] TO: Secretary STAAR Surgical Company 1911 Walker Avenue Monrovia, California 91016 The undersigned, the holder of an Option under that certain Amended and |
Restated Stock Option Certificate dated effective the ______ day of ___________, _____ (the "Option Certificate"), between STAAR Surgical Company, a Delaware corporation (the "Company") and the undersigned (the "Recipient"), hereby irrevocably elects, in accordance with the terms and conditions of that certain 1998 STAAR Surgical Company Stock Plan (the "Plan") adopted by the Board of Directors on April 17, 1998 and approved by the shareholders on May 29, 1998, under which the Option Certificate was granted, to exercise the undersigned's Option to purchase (___)(1) shares of the Company's voting common stock, $ .01 per share par value ("Common Stock") (collectively and severally, the "Option Shares"), for the aggregate purchase price of ($_____)(2).
(1) Insert number of Option Shares as specified in the Option Certificate which are vested Option Shares (as defined by the Plan) which the Recipient is exercising the Option to purchase.
(2) Number of Option Shares to be exercised as hereinabove specified multiplied by the Option Price per share.
Signature:________________________________________
Print Name:_______________________________________
Address:__________________________________________
Date:_____________________________________________
EXHIBIT 10.39
AMENDED AND RESTATED STOCK OPTION CERTIFICATE
This Amended and Restated Stock Option Certificate dated February 12, 2003 replaces in its entirety the Amended and Restated Stock Option Certificate dated February 12, 2003 and is entered into between STAAR Surgical Company, a Delaware corporation (the "Company"), whose principal executive office is located at 1911 Walker Avenue, Monrovia, California 91016, and NICHOLAS T. CURTIS (the "Recipient") whose address 1911 Walker Avenue, Monrovia, California 91016, pursuant to that certain 1998 STAAR Surgical Company Stock Plan (the "Plan") adopted by the Board of Directors on April 17, 1998 and approved by the shareholders on May 29, 1998.
1. GRANT OF OPTION. Subject to the terms and conditions included herein, this Amended and Restated Stock Option Certificate certifies that the Company has granted to the Recipient, pursuant to the terms of the Plan, an option (the "Option") to purchase, in whole or in part, sixty thousand (60,000) shares of the Company's voting common stock, par value $.01 (the "Common Stock") (collectively and severally, the "Option Shares"), at the price of three dollars and sixty cents ($3.60) per Option Share (the "Option Price"). The date of this grant is February 13, 2003 (the "Grant Date").
2. PLAN; PLAN SUMMARY. The Recipient's rights to purchase the Option Shares are governed by the Plan, the terms of which are incorporated herein by this reference.
3. CHARACTER OF OPTION. This Option is [__] a Non-Qualified Option or [X] an Incentive Option.
4. CAPACITY OF RECIPIENT. This Option is granted to the Recipient in the Recipient's capacity as (i) [X] an employee, (ii) [__] a director, or (iii) [__] a consultant.
5. EXPIRATION OF OPTION. Subject to the terms and conditions set forth in this Stock Option Certificate and in the Plan, the right to exercise the Options granted by this Stock Option Certificate shall expire and be null and void and of no further force or effect to the extent not exercised by 5:00 p.m. Pacific Time, on the 12th day of February, 2008 (the "Option Expiration Date").
6. EXERCISE VESTING CONDITIONS. The Option is (i) [__] fully vested upon date of grant, or (ii) [X] subject to the following vesting schedule as well as based upon Recipient's continued performance of services in the capacity hereinabove indicated:
Cumulative Vested Percentage of Date Shares ----------------- ----------------- February 13, 2004 33 1/3% February 13, 2005 66 2/3% February 13, 2006 100.0% |
The above vesting schedule will be accelerated according to the Recipient's achievement of certain goals and objectives as stated below:
(i) the right to purchase thirty thousand (30,000) Option Shares shall vest on April 1, 2004, so long as the Company achieves twenty-eight million dollars ($28,000,000) in sales at the budgeted gross profit percentage for the U.S. for fiscal year 2003; or
(ii) the right to purchase forty thousand (40,000) Option Shares shall vest on April 1, 2004, so long as the Company achieves twenty-nine million dollars ($29,000,000) in sales at the budgeted gross profit percentage for the U.S. for fiscal year 2003; or
(iii) the right to purchase sixty thousand (60,000) Option Shares shall vest on April 1, 2004, so long as the Company achieves thirty million dollars ($30,000,000) in sales at the budgeted gross profit percentage for the U.S. for fiscal year 2003.
7. MANNER OF EXERCISE AND PAYMENT. This Option shall be exercised by delivery of this Option Certificate to the Secretary of the Company, together with:
(a) A Consent of Spouse (as such consent is defined in the Plan) from the spouse of the Recipient, if any, duly signed by such spouse; and
(b) Full payment for the Option Shares to be purchased in goods funds (in U.S. dollars) by cash or check or through a "same day sale" commitment from the Recipient and a broker-dealer that is a member of the National Association of Securities Dealers (an "NASD Dealer") whereby the Recipient irrevocably elects to exercise the Option and to sell a portion of the Option Shares so purchased to pay for the Option Price, and whereby the NASD Dealer irrevocably commits upon receipt of such Option Shares to forward the Option Price directly to the Company.
8. FORFEITURE; VESTING CONDITIONS. This Option (i) [__] will be fully vested upon date of grant, or (ii) [X] will be subject to Article V, Section 5.05 and Article X of the Plan, inasmuch as the Option will be subject to: (A) the vesting schedule set forth above and (B) the special rules regulating vesting and forfeiture on Termination of Recipient.
9. RECIPIENT'S REPRESENTATIONS. The Recipient represents that the Recipient has received a Section 10(a) Prospectus, which explains the administration and operation of the Plan, and has received a copy of the Plan.
10. MISCELLANEOUS.
(a) PREPARATION OF STOCK OPTION CERTIFICATE. This Amended and Restated Stock Option Certificate was prepared by the Company or its legal counsel solely on behalf of the Company. It is acknowledged by the Recipient that he or she was not represented by the Company or any of its officers, directors, employees or agents (including the Company's legal counsel) in connection with the transaction contemplated by this Amended and Restated Stock Option Certificate, and that the Recipient had separate and independent advice of counsel. In light of the
foregoing it is acknowledged by the Recipient that the Company shall not be construed to be solely responsible for the drafting hereof, and that any ambiguity in the Plan or this Amended and Restated Stock Option Certificate, or the interpretation thereof or hereof, shall not be construed against the Company as the alleged draftsman of this Amended and Restated Stock Option Certificate.
(b) INTERPRETATION.
(i) Entire Agreement/No Collateral Representations. The Recipient acknowledges and agrees that this Amended and Restated Stock Option Certificate, together with and subject to the Plan: (1) is the final, complete and exclusive statement of the agreement of the parties with respect to the subject matter hereof; (2) supersedes any prior or contemporaneous agreements or understandings of any kind, oral or written (collectively and severally, the "prior agreements"), and that any such prior agreements are of no force or effect except as expressly set forth herein; and (3) may not be varied, supplemented or contradicted by evidence of prior agreements, or by evidence of subsequent oral agreements.
(ii) Amendment; Waiver. Except as expressly otherwise provided herein, neither this Amended and Restated Stock Option Certificate nor any of its terms may be amended, supplemented, discharged or terminated (other than by performance), except as provided in the Plan or by a written instrument or instruments signed by all of the parties to this Amended and Restated Stock Option Certificate. No waiver of any acts or obligations hereunder shall be effective unless such waiver shall be in a written instrument or instruments signed by each party claimed to have given or consented to such waiver and each party affected by such waiver.
(iii) Severability. If any term or provision of this Amended and Restated Stock Option Certificate or the application thereof to any person or circumstance shall, to any extent, be determined to be invalid, illegal or unenforceable under present or future laws effective during the term of this Amended and Restated Stock Option Certificate, then, and in that event: (A) the performance of the offending term or provision (but only to the extent its application is invalid, illegal or unenforceable) shall be excused as if it had never been incorporated into this Amended and Restated Stock Option Certificate, and, in lieu of such excused provision, there shall be added a provision as similar in terms and amount to such excused provision as may be possible and be legal, valid and enforceable, and (B) the remaining part of this Amended and Restated Stock Option Certificate (including the application of the offending term or provision to persons or circumstances other than those as to which it is held invalid, illegal or unenforceable) shall not be affected thereby and shall continue in full force and effect to the fullest extent provided by law.
(c) ENFORCEMENT. This Amended and Restated Stock Option Certificate and the rights and remedies of each party arising out of or relating to this Amended and Restated Stock Option Certificate shall be solely governed in accordance with the laws (without regard to the conflicts of law principles thereof) of the state of Delaware.
(d) SUCCESSORS AND ASSIGNS. The Recipient may not assign his rights or benefits or delegate any of his duties or obligations under this Amended and Restated Stock Option
Certificate, in whole or in part, without the prior written consent of the Company, except pursuant to the terms of the Plan. Subject to the foregoing, all of the representations, warranties, covenants, conditions and provisions of this Amended and Restated Stock Option Certificate shall be binding upon and shall inure to the benefit of each party and such party's respective successors and permitted assigns, spouses, heirs, executors, administrators, and personal and legal representatives.
(e) NOTICES. Unless otherwise specifically provided in this Amended and Restated Stock Option Certificate, all notices, demands, requests, consents, approvals or other communications (collectively and severally called "notices") required or permitted to be given hereunder, or which are given with respect to this Amended and Restated Stock Option Certificate, shall be in writing, and shall be given by: (A) personal delivery (which form of notice shall be deemed to have been given upon delivery), (B) by telegraph or by private airborne/overnight delivery service (which forms of notice shall be deemed to have been given upon confirmed delivery by the delivery agency), (C) by electronic or facsimile or telephonic transmission, provided the receiving party has a compatible device or confirms receipt thereof (which forms of notice shall be deemed delivered upon confirmed transmission or confirmation of receipt), or (D) by mailing in the United States mail by registered or certified mail, return receipt requested, postage prepaid (which forms of notice shall be deemed to have been given upon the fifth {5th} business day following the date mailed).
WHEREFORE, the parties hereto have for purposes of this Amended and Restated Stock Option Certificate executed this Amended and Restated Stock Option Certificate in the City of Monrovia, County of Los Angeles, State of California, effective as of the 12th day of February, 2003.
COMPANY:
STAAR Surgical Company,
a Delaware corporation
By: /s/ John Bily ----------------------- John C. Bily, Secretary ATTEST: |
[SEAL]
RECIPIENT:
/s/ Nicholas T. Curtis ---------------------- Nicholas T. Curtis |
ATTACHMENT
TO
STOCK OPTION CERTIFICATE
NOTICE OF EXERCISE OF STOCK OPTION
NOTICE OF EXERCISE OF STOCK OPTION
[To be signed by the Recipient only upon exercise of Option]
TO: Secretary
STAAR Surgical Company
1911 Walker Avenue
Monrovia, California 91016
The undersigned, the holder of an Option under that certain Amended and Restated Stock Option Certificate dated effective the _________ day of ____________________, _______ (the "Option Certificate"), between STAAR Surgical Company, a Delaware corporation (the "Company") and the undersigned (the "Recipient"), hereby irrevocably elects, in accordance with the terms and conditions of that certain 1998 STAAR Surgical Company Stock Plan (the "Plan") adopted by the Board of Directors on April 17, 1998 and approved by the shareholders on May 29, 1998, under which the Option Certificate was granted, to exercise the undersigned's Option to purchase (____)(1) shares of the Company's voting common stock, $ .01 per share par value ("Common Stock") (collectively and severally, the "Option Shares"), for the aggregate purchase price of ($______)(2).
(1) Insert number of Option Shares as specified in the Option Certificate which are vested Option Shares (as defined by the Plan) which the Recipient is exercising the Option to purchase.
(2) Number of Option Shares to be exercised as hereinabove specified multiplied by the Option Price per share.
Signature:________________________________________
Print Name:_______________________________________
Address:__________________________________________
Date:_____________________________________________
EXHIBIT 10.40
EMPLOYMENT AGREEMENT
This Employment Agreement is made and entered into by and between STAAR Surgical Company (the Company), a Delaware corporation located at 1911 Walker Avenue, Monrovia, California 91016 and Thomas Paul, PhD., (hereinafter the Employee), located at 1911 Walker Ave., Monrovia, CA, 91016 effective March 18, 2005.
RECITALS
A. WHEREAS, the Company wishes to retain the services of Employee and Employee wishes to render services to Company as Vice President of Research and Development.
B. WHEREAS, the Employee and the Company desire to enter into this Employment Agreement and to establish the terms and conditions of the Employees employment.
C. WHEREAS, the Company and the Employee intend that this Agreement will supercede and replace any and all other employment agreements or arrangements for employment entered into by and between the Company and the Employee, and that such employment agreements or arrangements shall have no further force or effect.
AGREEMENT
NOW, THEREFORE, for and in consideration of the promises, covenants, and agreements contained herein, the parties hereto agree as follows:
ARTICLE 1
EMPLOYMENT
1.1 Employment . The Company hereby agrees to employ the Employee and the Employee hereby agrees to serve the Company in the capacity of Vice President Research and Development, based upon the terms and conditions set forth in this agreement.
1.2 Duties . During the term of his employment, the Employee shall devote his full time, efforts, abilities, and energies to the Companys business and, in particular, shall use his best efforts, skill, and abilities to promote the general welfare and interests of the Company. The Employee shall loyally, conscientiously, and professionally do and perform all such duties and responsibilities as shall be reasonably assigned by the Company and the Employees superiors from time to time, and shall
comply with all of the Companys personnel policies and procedures, including, but not limited to, those contained in The Companys Employee Handbook.
1.3 Noncompetition, Nonsolicitation and Noninterference and Proprietary Property and Confidential Information Provisions .
(a) Applicable Definitions .
For purposes of this paragraph, the following capitalized terms shall have the definitions set forth below:
(i) Business Segments The term Business Segments is defined as each of Companys (or Companys affiliates) products or product lines.
(ii) Competitive Business The term Competitive Business is defined as any business that is or may be competitive with or similar to or adverse to any of Companys (or Companys affiliates) Business Segments, whether such business is conducted by a proprietorship, partnership, corporation or other entity or venture.
(b) Nonsolicitation and Noninterference .
(1) Covenants . Employee hereby covenants and agrees that Employee shall not, either for Employees own account or directly or indirectly in conjunction with or on behalf of any person, partnership, corporation or other entity or venture:
(i) During the term of this Agreement and for a period of one (1) year from the date this Agreement terminates or expires, solicit or employ or attempt to solicit or employ any person who is then or has, within twelve (12) months prior thereto, been an officer, partner, manager, agent or employee of Company or any affiliate of Company whether or not such a person would commit a breach of that persons contract of employment with Company or any affiliate of Company, if any, by reason of leaving the service of Company or any affiliate of Company (the Nonsolicitation Covenant ); or
(ii) During the term of this Agreement and for a period of one (1) year from the date of the Agreement, on behalf of, directly or indirectly, any Competitive Business, or for the purpose of or with the reasonably foreseeable effect of harming the business of Company, solicit the business of any person, firm or company which is then, or has been at any time during the preceding twelve (12) months prior to such solicitation, a customer, client, contractor, supplier or vendor of Company or any affiliate of Company (the Noninterference Covenant).
(2) Acknowledgements . Each of the parties acknowledges that: (i) the covenants and the restrictions contained in the Nonsolicitation and Noninterference Covenants are necessary, fundamental, and required for the protection of the business of Company; (ii) such Covenants relate to matters which are of a special, unique and extraordinary value; and (iii) a breach of either of such Covenants will result in irreparable harm and damages which cannot be adequately compensated by a monetary award.
(3) Judicial Limitation . Notwithstanding the foregoing, if at any time, despite the express agreement of Company and Employee, a court of competent jurisdiction holds that any portion of this Nonsolicitation and/or Noninterference Covenant is unenforceable by reason of its extending for too great a period of time or by reason of its being too extensive in any other respect, such Covenant shall be interpreted to extend only over the maximum period of time or to the maximum extent in all other respects, as the case may be, as to which it may be enforceable, all as determined by such court in such action.
(4) Termination of Agreement . The covenants and agreements contained in the Nonsolicitation and Noninterference Covenant shall terminate and be of no effect if this Agreement is terminated by Company without Cause.
(c) Proprietary Property; Confidential Information .
(1) Applicable Definitions For purposes of this paragraph, the following capitalized terms shall have the definitions set forth below:
(i) Confidential Information The term Confidential Information is collectively and severally defined as any information, matter or thing of a secret, confidential or private nature, whether or not so labeled, which is connected with Companys business or methods of operation or concerning any of Companys suppliers, customers, licensors, licensees or others with whom Company has a business relationship, and which has current or potential value to Company or the unauthorized disclosure of which could be detrimental to Company. Confidential Information shall be broadly defined and shall include, by way of example and not limitation: (i) matters of a business nature available only to management and owners of Company of which Employee may become aware (such as information concerning customers, vendors and suppliers, including their names, addresses, credit or financial status, buying or selling habits, practices, requirements, and any arrangements or contracts that Company may have with such parties, Companys marketing methods, plans and strategies, the costs of materials, the prices Company obtains or has obtained or at which Company sells or has sold its products or services, Companys manufacturing and sales costs, the amount of compensation paid to employees of Company and other terms of their employment, financial information such as financial statements, budgets and projections, and the terms of any contracts or agreements Company has entered into)
and (ii) matters of a technical nature (such as product information, trade secrets, know-how, formulae, innovations, inventions, devices, discoveries, techniques, formats, processes, methods, specifications, designs, patterns, schematics, data, compilation of information, test results, and research and development projects). For purposes of the foregoing, the term trade secrets shall mean the broadest and most inclusive interpretation of trade secrets as defined by Section 3426.1(d) of the California Civil Code (the Uniform Trade Secrets Act) and cases interpreting the scope of said Section.
(ii) Proprietary Property The term Proprietary Property is collectively and severally defined as any written or tangible property owned or used by Company in connection with Companys business, whether or not such property also qualifies as Confidential Information. Proprietary Property shall be broadly defined and shall include, by way of example and not limitation, products, samples, equipment, files, lists, books, notebooks, records, documents, memoranda, reports, patterns, schematics, compilations, designs, drawings, data, test results, contracts, agreements, literature, correspondence, spread sheets, computer programs and software, computer print outs, other written and graphic records, and the like, whether originals, copies, duplicates or summaries thereof, affecting or relating to the business of Company, financial statements, budgets, projections, invoices.
(2) Ownership of Proprietary Property . Employee acknowledges that all Proprietary Property which Employee may prepare, use, observe, come into possession of and/or control shall, at all times, remain the sole and exclusive property of Company. Employee shall, upon demand by Company at any time, or upon the cessation of Employees employment, irrespective of the time, manner, cause or lack of cause of such cessation, immediately deliver to Company or its designated agent, in good condition, ordinary wear and tear and damage by any cause beyond the reasonable control of Employee excepted, all items of the Proprietary Property which are or have been in Employees possession or under his control, as well as a statement describing the disposition of all items of the Proprietary Property beyond Employees possession or control in the event Employee has not previously returned such items of the Proprietary Property to Company.
(3) Agreement Not to Use or Divulge Confidential Information . Employee agrees that he will not, in any fashion, form or manner, unless specifically consented to in writing by Company, either directly or indirectly use, divulge, transmit or otherwise disclose or cause to be used, divulged, transmitted or otherwise disclosed to any person, firm or corporation, in any manner whatsoever (other than in Employees performance of duties for Company or except as required by law) any Confidential Information of any kind, nature or description. The foregoing provisions shall not be construed to prevent Employee from making use of or disclosing information which is in the public domain through no fault of Employee, provided, however, specific information shall not be deemed to be in the public domain merely because it is
encompassed by some general information that is published or in the public domain or in Employees possession prior to Employees employment with Company.
(4) Acknowledgement of Secrecy . Employee acknowledges that the Confidential Information is not generally known to the public or to other persons who can obtain economic value from its disclosure or use and that the Confidential Information derives independent economic value thereby, and Employee agrees that he shall take all efforts reasonably necessary to maintain the secrecy and confidentiality of the Confidential Information and to otherwise comply with the terms of this Agreement.
(5) Inventions, Discoveries . Employee acknowledges that any inventions, discoveries or trade secrets, whether patentable or not, made or found by Employee in the scope of his employment with Company constitute property of Company and that any rights therein now held or hereafter acquired by Employee individually or in any capacity are hereby transferred and assigned to Company, and agrees to execute and deliver any confirmatory assignments, documents or instruments of any nature necessary to carry out the intent of this paragraph when requested by Company without further compensation therefore, whether or not Employee is at the time employed by Company. Provided, however, notwithstanding the foregoing, Employee shall not be required to assign his rights in any invention which qualifies fully under the provisions of Section 2870(a) of the California Labor Code , which provides, in pertinent part, that the requirement to assign shall not apply to any invention that the employee developed entirely on his or her own time without using employers equipment, supplies, facilities or trade secret information except for those inventions that either:
(i) Relate at the time of conception or reduction to practice of the invention to the employers business, or actual or demonstrably anticipated research or development of the employer; or
(ii) Result from any work performed by the employee for the employer.
Employee understands that he bears the full burden of proving to Company that an invention qualifies fully under Section 2870(a). By signing this Agreement, Employee acknowledges receipt of a copy of this Agreement and of written notification of the provisions of Section 2870.
ARTICLE 2
COMPENSATION
2.1 Salary . The Company shall pay the Employee a salary payable at the gross rate of $6346.15 per pay period, to be paid on a bi-weekly basis. Employees annual salary shall be reviewed periodically by Company for the purpose of determining whether Employees salary shall be increased.
2.2 Employee Benefits . In addition to the compensation specified above, the Employee shall be permitted to participate in certain employee benefit programs in the same manner and subject to the same terms, conditions, and limitations as other full-time employees of the Company. The Employee shall also be eligible for four weeks vacation per year.
2.3 Business Expenses . The Company will reimburse the Employee for reasonable business expenses as outlined in the companys business expense policy and provided that these expenses were incurred on Company business and that expense reports regarding these expenses are submitted to the Company in a timely manner.
2.4 Bonus . In addition to the salary described above, the Employee shall be eligible for an annual bonus of up to 25% of Employees base salary, with 30% of the 25% based on the achievement of individual objectives, 70% based on the achievement of Corporate financial targets. This bonus will be payable on Employees anniversary date of hire and subject to the successful achievement of the goals and objectives.
ARTICLE 3
TERMINATION OF EMPLOYMENT
3.1 Termination . This employment relationship may be terminated for any of the reasons provided below:
a. Termination for Cause . Company may terminate this Agreement for Cause, upon 15 days written notice. Cause means any of the following: (1) willful breach or habitual neglect of the duties which Employee is required to perform under the terms of this Agreement, (2) any act of dishonesty, fraud, insubordination, misrepresentation, gross negligence or willful misconduct, (3) conviction of a felony, or (4) intentional violation of any Company policy. With the exception of the covenants set forth in Paragraph 1.3, 4.1 and 4.3, upon such termination the obligations of Employee and Company under this Agreement shall immediately cease. Such termination shall be without prejudice to any other remedy to which Company may be entitled either at law, in equity, or under this Agreement. If Employees employment is terminated pursuant to this paragraph, the Company shall pay to Employee, immediately upon such termination, any accrued but unpaid compensation to which Employee is entitled on the date of such termination.
b. Termination for Poor Performance . Employer may terminate employees employment under this Agreement for Poor Performance. Poor Performance is a failure of the Employee to properly meet the duties and responsibilities of his position in a competent fashion, as determined by the Chief Executive Officer. Such termination for Poor Performance shall occur only after employee has been advised in writing of the failure to meet the duties and responsibilities, or
guidelines/goals and given a reasonable period of time of at least 30 days to cure the Poor Performance. Following the termination for Poor Performance, the Employee shall be entitled to payment of his base salary through the last day of his employment. Employee shall be entitled to no other payments or benefits after a termination for Poor Performance. With the exception of the covenants set forth in Paragraph 1.3, 4.1 and 4.3, upon such termination the obligations of Employee and Company under this Agreement shall immediately cease.
c. Death . Employees employment shall terminate upon the death of Employee. Upon such termination, the obligations of Employee and Company under this Agreement shall immediately cease. In the event of a termination pursuant to this paragraph, Employee shall be entitled to receive any amount of compensation earned but unpaid. All other rights Employee has under any benefit or stock option plans and programs shall be determined in accordance with the terms and conditions of such plans and programs.
d. Election By Employee . Employees employment may be terminated at any time by Employee upon not less than thirty (30) days written notice to Company. With the exception of the covenants set forth in Paragraphs 1.3, 4.1 and 4.3, upon such termination the obligations of Employee and the Company under this Agreement shall immediately cease. In the event of a termination pursuant to this paragraph, Employee shall be entitled to receive any amount of compensation earned but unpaid. All other rights Employee has under any benefit or stock option plans and programs shall be determined in accordance with the terms and conditions of such plans and programs.
e. Election by Company Due to a Change of Control . If Employees employment is terminated by Company due to the sale or disposition by the Company of substantially all of its business or assets or the sale of the capital stock of Company in connection with the sale or transfer of a controlling interest in Company to a third party or the merger or consolidation of Company with another corporation as part of a sale or transfer of a controlling interest in Company to a third party and if the Employees essential duties and responsibilities as set forth in the job description for the position that Employee is in at the time of the change of control are significantly changed due to a change in control, then in lieu of any other rights or benefits under this Agreement, Employee shall be entitled to six months base salary, and any option held by Employee which is unvested on the date of termination shall immediately vest. A controlling interest shall be defined as 50% or more of the common stock of the Company. Six months base salary shall be defined as only the cash compensation paid to Employee pursuant to paragraph 2.1, as it may be modified from time to time, and shall not include employee benefits, bonus, stock options, automobile allowance or debt forgiveness, if any. With the exception of the covenants contained in Paragraphs 1.3(c), 4.1 and 4.3, upon such termination the obligations of Employee and the Company shall immediately cease.
f. Termination Without Cause . Company is entitled to terminate the Employees employment without cause for any reason; provided, however, that the Employee shall be entitled to 30 days written notice and five months pay as severance, as well as any accrued but unpaid compensation in lieu of any other rights or benefits under this Agreement, to which Employee is entitled on the date of such termination. With the exception of the covenants contained in Paragraphs 1.3(c), 4.1 and 4.3, upon such termination the obligations of Employee and the Company shall immediately cease.
ARTICLE 4
ADDITIONAL OBLIGATIONS
4.1 Non-Interference . The Employee shall not now or in the future, either during or subsequent to the period of the Employees employment, disrupt, damage, impair or interfere with the business of the Company in any manner, including, without limitation, inducing an employee to leave the employ of the Company or inducing an employee, a consultant, a sales representative, or an independent contractor to sever that persons relationship with the Company either by interfering with or raiding the Companys employees or sales representatives, disrupting the relationships with customers, agents, independent contractors, representatives or vendors, or otherwise.
4.2 Conflicts of Interest . If the Employee is involved, directly or indirectly, in an activity that presents a potential or actual conflict of interest, as determined by the Company, by virtue of the Employees employment or employment relationship with the Company, the Employee shall immediately terminate such activity, employment and/or relationship unless the Employee has the express written permission of the Company to continue it. If the Employee has any doubts as to whether a potential or actual conflict of interest is involved, the Employee must disclose all pertinent facts to the Company before undertaking the activity. The Company shall make the final decision as to whether such a conflict or potential conflict exists in its sole and subjective discretion.
4.3 Confidentiality . The Employee agrees, at all times during and after the Employees employment hereunder, to hold in the strictest confidence, and not to disclose to any person, firm or corporation without the express written authorization of the Chairman of the Board of the Company, any trade secret, such as any financial
information or any secret, proprietary, or confidential information relating to the research and development programs, vendor and marketing programs, customers, customers information, sales or business of the Company, except as such disclosure or use may be required in connection with his work for the Company or is published or is otherwise readily available to the public or becomes known to the public other than by his breach of this Agreement. If it is at any time determined that any of the information or materials identified above are, in whole or in part, not entitled to protection as trade secrets, the Employee and the Company agree that they shall nevertheless be considered and treated as confidential information that is protected under this Agreement, in the same manner as trade secrets, to the extent permitted by law.
The Employee further agrees, upon termination of this Agreement, to promptly deliver to the Company all notes, books, correspondence, drawings, computer storage information, and any and all other written and graphical records in his possession or under his control relating to the past, present or future business, accounts, or projects of the Company.
ARTICLE 5
MISCELLANEOUS
5.1 Entire Agreement . This Agreement constitutes the entire agreement and understanding between the parties with respect to the subject matter hereof and supersedes any and all other arrangements, communications, understandings, promises, stipulations, arrangements, whether any of the same are either oral or in writing, or express or implied, between the parties hereto with respect to the subject matter hereof, including, but not limited to, any implied-in-law or implied-in-fact covenants or duties relating to employment or the termination of employment. No change to or modification of this Agreement shall be valid or binding unless the same shall be in writing and signed by both the Employee and the President of the Company.
5.2 Severability . In the event that any one or more of the provisions of this Agreement shall be held invalid, illegal, or unenforceable, in any respect, by a court of competent jurisdiction, the validity, legality, and enforceability of the remaining provisions contained herein shall not in any way be affected thereby.
5.3 Applicable Law . This Agreement and the rights and remedies of each party arising out of or relating to this Agreement, shall be governed by, interpreted under and enforced under the laws of the State of California.
5.4 Counterparty . This Agreement may be executed in counterparts, each of which shall be deemed an original.
IN WITNESS WHEREOF, the parties hereto acknowledge that they have read this Agreement, fully understand it, and have freely and voluntarily entered into it.
|
EMPLOYEE | ||||||
|
|||||||
DATED:
|
|||||||
|
|||||||
|
|||||||
|
The Company | ||||||
|
|||||||
DATED:
|
By | ||||||
|
|||||||
|
STAAR Surgical Company |
EXHIBIT 10.41
EMPLOYMENT AGREEMENT
This Employment Agreement is made and entered into by and between STAAR Surgical Company (the Company), a Delaware corporation located at 1911 Walker Avenue, Monrovia, California 91016 and James Farnworth (hereinafter the Employee), located at 1911 Walker Ave., Monrovia, CA, 91016, effective March 18, 2005.
RECITALS
A. WHEREAS, the Company wishes to retain the services of Employee and Employee wishes to render services to Company as Vice President Regulatory Affairs and Quality Assurance.
B. WHEREAS, the Employee and the Company desire to enter into this Employment Agreement and to establish the terms and conditions of the Employees employment.
C. WHEREAS, the Company and the Employee intend that this Agreement will supercede and replace any and all other employment agreements or arrangements for employment entered into by and between the Company and the Employee, and that such employment agreements or arrangements shall have no further force or effect.
AGREEMENT
NOW, THEREFORE, for and in consideration of the promises, covenants, and agreements contained herein, the parties hereto agree as follows:
ARTICLE 1
EMPLOYMENT
1.1 Employment . The Company hereby agrees to employ the Employee and the Employee hereby agrees to serve the Company in the capacity of Vice President Regulatory Affairs and Quality Assurance, based upon the terms and conditions set forth in this agreement.
1.2 Duties . During the term of his employment, the Employee shall devote his full time, efforts, abilities, and energies to the Companys business and, in particular, shall use his best efforts, skill, and abilities to promote the general welfare and interests of the Company. The Employee shall loyally, conscientiously, and professionally do and perform all such duties and responsibilities as shall be reasonably assigned by the Company and the Employees superiors from time to time, and shall
comply with all of the Companys personnel policies and procedures, including, but not limited to, those contained in The Companys Employee Handbook.
1.3 Noncompetition, Nonsolicitation and Noninterference and Proprietary Property and Confidential Information Provisions .
(a) Applicable Definitions .
For purposes of this paragraph, the following capitalized terms shall have the definitions set forth below:
(i) Business Segments The term Business Segments is defined as each of Companys (or Companys affiliates) products or product lines.
(ii) Competitive Business The term Competitive Business is defined as any business that is or may be competitive with or similar to or adverse to any of Companys (or Companys affiliates) Business Segments, whether such business is conducted by a proprietorship, partnership, corporation or other entity or venture.
(b) Nonsolicitation and Noninterference .
(1) Covenants . Employee hereby covenants and agrees that Employee shall not, either for Employees own account or directly or indirectly in conjunction with or on behalf of any person, partnership, corporation or other entity or venture:
(i) During the term of this Agreement and for a period of one (1) year from the date this Agreement terminates or expires, solicit or employ or attempt to solicit or employ any person who is then or has, within twelve (12) months prior thereto, been an officer, partner, manager, agent or employee of Company or any affiliate of Company whether or not such a person would commit a breach of that persons contract of employment with Company or any affiliate of Company, if any, by reason of leaving the service of Company or any affiliate of Company (the Nonsolicitation Covenant ); or
(ii) During the term of this Agreement and for a period of one (1) year from the date of the Agreement, on behalf of, directly or indirectly, any Competitive Business, or for the purpose of or with the reasonably foreseeable effect of harming the business of Company, solicit the business of any person, firm or company which is then, or has been at any time during the preceding twelve (12) months prior to such solicitation, a customer, client, contractor, supplier or vendor of Company or any affiliate of Company (the Noninterference Covenant).
(2) Acknowledgements . Each of the parties acknowledges that: (i) the covenants and the restrictions contained in the Nonsolicitation and Noninterference Covenants are necessary, fundamental, and required for the protection of the business of Company; (ii) such Covenants relate to matters which are of a special, unique and extraordinary value; and (iii) a breach of either of such Covenants will result in irreparable harm and damages which cannot be adequately compensated by a monetary award.
(3) Judicial Limitation . Notwithstanding the foregoing, if at any time, despite the express agreement of Company and Employee, a court of competent jurisdiction holds that any portion of this Nonsolicitation and/or Noninterference Covenant is unenforceable by reason of its extending for too great a period of time or by reason of its being too extensive in any other respect, such Covenant shall be interpreted to extend only over the maximum period of time or to the maximum extent in all other respects, as the case may be, as to which it may be enforceable, all as determined by such court in such action.
(4) Termination of Agreement . The covenants and agreements contained in the Nonsolicitation and Noninterference Covenant shall terminate and be of no effect if this Agreement is terminated by Company without Cause.
(c) Proprietary Property; Confidential Information .
(1) Applicable Definitions For purposes of this paragraph, the following capitalized terms shall have the definitions set forth below:
(i) Confidential Information The term Confidential Information is collectively and severally defined as any information, matter or thing of a secret, confidential or private nature, whether or not so labeled, which is connected with Companys business or methods of operation or concerning any of Companys suppliers, customers, licensors, licensees or others with whom Company has a business relationship, and which has current or potential value to Company or the unauthorized disclosure of which could be detrimental to Company. Confidential Information shall be broadly defined and shall include, by way of example and not limitation: (i) matters of a business nature available only to management and owners of Company of which Employee may become aware (such as information concerning customers, vendors and suppliers, including their names, addresses, credit or financial status, buying or selling habits, practices, requirements, and any arrangements or contracts that Company may have with such parties, Companys marketing methods, plans and strategies, the costs of materials, the prices Company obtains or has obtained or at which Company sells or has sold its products or services, Companys manufacturing and sales costs, the amount of compensation paid to employees of Company and other terms of their employment, financial information such as financial statements, budgets and projections, and the terms of any contracts or agreements Company has entered into)
and (ii) matters of a technical nature (such as product information, trade secrets, know-how, formulae, innovations, inventions, devices, discoveries, techniques, formats, processes, methods, specifications, designs, patterns, schematics, data, compilation of information, test results, and research and development projects). For purposes of the foregoing, the term trade secrets shall mean the broadest and most inclusive interpretation of trade secrets as defined by Section 3426.1(d) of the California Civil Code (the Uniform Trade Secrets Act) and cases interpreting the scope of said Section.
(ii) Proprietary Property The term Proprietary Property is collectively and severally defined as any written or tangible property owned or used by Company in connection with Companys business, whether or not such property also qualifies as Confidential Information. Proprietary Property shall be broadly defined and shall include, by way of example and not limitation, products, samples, equipment, files, lists, books, notebooks, records, documents, memoranda, reports, patterns, schematics, compilations, designs, drawings, data, test results, contracts, agreements, literature, correspondence, spread sheets, computer programs and software, computer print outs, other written and graphic records, and the like, whether originals, copies, duplicates or summaries thereof, affecting or relating to the business of Company, financial statements, budgets, projections, invoices.
(2) Ownership of Proprietary Property . Employee acknowledges that all Proprietary Property which Employee may prepare, use, observe, come into possession of and/or control shall, at all times, remain the sole and exclusive property of Company. Employee shall, upon demand by Company at any time, or upon the cessation of Employees employment, irrespective of the time, manner, cause or lack of cause of such cessation, immediately deliver to Company or its designated agent, in good condition, ordinary wear and tear and damage by any cause beyond the reasonable control of Employee excepted, all items of the Proprietary Property which are or have been in Employees possession or under his control, as well as a statement describing the disposition of all items of the Proprietary Property beyond Employees possession or control in the event Employee has not previously returned such items of the Proprietary Property to Company.
(3) Agreement Not to Use or Divulge Confidential Information . Employee agrees that he will not, in any fashion, form or manner, unless specifically consented to in writing by Company, either directly or indirectly use, divulge, transmit or otherwise disclose or cause to be used, divulged, transmitted or otherwise disclosed to any person, firm or corporation, in any manner whatsoever (other than in Employees performance of duties for Company or except as required by law) any Confidential Information of any kind, nature or description. The foregoing provisions shall not be construed to prevent Employee from making use of or disclosing information which is in the public domain through no fault of Employee, provided, however, specific information shall not be deemed to be in the public domain merely because it is
encompassed by some general information that is published or in the public domain or in Employees possession prior to Employees employment with Company.
(4) Acknowledgement of Secrecy . Employee acknowledges that the Confidential Information is not generally known to the public or to other persons who can obtain economic value from its disclosure or use and that the Confidential Information derives independent economic value thereby, and Employee agrees that he shall take all efforts reasonably necessary to maintain the secrecy and confidentiality of the Confidential Information and to otherwise comply with the terms of this Agreement.
(5) Inventions, Discoveries . Employee acknowledges that any inventions, discoveries or trade secrets, whether patentable or not, made or found by Employee in the scope of his employment with Company constitute property of Company and that any rights therein now held or hereafter acquired by Employee individually or in any capacity are hereby transferred and assigned to Company, and agrees to execute and deliver any confirmatory assignments, documents or instruments of any nature necessary to carry out the intent of this paragraph when requested by Company without further compensation therefore, whether or not Employee is at the time employed by Company. Provided, however, notwithstanding the foregoing, Employee shall not be required to assign his rights in any invention which qualifies fully under the provisions of Section 2870(a) of the California Labor Code , which provides, in pertinent part, that the requirement to assign shall not apply to any invention that the employee developed entirely on his or her own time without using employers equipment, supplies, facilities or trade secret information except for those inventions that either:
(i) Relate at the time of conception or reduction to practice of the invention to the employers business, or actual or demonstrably anticipated research or development of the employer; or
(ii) Result from any work performed by the employee for the employer.
Employee understands that he bears the full burden of proving to Company that an invention qualifies fully under Section 2870(a). By signing this Agreement, Employee acknowledges receipt of a copy of this Agreement and of written notification of the provisions of Section 2870.
ARTICLE 2
COMPENSATION
2.1 Salary . The Company shall pay the Employee a salary payable at the gross rate of $5769.23 per pay period, to be paid on a bi-weekly basis. Employees annual salary shall be reviewed periodically by Company for the purpose of determining whether Employees salary shall be increased.
2.2 Employee Benefits . In addition to the compensation specified above, the Employee shall be permitted to participate in certain employee benefit programs in the same manner and subject to the same terms, conditions, and limitations as other full-time employees of the Company. The Employee will also be eligible for three weeks vacation per year.
2.3 Business Expenses . The Company will reimburse the Employee for reasonable business expenses as outlined in the companys business expense policy and provided that these expenses were incurred on Company business and that expense reports regarding these expenses are submitted to the Company in a timely manner.
2.4 Bonus . In addition to the salary described above, the Employee shall be eligible for an annual bonus of up to 15% of Employees annual base salary, which will be payable on an annual basis and subject to the successful achievement of company and individual goals and objectives.
ARTICLE 3
TERMINATION OF EMPLOYMENT
3.1 Termination . This employment relationship may be terminated for any of the reasons provided below:
a. Termination for Cause . Company may terminate this Agreement for Cause, upon 15 days written notice. Cause means any of the following: (1) willful breach or habitual neglect of the duties which Employee is required to perform under the terms of this Agreement, (2) any act of dishonesty, fraud, insubordination, misrepresentation, gross negligence or willful misconduct, (3) conviction of a felony, or (4) intentional violation of any Company policy. With the exception of the covenants set forth in Paragraph 1.3, 4.1 and 4.3, upon such termination the obligations of Employee and Company under this Agreement shall immediately cease. Such termination shall be without prejudice to any other remedy to which Company may be entitled either at law, in equity, or under this Agreement. If Employees employment is terminated pursuant to this paragraph, the Company shall pay to Employee, immediately upon such termination, any accrued but unpaid compensation to which Employee is entitled on the date of such termination.
b. Termination for Poor Performance . Employer may terminate employees employment under this Agreement for Poor Performance. Poor Performance is a failure of the Employee to properly meet the duties and responsibilities of his position in a competent fashion, as determined by the Chief Executive Officer. Such termination for Poor Performance shall occur only after employee has been
advised in writing of the failure to meet the duties and responsibilities, or guidelines/goals and given a reasonable period of time of at least 30 days to cure the Poor Performance. Following the termination for Poor Performance, the Employee shall be entitled to payment of his base salary through the last day of his employment. Employee shall be entitled to no other payments or benefits after a termination for Poor Performance. With the exception of the covenants set forth in Paragraph 1.3, 4.1 and 4.3, upon such termination the obligations of Employee and Company under this Agreement shall immediately cease.
c. Death . Employees employment shall terminate upon the death of Employee. Upon such termination, the obligations of Employee and Company under this Agreement shall immediately cease. In the event of a termination pursuant to this paragraph, Employee shall be entitled to receive any amount of compensation earned but unpaid. All other rights Employee has under any benefit or stock option plans and programs shall be determined in accordance with the terms and conditions of such plans and programs.
d. Election By Employee . Employees employment may be terminated at any time by Employee upon not less than thirty (30) days written notice to Company. With the exception of the covenants set forth in Paragraphs 1.3, 4.1 and 4.3, upon such termination the obligations of Employee and the Company under this Agreement shall immediately cease. In the event of a termination pursuant to this paragraph, Employee shall be entitled to receive any amount of compensation earned but unpaid. All other rights Employee has under any benefit or stock option plans and programs shall be determined in accordance with the terms and conditions of such plans and programs.
e. Election by Company Due to a Change of Control . If Employees employment is terminated by Company due to the sale or disposition by the Company of substantially all of its business or assets or the sale of the capital stock of Company in connection with the sale or transfer of a controlling interest in Company to a third party or the merger or consolidation of Company with another corporation as part of a sale or transfer of a controlling interest in Company to a third party and if the Employees essential duties and responsibilities as set forth in the job description for the position that Employee is in at the time of the change of control are significantly changed due to a change in control, then in lieu of any other rights or benefits under this Agreement, Employee shall be entitled to six months base salary, and any option held by Employee which is unvested on the date of termination shall immediately vest. A controlling interest shall be defined as 50% or more of the common stock of the Company. Six months base salary shall be defined as only the cash compensation paid to Employee pursuant to paragraph 2.1, as it may be modified from time to time, and shall not include employee benefits, bonus, stock options, automobile allowance or debt forgiveness, if any. With the exception of the covenants contained in Paragraphs 1.3(c), 4.1 and 4.3,
upon such termination the obligations of Employee and the Company shall immediately cease.
f. Termination Without Cause . Company is entitled to terminate the Employees employment without cause for any reason; provided, however, that the Employee shall be entitled to 30 days written notice and five months pay as severance, as well as any accrued but unpaid compensation in lieu of any other rights or benefits under this Agreement, to which Employee is entitled on the date of such termination. With the exception of the covenants contained in Paragraphs 1.3(c), 4.1 and 4.3, upon such termination the obligations of Employee and the Company shall immediately cease.
ARTICLE 4
ADDITIONAL OBLIGATIONS
4.1 Non-Interference . The Employee shall not now or in the future, either during or subsequent to the period of the Employees employment, disrupt, damage, impair or interfere with the business of the Company in any manner, including, without limitation, inducing an employee to leave the employ of the Company or inducing an employee, a consultant, a sales representative, or an independent contractor to sever that persons relationship with the Company either by interfering with or raiding the Companys employees or sales representatives, disrupting the relationships with customers, agents, independent contractors, representatives or vendors, or otherwise.
4.2 Conflicts of Interest . If the Employee is involved, directly or indirectly, in an activity that presents a potential or actual conflict of interest, as determined by the Company, by virtue of the Employees employment or employment relationship with the Company, the Employee shall immediately terminate such activity, employment and/or relationship unless the Employee has the express written permission of the Company to continue it. If the Employee has any doubts as to whether a potential or actual conflict of interest is involved, the Employee must disclose all pertinent facts to the Company before undertaking the activity. The Company shall make the final decision as to whether such a conflict or potential conflict exists in its sole and subjective discretion.
4.3 Confidentiality . The Employee agrees, at all times during and after the Employees employment hereunder, to hold in the strictest confidence, and not to disclose to any person, firm or corporation without the express written authorization of the Chairman of the Board of the Company, any trade secret, such as any financial information or any secret, proprietary, or confidential information relating to the research and development programs, vendor and marketing programs, customers, customers information, sales or business of the Company, except as such disclosure or use may be required in connection with his work for the Company or is published or is otherwise readily available to the public or becomes known to the public other than by his breach of this Agreement. If it is at any time determined that any of the information or materials identified above are, in whole or in part, not entitled to protection as trade secrets, the Employee and the Company agree that they shall nevertheless be considered and treated as confidential information that is protected under this Agreement, in the same manner as trade secrets, to the extent permitted by law.
The Employee further agrees, upon termination of this Agreement, to promptly deliver to the Company all notes, books, correspondence, drawings, computer storage information, and any and all other written and graphical records in his possession or under his control relating to the past, present or future business, accounts, or projects of the Company.
ARTICLE 5
MISCELLANEOUS
5.1 Entire Agreement . This Agreement constitutes the entire agreement and understanding between the parties with respect to the subject matter hereof and supersedes any and all other arrangements, communications, understandings, promises, stipulations, arrangements, whether any of the same are either oral or in writing, or express or implied, between the parties hereto with respect to the subject matter hereof, including, but not limited to, any implied-in-law or implied-in-fact covenants or duties relating to employment or the termination of employment. No change to or modification of this Agreement shall be valid or binding unless the same shall be in writing and signed by both the Employee and the President of the Company.
5.2 Severability . In the event that any one or more of the provisions of this Agreement shall be held invalid, illegal, or unenforceable, in any respect, by a court of competent jurisdiction, the validity, legality, and enforceability of the remaining provisions contained herein shall not in any way be affected thereby.
5.3 Applicable Law . This Agreement and the rights and remedies of each party arising out of or relating to this Agreement, shall be governed by, interpreted under and enforced under the laws of the State of California.
5.4 Counterparty . This Agreement may be executed in counterparts, each of which shall be deemed an original.
IN WITNESS WHEREOF, the parties hereto acknowledge that they have read this Agreement, fully understand it, and have freely and voluntarily entered into it.
|
EMPLOYEE | ||||||
|
|||||||
DATED:
|
|||||||
|
|||||||
|
|||||||
|
The Company | ||||||
|
|||||||
DATED:
|
By | ||||||
|
|||||||
|
STAAR Surgical Company |
EXHIBIT 10.42
FORM OF INDEMNIFICATION AGREEMENT WITH CERTAIN DIRECTORS AND OFFICERS
This Agreement is made and entered into this ___ day of ____________ (the "Agreement"), by and between STAAR Surgical Company, a Delaware corporation (the "Company", which term shall include, where appropriate, any Entity (as hereinafter defined) controlled directly or indirectly by the Company) and ______________ (the "Indemnitee").
WHEREAS, it is essential to the Company that it be able to retain and attract as directors and officers the most capable persons available;
WHEREAS, increased corporate litigation has subjected directors and officers to litigation risks and expenses, and the limitations on the availability of directors and officers liability insurance have made it increasingly difficult for the Company to attract and retain such persons;
WHEREAS, the Company desires to provide the Indemnitee with specific contractual assurance of the Indemnitee's rights to full indemnification against litigation risks and expenses (regardless, among other things, of any amendment to or revocation of any the Company's Certificate of Incorporation or by-laws or any change in the ownership of the Company or the composition of its Board of Directors); and
WHEREAS, the Indemnitee is relying upon the rights afforded under this Agreement in agreeing to continue to act as a director of the Company.
NOW, THEREFORE, in consideration of the promises and the covenants contained herein, the Company and the Indemnitee do hereby covenant and agree as follows:
1. Definitions.
(a) "Corporate Status" describes the status of a person who is serving or has served (i) as a director of the Company, including as a member of any committee thereof, (ii) as an officer of the Company, (iii) in any capacity with respect to any employee benefit plan of the Company, or (iv) as a director, partner, trustee, officer, employee, or agent of any other Entity at the request of the Company. For purposes of subsection (iv) of this Section 1(a), an officer or director of the Company who is serving or has served as a director, partner, trustee, officer, employee or agent of a Subsidiary (as defined below) shall be deemed to be serving at the request of the Company.
(b) "Entity" shall mean any corporation, partnership, limited liability company, joint venture, trust, foundation, association, organization or other legal entity.
(c) "Expenses" shall mean all direct and indirect fees, costs and expenses of any nature whatsoever actually and reasonably incurred in connection with the investigation, preparation of a defense, appeal of or settlement of any Proceeding (as defined below), including, without limitation, reasonable attorneys fees, disbursements and retainers (including,
without limitation, any such fees, disbursements and retainers incurred by the Indemnitee pursuant to Sections 8 and 11(c) of this Agreement), fees and disbursements of expert witnesses, private investigators and professional advisors (including, without limitation, accountants and investment bankers), court costs, transcript costs, fees of experts, travel expenses, duplicating, printing and binding costs, telephone and fax transmission charges, postage, delivery services, secretarial services and other disbursements and expenses; provided, however, that Expenses shall not include judgments, fines, penalties or amounts paid in settlement of a Proceeding.
(d) "Indemnifiable Expenses", "Indemnifiable Liabilities" and
"Indemnifiable Amounts" shall have the meanings ascribed to those terms in
Section 3(a) below.
(e) "Liabilities" shall mean judgments, damages, liabilities, losses, penalties, excise taxes, fines and amounts paid in settlement.
(f) "Proceeding" shall mean any threatened, pending or completed claim, action, suit, arbitration, alternate dispute resolution process, investigation, administrative hearing, appeal, or any other proceeding, whether civil, criminal, administrative, arbitrative or investigative, whether formal or informal, whether or not he is serving in such capacity at the time any Expense or Liability is incurred for which indemnification or reimbursement can be provided under this Agreement, including a proceeding initiated by the Indemnitee pursuant to Section 11 of this Agreement to enforce the Indemnitee's rights hereunder or an action brought by or in the right of the Company.
(g) "Subsidiary" shall mean any corporation, partnership, limited liability company, joint venture, trust or other Entity of which the Company owns (either directly or through or together with another Subsidiary of the Company) either (i) a general partner, managing member or other similar interest or (ii) (A) 50% or more of the voting power of the voting capital stock or other voting equity interests of any corporation, partnership, limited liability company, joint venture or other Entity, or (B) 50% or more of the outstanding voting capital stock or other voting equity interests of any corporation, partnership, limited liability company, joint venture or other Entity.
2. Services of the Indemnitee. In consideration of the Company's covenants and commitments hereunder, the Indemnitee agrees to serve or continue to serve as a director of the Company. However, this Agreement shall not impose any obligation on the Indemnitee or the Company to continue the Indemnitee's service to the Company beyond any period otherwise required by law or by other agreements or commitments of the parties, if any.
3. Agreement to Indemnify. The Company agrees to indemnify the Indemnitee as follows:
(a) Subject to the exceptions contained in Section 4(a) below, if the Indemnitee was or is a party or is threatened to be made a party to any Proceeding (other than an action by or in the right of the Company) by reason of the Indemnitee's Corporate Status, the Indemnitee shall be indemnified by the Company against all Expenses and Liabilities incurred or paid by the Indemnitee in connection with such Proceeding (referred to herein as "Indemnifiable
Expenses" and "Indemnifiable Liabilities", respectively, and collectively as "Indemnifiable Amounts").
(b) To the fullest extent permitted by applicable law and subject to the exceptions contained in Section 4(b) below, if the Indemnitee was or is a party or is threatened to be made a party to any Proceeding by or in the right of the Company to procure a judgment in its favor by reason of the Indemnitee's Corporate Status, the Indemnitee shall be indemnified by the Company against all Indemnifiable Expenses as well as against any amount paid by Indemnitee in settlement of the Proceeding.
4. Exceptions to Indemnification. Upon receipt of a written claim addressed to the Board of Directors for indemnification pursuant to Section 3, the Company shall determine by any of the methods set forth in Section 145(d) of the Delaware General Corporation Law whether the Indemnitee has met the applicable standards of conduct which makes is permissible under applicable law to indemnify the Indemnitee. If it is determined that the Indemnitee is entitled to indemnification, the Indemnitee shall be entitled to such indemnification under Sections 3(a) and 3(b) above in all circumstances other than the following:
(a) If indemnification is requested under Section 3(a) and it
has been determined that, in connection with the subject of the Proceeding out
of which the claim for indemnification has arisen, the Indemnitee failed to act
(i) in good faith and (ii) in a manner the Indemnitee reasonably believed to be
in or not opposed to the best interests of the Company and, with respect to any
criminal action or proceeding, the Indemnitee had reasonable cause to believe
that the Indemnitee's conduct was unlawful, the Indemnitee shall not be entitled
to payment of Indemnifiable Amounts hereunder.
(b) If indemnification is requested under Section 3(b) and
(i) it has been determined that, in connection with the subject of the Proceeding out of which the claim for indemnification has arisen, the Indemnitee failed to act (A) in good faith and (B) in a manner the Indemnitee reasonably believed to be in or not opposed to the best interests of the Company, the Indemnitee shall not be entitled to payment of Indemnifiable Expenses hereunder; or
(ii) it has determined that the Indemnitee is liable to the Company with respect to any claim, issue or matter involved in the Proceeding out of which the claim for indemnification has arisen, no Indemnifiable Expenses shall be paid with respect to such claim, issue or matter unless the Court of Chancery or another court in which such Proceeding was brought shall determine upon application that, despite the adjudication of liability, but in view of all the circumstances of the case, Indemnitee is fairly and reasonably entitled to indemnity for such Indemnifiable Expenses which such court shall deem proper.
5. Procedure for Payment of Indemnifiable Amounts. The Indemnitee shall submit to the Company a written request specifying the Indemnifiable Amounts for which the
Indemnitee seeks payment under Section 3 of this Agreement and the basis for the claim. The Company shall pay such Indemnifiable Amounts to the Indemnitee within ten (10) calendar days of receipt of the request. At the request of the Company, the Indemnitee shall furnish such documentation and information as is reasonably available to the Indemnitee and necessary to establish that the Indemnitee is entitled to indemnification hereunder.
6. Indemnification for Expenses of a Party Who is Wholly or Partly Successful. Notwithstanding any other provision of this Agreement, and without limiting any such provision, to the extent that the Indemnitee is, by reason of the Indemnitee's Corporate Status, a party to and is successful, on the merits or otherwise, in any Proceeding, the Indemnitee shall be indemnified against all Expenses reasonably incurred by the Indemnitee or on the Indemnitee's behalf in connection therewith. If the Indemnitee is not wholly successful in such Proceeding but is successful, on the merits or otherwise, as to one or more but less than all claims, issues or matters in such Proceeding, the Company shall indemnify the Indemnitee against all Expenses reasonably incurred by the Indemnitee or on the Indemnitee's behalf in connection with each successfully resolved claim, issue or matter. For purposes of this Agreement, the termination of any claim, issue or matter in such a Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful result as to such claim, issue or matter.
7. Effect of Certain Resolutions. Neither the settlement or termination of any Proceeding nor the failure of the Company to award indemnification or to determine that indemnification is payable shall create an adverse presumption that the Indemnitee is not entitled to indemnification hereunder. In addition, the termination of any proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent shall not create a presumption that the Indemnitee did not act in good faith and in a manner which the Indemnitee reasonably believed to be in, or not opposed to, the best interests of the Company or, with respect to any criminal action or proceeding, had reasonable cause to believe that the Indemnitee's action was unlawful.
8. Agreement to Advance Expenses; Conditions. The Company shall pay to the Indemnitee all Indemnifiable Expenses incurred by the Indemnitee in connection with any Proceeding, including a Proceeding by or in the right of the Company, in advance of the final disposition of such Proceeding, as the same are incurred. In making any such advance, the ability of the Indemnitee to repay shall not be a factor. To the extent required by Delaware law, the Indemnitee hereby undertakes to repay the amount of Indemnifiable Expenses paid to the Indemnitee if it is finally determined by a court of competent jurisdiction that the Indemnitee is not entitled under this Agreement to indemnification with respect to such Expenses. This undertaking is an unlimited general obligation of the Indemnitee.
9. Procedure for Advance Payment of Expenses. The Indemnitee shall submit to the Company a written request specifying the Indemnifiable Expenses for which the Indemnitee seeks an advancement under Section 8 of this Agreement, together with documentation evidencing that the Indemnitee has incurred such Indemnifiable Expenses. Payment of Indemnifiable Expenses under Section 8 shall be made no later than ten (10) calendar days after the Company's receipt of such request.
10. Selection of Counsel. In the event the Company shall be obligated
under this Agreement to pay Indemnifiable Expenses with respect to any
Proceeding, the Company shall be entitled to assume the defense of such
Proceeding with counsel approved by the Indemnitee, which approval shall not be
unreasonably withheld, upon delivery of written notice to the Indemnitee of the
Company's election to do so. After the Company's assumption of the defense, the
Company shall not be liable to the Indemnitee under this Agreement for any fees
of counsel subsequently incurred by the Indemnitee with respect to such
Proceeding; provided, however, that (i) the Indemnitee shall have the right to
employ his own counsel in any such Proceeding at the Indemnitee's expense; and
(ii) if the Indemnitee shall have reasonably concluded that there may be a
conflict of interest by reason of the representation in such Proceeding of the
Indemnitee and the Company and/or any other defendants by the same counsel, then
the Indemnitee may retain his own counsel with respect to such Proceeding and
the fees and expenses of such counsel shall be an amount for which the
Indemnitee is entitled to indemnification from the Company under this Agreement,
and (iii) if the Company does not retain counsel after assuming the defense of
the Proceeding or if counsel does not vigorously defend the Proceeding, then the
Indemnitee may retain his own counsel with respect to such Proceeding and the
fees and expenses of such counsel shall be an amount for which the Indemnitee is
entitled to indemnification from the Company under this Agreement. The
Indemnitee shall notify the Company in writing of any matter with respect to
which the Indemnitee intends to seek indemnification hereunder as soon as
reasonably practicable following the receipt by the Indemnitee of written notice
thereof. The written notification to the Company shall be addressed to the Board
of Directors and shall include a description of the nature of the Proceeding and
the facts underlying the Proceeding and be accompanied by copies of any
documents filed with the court in which the Proceeding is pending. In addition,
the Indemnitee shall give the Company such information and cooperation as it may
reasonably require and as shall be within the Indemnitee's power.
11. Remedies of Indemnitee.
(a) Right to Petition Court. In the event that the Indemnitee makes a request for payment of Indemnifiable Amounts under Sections 3 and 5 above, or a request for an advance of Indemnifiable Expenses under Sections 8 and 9 above, and the Company fails to make such payment or advance in a timely manner pursuant to the terms of this Agreement, the Indemnitee may petition a court of law to enforce the Company's obligations under this Agreement.
(b) Burden of Proof. In any judicial proceeding brought under
Section 11(a) above, the Company shall have the burden of proving that the
Indemnitee is not entitled to payment of the Indemnifiable Amounts hereunder.
(c) Expenses. So long as the Indemnitee prevails in any action he files pursuant to Section 11(a) or if the Company and the Indemnitee settle such action, the Company agrees to reimburse the Indemnitee in full for any Expenses incurred by the Indemnitee in connection with investigating, preparing for, litigating, defending or settling any action brought by the Indemnitee under Section 11(a) above, or in connection with any claim or counterclaim brought by the Company in connection therewith.
(d) Validity of Agreement. The Company shall be precluded from
asserting in any Proceeding, including, without limitation, an action under
Section 11(a) above, that the provisions of this Agreement are not valid,
binding and enforceable or that there is insufficient consideration for this
Agreement and shall stipulate in court that the Company is bound by all the
provisions of this Agreement.
(e) Failure to Act Not a Defense. The failure of the Company (including its Board of Directors or any committee thereof, independent legal counsel or stockholders) to make a determination concerning the permissibility of the payment of Indemnifiable Amounts or the advance of Indemnifiable Expenses under this Agreement shall not be a defense in any action brought under Section 11(a) above, and shall not create a presumption that such payment or advance is not permissible.
12. Representations and Warranties of the Company. The Company hereby represents and warrants to the Indemnitee as follows:
(a) Authority. The Company has all necessary power and authority to enter into, and be bound by the terms of, this Agreement, and the execution, delivery and performance of the undertakings contemplated by this Agreement have been duly authorized by the Company.
(b) Enforceability. This Agreement, when executed and delivered by the Company in accordance with the provisions hereof, shall be a legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, moratorium, reorganization or similar laws affecting the enforcement of creditors' rights generally.
13. Insurance. The Company maintains directors and officer liability insurance coverage on terms satisfactory to the Indemnitee, covering, among other things, violations of federal or state securities laws. The Company shall use its reasonable best efforts to maintain such coverage in effect. In all policies of director and officer liability insurance, the Indemnitee shall be named as an insured in such a manner as to provide the Indemnitee the same rights and benefits as are accorded to the most favorably insured of the Company's officers and directors.
(a) Inability to Obtain or Maintain Insurance. Notwithstanding the foregoing, the Company shall have no obligation to obtain or maintain director and officer liability insurance if the Company determines in good faith that such insurance is not reasonably available, the premium costs for such insurance are disproportionate to the amount of coverage provided, the coverage provided by the insurance is limited by exclusions so as to provide an insufficient benefit, or the Indemnitee is covered by similar insurance maintained by a subsidiary or parent of the Company.
(b) Notice to Insurer. If, at the time of the receipt of a notice of a claim pursuant to Section 8 hereof, the Company has director and officer liability insurance in effect, the Company shall give prompt notice of the commencement of such Proceeding to the insurers in accordance with the procedures set forth in the respective policies. The Company shall
thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of the Indemintee, all amounts payable as a result of such Proceeding in accordance with the terms of such policies.
14. Fees and Expenses. During the term of the Indemnitee's service as a director, the Company shall promptly reimburse the Indemnitee for all reasonable travel and other reasonable expenses incurred by him in connection with his service as a director or member of any board committee or otherwise in connection with the Company's business.
15. Contract Rights Not Exclusive. The rights to payment of Indemnifiable Amounts and advancement of Indemnifiable Expenses provided by this Agreement shall be in addition to, but not exclusive of, any other rights which Indemnitee may have at any time under applicable law, the Company's by-laws or certificate of incorporation, or any other agreement, vote of stockholders or directors (or a committee of directors), or otherwise, both as to action in Indemnitee's official capacity and as to action in any other capacity as a result of Indemnitee's serving as a director of the Company.
16. Successors. This Agreement shall be (a) binding upon all successors and assigns of the Company (including any transferee of all or a substantial portion of the business, stock and/or assets of the Company and any direct or indirect successor by merger or consolidation or otherwise by operation of law) and (b) binding on and shall inure to the benefit of the heirs, personal representatives, executors and administrators of Indemnitee. This Agreement shall continue for the benefit of Indemnitee and such heirs, personal representatives, executors and administrators after Indemnitee has ceased to have Corporate Status.
17. Subrogation. In the event of any payment of Indemnifiable Amounts under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of contribution or recovery of Indemnitee against other persons, and Indemnitee shall take, at the request of the Company, all reasonable action necessary to secure such rights, including the execution of such documents as are necessary to enable the Company to bring suit to enforce such rights.
18. Change in Law. To the extent that a change in Delaware law (whether by statute or judicial decision) shall permit broader indemnification or advancement of expenses than is provided under the terms of the by-laws of the Company and this Agreement, Indemnitee shall be entitled to such broader indemnification and advancements, and this Agreement shall be deemed to be amended to such extent.
19. Severability. Whenever possible, each provision of this Agreement shall be interpreted in such a manner as to be effective and valid under applicable law, but if any provision of this Agreement, or any clause thereof, shall be determined by a court of competent jurisdiction to be illegal, invalid or unenforceable, in whole or in part, such provision or clause shall be limited or modified in its application to the minimum extent necessary to make such provision or clause valid, legal and enforceable, and the remaining provisions and clauses of this Agreement shall remain fully enforceable and binding on the parties.
20. Indemnitee as Plaintiff. Except as provided in Section 11(c) of this Agreement and in the next sentence, Indemnitee shall not be entitled to payment of Indemnifiable Amounts or advancement of Indemnifiable Expenses with respect to any Proceeding brought by Indemnitee against the Company, any Entity which it controls, any director or officer thereof, or any third party, unless the Company has consented to the initiation of such Proceeding. This Section shall not apply to counterclaims or affirmative defenses asserted by Indemnitee in an action brought against Indemnitee.
21. Modifications and Waiver. Except as provided in Section 18 above with respect to changes in Delaware law which broaden the right of Indemnitee to be indemnified by the Company, no supplement, modification or amendment of this Agreement shall be binding unless executed in writing by each of the parties hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions of this Agreement (whether or not similar), nor shall such waiver constitute a continuing waiver.
22. Notices. Any notice or demand which is required or provided to be given under this Agreement shall be deemed to have been sufficiently given and received for all purposes when delivered by hand, telecopy, telex or other method of facsimile, or five days after being sent by certified or registered mail, postage and charges prepaid, return receipt requested, or two days after being sent by overnight delivery providing receipt of delivery, to the following addresses if to the Company, 1911 Walker Avenue, Monrovia, California 91016 or at any other address designated by the Company to the Indemnitee in writing; if to the Indemnitee, at the address set forth below such Indemnitee's name on the signature page hereto, or at any other address designated by the Indemnitee to the Company in writing.
23. Governing Law. This Agreement shall be governed by and construed and enforced under the laws of the State of Delaware without giving effect to the provisions thereof relating to conflicts of law.
24. Inability of the Company to Indemnify. Both the Company and the Indemnitee acknowledge that in certain instances federal law or applicable public policy may prohibit the Company from indemnifying its directors and officers under this Agreement or otherwise. The Indemnitee understands and acknowledges that the Company has undertaken or may be required in the future to undertake with the appropriate state or federal regulatory agency to submit for approval any request for indemnification, and has undertaken or may be required in the future to undertake with the Securities and Exchange Commission to submit the question of indemnification to a court in certain circumstances for a determination of the Company's right under public policy to indemnify the Indemnitee.
IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above written.
COMPANY:
STAAR Surgical Company
By: /s/ David Bailey ---------------------------------------- Name: David Bailey Title: President, Chief Executive Officer: |
INDEMNITEE:
/s/ -------------------------------------------- Name: |
EXHIBIT 10.43
MANAGING DIRECTOR'S CONTRACT OF EMPLOYMENT DATED JUNE 22, 1993
between
1. DOMILENS Vertrieb fur medizinische Produkte GmbH, represented by
a) Guenther Roepstorff, shareholder
b) FRISIA BV, Shareholder, represented by its Managing Director with sole powers of representation
- referred to below as "Company" -
and
2. Mr. Guenther Roepstorff, Achtern Felln 20, 2087 Hasloh
ARTICLE 1 TASKS AND OBLIGATIONS
1. By virtue of a resolution of the meeting of shareholders of 22 May 1987 Mr. Roepstorff has been appointed as Managing Director immediate effect. He has sole authority to represent the Company. Mr. Roepstorff is exempt from the restrictions set out in s. 181 of the German Civil Code (BGB).
2. Mr. Roepstorff shall manage the business in compliance with the law, the provisions of this contract of employment and the Company's shareholders' agreement.
3. In the Company's line of business Mr. Roepstorff may conduct transactions on his own account and on the account of third parties, act on behalf of other companies or become a shareholder in such companies. The exemption is exclusively restricted to trade with all ophthalmology products, particularly with diagnostic and optical goods and with pharmaceuticals, in as far as these products were not part of the Company's distribution programme on 1 January 1993.
The exemption from the prohibition of competition is non-gratuitous. The consideration shall amount to 20% of the annual profit as stated in the commercial balance sheet before tax as a result of this work.
4. This shall only apply to companies in which Mr. Roepstorff is a shareholder if court rulings concerning the assumption of a disguised profit distribution in the case of a gratuitous exemption from the prohibition of competition also extends to the activities of such companies.
The agreed share of the profit shall be adjusted in accordance with any change in the circumstances.
ARTICLE 2 THE TERM OF THE CONTRACT OF EMPLOYMENT
1. This contract of employment shall commence on 1 January 1993 and may not be terminated before 31 December 1995. It shall be renewed for three years if it is not terminated at least six months before 31 December 1995 or six months before the end of one of the subsequent three-year periods.
2. Notice of termination must be given in writing.
3. Mr. Roepstorff's appointment as Managing Director may be revoked at any time by a resolution of the meeting of shareholders without prejudice to his claims to compensation under this contract of employment. The revocation shall be regarded as the termination of the contract of employment by the next possible date.
4. The control of employment shall end without notice of termination being needle at the end of the month in which Mr. Roepstorff reaches the age of 65.
ARTICLE 3 EMOLUMENTS
1. In return for this services Mr. Roepstorff shall be paid the following remuneration:
a) a gross annual salary of DM 234,000. -- which shall be paid in eleven equal installments of DM 18,000.- at the end of each month and DM 36,000.- on 30 November of each year,
b) a commission of 5% on all sales of lenses achieved in a sales area personally attended to by Mr. Roepstorff, payable at the end of the month following the month in which the sales are achieved,
c) an annual management bonus to be decided on by the meeting of shareholders after the adoption of the annual financial statements taking account of the business results for the financial year and Mr. Roepstorff's achievements,
d) expenses according to the expenses incurred and vouchers, payable at the end of the month in which the expenses are incurred.
2. In addition to the remuneration set out in para. 1 Mr. Roepstorff shall be given a car for business purposes and for his own personal use within the framework decided on by the meeting of shareholders.
The tax payable on this remuneration in kind shall be bome by Mr. Roepstorff.
ARTICLE 4 EMOLUMENTS IN THE EVENT OF SICKNESS, ACCIDENT, DEATH
1. If Mr. Roepstorff should be temporarily unfit for work due to sickness or for any other reason which is not his own fault, Mr Roepstorff shall keep his claims to the emoluments set out in Article 3 para. 1 (salary and guaranteed management bonus) as long as he remains unfit for work up to an uninterrupted period of six months.
2. If Mr. Roepstorff should pass away during the term of the contract of employment, his widow and his legitimate children, if they have not yet reached the age of 25 and are still learning a trade or profession, shall, as joint and several creditors, have a claim to the continuing payment of the salary set out in Article 3 para. 1 a) for the month in which Mr. Roepstorff passes away and for twelve months following this month.
3. The Company shall insure Mr. Roepstorff against accidents to the extent that is usual for the Company's managing directors.
ARTICLE 5 VACATION
Mr. Roepstorff shall be entitled to an annual vacation of 30 working days which may also be taken in parts.
ARTICLE 6 DIRECT INSURANCE
1 a) The Company has already taken out an endowment insurance in Mr.
Roepstorff favour. This shall be continued on the previous terms
1.b) With effect from 1 January 1993 the Company shall take out an endowment insurance in Mr. Roepstorff `s favour which shall guarantee him a monthly pension of at least DM 8,000.- when he reaches the age of 65. The sum insured shall be increased by benefits from profit sharing. It shall be due for payment on Mr. Roepstorff's death and no later than by the date when he reaches the age of 65.
2. The beneficiary for the insurance benefits are Mr. Roepstorff or, if he should pass away, the persons that Mr. Roepstorff has indicated to the Company. If Mr. Roepstorff has not indicated any persons to the Company the beneficiaries shall be his heirs.
3. The insurance premiums shall be paid by the Company as the policyholder. In addition to this, the Company shall pay the wage tax and church tax payable on the premiums. The wage tax and church tax on the premiums is payable at the end of the calendar year.
4. If the contract of employment should end before the insured event, the claims under the contract of insurance shall be limited to the benefits that are payable under the contract of insurance due to the payment of premiums until the date that Mr. Roepstorff leaves the Company (s. 2 para. 2 BetrAVG). Mr. Roepstorff shall have the right to continue the contract of insurance by paying the premiums himself or to convert it into a policy on which no premiums are payable.
5. It is not permitted to use the irrevocable right to benefits as security for a loan nor to assign or pledge this right.
ARTICLE 7 FINAL PROVISIONS
1. If any term of this contract of employment should be void, either in part or in full, or if it should cease to be legally valid at a later date, this shall not affect the validity of the remaining terms. In as far as it is legally permissible, the invalid term shall be replaced by another appropriate provision which comes closest in a commercial sense to what the Contracting Parties intended or would have intended if they had given consideration to the fact that the provision was void.
2. Any amendments or additions to this contract of employment must be made in writing.
3. This agreement shall replace the existing contract of contract of employment between the Parties dated 12 June 1987.
Hamburg, 22 June 1993
(Hamburg crossed out and replaced by an illegible word - translator's note.)
(signature) (signature)
The Company Gunther Roepstorff
EXHIBIT 10.44
SUPPLEMENTARY AGREEMENT # 1 TO THE MANAGING DIRECTOR'S
CONTRACT OF EMPLOYMENT DATED NOVEMBER 25, 1997 BETWEEN
STAAR SURGICAL AG AND GUENTHER ROEPSTORFF
No. 1075 of the register of documents for 1997
Negotiated
in Pinneberg
on 25 November 1997
Before me, the officiating notary
AXEL MALLICK
officially based in Pinneberg,
the following appeared today of known identity:
1. Mr. Guenther Roepstorff, born on 05/08/1945, businessman resident in Achtern Felln 20, 25474 Hasloh business address: Holsteiner Chaussee 303a, 22457 Hamburg
2. Dr Volker Dietrich Anhausser, lawyer business address: Kriegsstraae 85, 76133 Karlsruhe
on the basis of an authorization to be submitted acting for:
a) STAAR SURGICAL AG
Hauptstrabe 104 C81-2560 Nidau
B) HIMSELF regarding the following ' 13
The persons appearing acting as specified requested the officiating notary to authenticate the following
AGREEMENT
REGARDING THE PURCHASE OF SHARES
and declared:
PREAMBLE
Mr. Guenter Roepstorff| is the sole owner and proprietor of all business shares of Domilens Vertrieb fuer medizinische Produkte GmbH with a nominal capital totalling DM 1,000,000.00 registered in the commercial register of the Local Court in Hamburg (HRB 38182). The initial capital contributions for the shares have been paid in full.
Staar Surgical AG is a joint stock company in accordance with Swiss law. The
joint stock company is represented by Vladimir Feingold (president of the board
of directors) and John Wolf (vice-president of the board of directors).
' 1 OBJECT OF PURCHASE, TRANSFER
The Seller sells the Buyer the business shares at the par value of
DM 20,000.00
DM 30,000.00
DM 17,000.00
DM 233,000.00 and
DM 300,000.00
with all the appertaining rights to future profits and other ancillary rights which arise from 05 January 1998 onwards. The aforementioned business shares are united in a separate deed to form a business share of DM 600,000.00.
The economic transition deadline for the business shares described in paragraph 1 and for the combined business share is 05 January 1998.
In his capacity as sole shareholder and managing director, the Seller, Mr. Gruenter Roepstorff, grants his consent as is required in ' 11 para. 1 of the Articles, in the version of the Articles changed today before the officiating notary in register of documents no. 1077/1977.
' 2 PURCHASE PRICE
The purchase price is DM 7,800,000.00 (in words: seven million eight hundred thousand Deutschmarks). The purchase price was determined on the basis of the company valuation executed by the accountant Dipl.-Kauffrau Hortense Thielsen, Hamburg, of 29/07/97 which is an integral part of the agreement of purchase of the Company and is enclosed with this agreement as
APPENDIX 1.
The valuation was also based on the Company's audited annual accounts for 1994, 1995, 1996 and the non-audited interim balance sheet for the period January 1997 to 31 October 1997. The estimated further development of sales and profits for the period 1997 to the year 2000, predicted by the Seller was of decisive importance for determining the purchase price.
The purchase price is to be paid as follows: The payment of the purchase price is to be arranged on 05 January 1998, with the proviso that the proprietorship of the purchase price objects has been proven by then. The payment is to be transferred to an account which is still to be named, kept by the attesting notary in his own name for the Buyer on a trust basis. The notary drew the parties' attention to the standard deadlines in international payment transactions. The notary is instructed only to dispose of the purchase price In favour of the buyer once one of the parties of this agreement has proven that the buyer has become proprietor of the purchase object mentioned in ' 1 or when both parties declare this unanimously.
The Seller has made distributions in advance on the company profits expected for 1997.
If and in so far as these advance distributions should exceed the yields from the annual statement of accounts of 31/12/1997 applicable for the distribution of profits, any excess distributions are to be reimbursed without delay.
Additional uncovered expenses for taxes and contributions due to entering on the liabilities side in the annual statement of accounts of 31/12/1997 are to be reimbursed to the Buyer by the Seller. This also applies if this first results following external audits at a later date.
' 3 GUARANTEES FROM THE SELLER
The Seller guarantees the Buyer as follows:
The share capital has been paid in full. No repayments from the assets necessary to maintain the share capital have been made. The shares are not encumbered with third party's rights.
The annual statements of accounts on which the valuation of the Company is based have been drawn up according to the principles of proper accounting and the continuity of balance sheet preservation. They reflect the actual state of the Company with regard to their assets, income and financial situation. Any write-offs, devaluations, valuation adjustments and operating reserves, especially for taxes, were made in the sufficient amount.
The Seller has not concluded any agreements between him and the Company apart from the contract of employment as Managing Director, including any which affect the partnership beyond 31/12/97. There are also no agreements with the shareholder ECC GmbH who has withdrawn and the shareholders who are legally and financially behind ECC.
Agreements regarding cooperations, joint ventures etc were also not concluded.
There are no letters of support in favour of third parties.
The purchase of the initial contributions by the Buyer is not classified as taking over the property of another person as defined by ' 419 German Civil Code. The Seller assures that he additionally owns other actual net assets which are worth at least 20% of the purchase price agreed.
There are no preemptive rights, option rights or other purchase rights governing the object of purchase.
The fixed assets which were taken into consideration in the company valuation and are included in the list of the development of the fixed assets of 01/01/1996 and are handed over as
APPENDIX 2
are in the unrestricted possession of the Company and are also available for the unlimited use of the Company with the exception of disposals caused by operational use.
All objects to be found in the Company are capable of being used without any limitations.
Existing delivery and performance commitments can be met.
The brands and trademarks listed in
APPENDIX 3
are due only to the Company without any restrictions. They are not encumbered with any rights of third parties. In particular no third parties hold usufructs for these trademarks and brands. No licenses have been awarded to third parties.
Al1 brands and trademarks are valid. These rights have not been challenged by third parties. As far as the Seller is aware, no industrial property rights of third parties have been violated by the use of the brands and trademarks.
Measures required to maintain the proper rights have without exception been initiated in good time and sufficient provisions have been made to guarantee that the property rights are upheld.
Finally, all fees which are due have also been paid in full.
No other distribution agreements have been made with manufacturers apart from those listed in
APPENDIX 4
of this agreement. The texts of the agreements have been enclosed in full. There are no supplementary stipulations, side letters etc. In so far as no written agreements were made the agreements have been fully and correctly transcribed. The agreements and oral agreements do not affect the interests of STAAR SURGICAL.
The Seller further assures that there are no sales representatives or - from the Company's viewpoint - similar persons who are entitled to represent the Company in connection with the sales and distribution of their products or otherwise result in financial commitments or temporal obligations for the Company.
The fixed assets and inventories are free of rights of third parties. In particular they have neither been attached nor has their ownership been transferred by way of security.
The Seller commits himself in good time before his withdrawal to train a successor for the management of the Company and to pass on to him/her all contacts with people, companies and institutions which are of importance for the management, in particular for sales and distribution, so that these can be implemented in the Company without any problems.
The orders on hand can be processed smoothly without exception. The individual orders are reasonably priced in accordance with the business procedures of the Company exercised to date. The orders are processed in accordance with the agreement. There are no deals pending which are connected with particular risks. The Seller is not aware of any other circumstances which could conceal the risk of permanently negatively affecting the intrinsic value or the earning power of the Company.
The list of customers which is submitted as
APPENDIX 5
is complete. The gross margins stated in it are correct.
There are no restrictions from authorities, judicial or neighbourly measures on the business currently practised. By conducting this business, as far as the Seller knows, no regulations of industrial law, criminal law or any other public legal matters are being violated.
The list of the company's liabilities which is submitted as
APPENDIX 6
is complete and correct.
The Company has fulfilled all its financial obligations punctually.
The Company does not receive any investment subsidies or other subsidies.
The Company is neither involved in a law suit or execution proceedings, nor is there any risk of a law suit or execution proceedings being lodged. An exception in this case is the legal action with the customer Morawetz GmbH against which claims to the amount of approx. DM 18,000.00 have been lodged. Bankruptcy proceedings have been petitioned for this customer's assets.
All known fiscal commitments have been fully met.
The list of stock in hand "Inventory October 1997 of 03/11/97" which has been submitted by the Seller and enclosed as
APPENDIX 7
contains the complete inventory. The values specified are the net purchase prices. The objects are at the free disposal of and unencumbered proper of the Company. The purchase prices have been paid. All inventories are fully functional and vendible.
Therefore no value adjustment was necessary.
There are no legal disputes between the (previous) shareholders and the Company.
The accounts receivables list which is submitted as
APPENDIX 8
is complete and correct. The claims are all good with the exception of the above mentioned claim against Morawetz GmbH. The Seller guarantees that he is not aware of any conditions, and there are also no signs of any which could make the ability of the claims listed to be collected questionable.
The Company has sufficient own financial funds to maintain the business operation as it has in the past and make the targeted profits.
No bad debt losses due to short term expiry of the limitation of action have to be dealt with.
There are only loan commitments to Bankhaus Wolbern & Co., Hamburg. A credit limit of DM 1.5 million has been granted which has been taken advantage of to the amount of DM 1,242,467.86 as of 14/11/97. The details of the loan commitment are outlined in the bank's letter of 23 July 97 which is submitted as
APPENDIX 9.
The credit balances are listed in the "Daily bank statement" lists,
APPENDIX 10.
None of the existing sales agreements are in conflict with the interests of the Buyer.
' 4 EMPLOYMENT
In
APPENDIX 11
all employees are listed with which written or oral contracts of employment have been made. Without any exceptions, identical contracts of employment have been concluded with the employees. Solely the wage agreements are different. With the sales representatives the employment form was concluded in each case which is submitted as
APPENDIX 12
With the other employees, a contract of employment was concluded subject to the proviso of the contract text enclosed as
APPENDIX 13.
The sample contracts of employment duly reflect the full agreements.
The list Appendix 11 referred to above specifies in full the total gross emoluments including bonuses, commissions and shares in profits. After the agreement has been concluded the contracts of employment are only concluded, changed or terminated with the prior approval of the Buyer.
Within the past 12 months no pay or wage increases have been made or assured by the Seller which have not been recorded in the payroll - Appendix 11. The increases which were expressed or assured therefore have no influence on the total payroll. Neither were agreements made to the effect that employees are entitled to old age or survivors' pensions. Assurances with regard to this were also not made.
There are no financial commitments made on the basis of Company practice.
Employees who have left the company and their dependants have not been made any undertakings that they should receive pensions or other payments.
The exception here is the Seller. As managing director he has been made a pension undertaking to receive a gross pension of DM 8,000.00 monthly. This undertaking does not however represent any financial burden for the Company with the exception of the contributions for the direct insurance as well as the employer's pension liability insurance. The financial commitments in the insured event are covered by an adequate employer's pension liability insurance.
Binding collective wage agreements, works agreements and commitments on the basis of Company practice to a degree of financial importance do not exist apart from Christmas and holiday pay.
The Seller will prevent, that after the agreement has been concluded new contracts for the Company will be concluded with today's shareholders or their near relatives without the Buyer issuing its prior approval.
' 5 MANAGING DIRECTOR CONTRACT OF EMPLOYMENT OF THE SELLER
The current contract of employment of the Seller is continued basically at the same financial conditions, however is considerably changed in the layout as is evident from
APPENDIX 14
The Seller receives an annual gross salary of DM 450,000.00 plus a share in profits of 5% of the annual net profit.
The Buyer's decision to buy is considerably based on the future trustworthy cooperation with the Seller. Additionally, that the succession of the Company is secured. On the basis of the latter, the Seller has agreed in ' 3 item 13 to train a successor in good time before he withdraws.
To cover the financial risk of the Company in the event of the Seller suddenly withdrawing due to death of the Seller, the Company will take out a term life Insurance policy on the life of the Seller Guenter Roepstorff. The Company in doing so is granted an irrevocable preemptive right. The sum insured will be DM 5.0 million. The policy will run for 10 years. If the event insured occurs, the sum insured received by the Company is left out of count when determining the amount of compensation for the Seller's business share in the Company.
The gross remuneration of the Seller is to be adapted to the modified situations of the Company. The details are regulated by the modified Managing director contract of employment in force from 05/01/1998.
The pension agreement is not affected by the paragraphs above.
The Seller will repay all financial commitments which he has towards the Company which result from
APPENDIX 15
by 31/12/1997 at the latest.
Additionally the company has extended other loans to third parties the current standing of which can be seen in
APPENDIX 16
The Seller guarantees that these loans will be paid back by 31/12/1997 at the latest.
' 6 COMPETITION CLAUSE
The Seller will not enter into competition neither indirectly nor directly with the Buyer, the Company or a company affiliated with these for the duration of 12 years from the day of the conclusion of this agreement. This prohibition to compete is limited to the field of ophthalmology. This mean: that for the relationship after the contract, a post-contractual prohibition to compete will exist for two years.
The Seller understands that the restrictions on competition were a decisive factor for the Buyer when concluding this agreement.
The Seller is aware that the Buyer supplies customers in Germany directly. Even after this agreement has been concluded and enforced, the Buyer may supply the customer Benemed without any restrictions. For the rest, the Buyer will terminate its other existing customer relations within an appropriate period from the enforcement of the agreement.
The Seller will ensure and commits itself, if necessary to agree at a shareholders' meeting that the Company ends the business relations with other suppliers within an appropriate period in accordance with an agreement having been made, in so far as they supply products which could be supplied by the Buyer, its parent company or subsidiaries.
The buyer intends to grant the Company the exclusive sales rights for Germany at a point in time which cannot yet be defined.
' 8 RESPONSIBILITY FOR TAXES, CONTRIBUTIONS AND OTHER CHARGES TO BE PAID
Any payment of taxes from the period up to 31/12/1997, if these are not listed in the balance sheet, reduce the purchase price in so far as they are based on expenditure of the Seller or members of his family which are not recognized as business expenses or other hidden profit distributions.
The payments for income tax on wages and salaries and social insurance contributions due before the transfer deadline for the employees have been or will be correctly determined, cleared and paid.
All tax returns have been given in correctly and punctually.
The buyer will inform the Seller without delay of a pending fiscal audit and give the Seller the opportunity to defend itself against this.
' 9 LEGAL PROCEEDINGS
The Seller once again expressly assures that there are no pending legal proceedings against the Company and that there are no claimed or threatened legal or contractual claims against the Company with the exception of the claims expressly mentioned in this agreement.
' 10 CONSEQUENCES IN THE EVENT OF BREACH OF AGREEMENT
If the Seller should not meet his obligations taken on with this agreement at all or in full or does not meet them in keeping with the agreement in any other way, the Buyer is entitled to set a reasonable period of grace to give the Seller the opportunity to create the state as conformable to the agreement. The period of grace should be no less than two weeks. It is however dispensable if the state as conformable to the agreement cannot be created or the Seller refuses performance or if this is unreasonable for the Buyer.
If the state as conformable to the agreement is not created within the time set or if the period of grace is dispensable, the Buyer can either demand that the financial prejudice sustained be made good or make use of the legally available rights with the exception of rescission.
The following applies for the compensation for financial prejudice sustained:
To be compensated is the expense of the Buyer, which is required to create the state as conformable to the agreement, or which results from the state as conformable to the agreement not being able to be created at all, in full permanently or only temporarily.
The expense proven by the Buyer is to be compensated. Advantages in excess what is required are duly taken into account. For the rest, the Buyer is to be financially reimbursed so that it is in the same position financially as it would be if the undertakings were correct or as it would be if the obligations had been executed as stipulated by the agreement.
' 11 COST OF THE AGREEMENT
The notary's office's costs for the authentication of this agreement are to be equally borne by both parties of this agreement. For the rest, each party pays for its own consulting costs separately.
' 12 PURCHASE THROUGH TRUSTEES
Both parties are in agreement that the shares will be purchased through Dr Volker D. Anhausser, lawyer in Karlsruhe, as trustee for the Buyer. This is because both parties consider it to be wise that it does not become known on the relevant market that the Buyer has shares in the Company.
Furthermore both parties are in agreement that, even if the purchase takes place through the trustee, the contractual parties treat each other as if the Buyer were the direct contractual partner.
This agreement is also met and enforced with the authentication of the assignment of the shares to the amount of DM 600,000.00 by the Swiss notary Dr Suter on Friday 21 November 1997.
Dr Anhausser (lawyer) enters into this agreement as party in so far as he commits himself to purchase the business shares for the Buyer as a trustee.
' 13 ASSIGNMENT OF THE SHARES
The Seller herewith declares the assignment of the shares listed in ' 1 para. 1 which following the agreement made with ECC GmbH still have to be formally assigned to him.
Dr Volker D. Anhausser, lawyer, accepts the assignment in his own name, however as trustee of the Buyer, STAAR SURGICAL AG, Nidau, Switzerland.
The agreement is subject to the condition precedent that the Seller purchases from the current copartner ECC GmbH the shares described in detail in ' 1 of this document by 10 December 1997. The assignment becomes effective with the assignment of the shares to the Buyer.
' 14 CHOICE OF LAW AND JURISDICTION
This agreement including all appendices, additional agreements and ancillary agreements is subject to German law. The parties are in agreement that the uniform UN law on the sale of goods should not apply.
(2) A court of arbitration decides about all legal disputes from this agreement and from all existing and future additional agreements and ancillary agreements ousting the jurisdiction of normal courts subject to the proviso of the arbitration agreement concluded in a separate deed.
' 15 LIMITATION OF ACTIONS
The parties agree a uniform limitation period of 4 years for all claims resulting from this contractual relationship.
' 16 OPTION TO BUY
For each sale, the parties agree a right of first refusal. In this instance, it is of no consequence whether the shares in the Company are being sold in pad or in full. The purchase price at which the shares are to be offered is to be determined with binding force for both parties by the Chamber of Auditors based in Dusseldorf.
The Seller's obligation to offer the shares for sale also exists if the parties unanimously establish that a further cooperation is no longer possible. In this case, a purchase price should if possible be determined by mutual agreement. Each contractual party can force the other to sell at a price which corresponds to 120% of the determined value of the shares.
If a third party with the approval of the board of directors of the Buyer's parent company should purchase shares in the parent company, which constitute a controlling interest, the Seller has the right to sell his shares in the Company. if in this case, he no longer wishes to continue the cooperation. This is to be assumed if either the majority of the shares issued which are freely traded on the market, *verb is missing* or in the case the assets are purchased or through a merger. The same applies if a share majority is acquired with which a decisive change in the executive management of the parent company (Staar Surgical Company) is enforced. The Buyer itself or a third pad to be named by it, in this case has the obligation to buy the shares at the determined value of the shares.
If the third party is not a buyer which was approved by the board of directors of the parent company, the Buyer or a third party to be named by it, must buy the shares at a price which constitutes 150% of the determined value if the Seller wishes to terminate cooperation (with the Company) in this case.
' 17 WRITTEN FORM
Changes and supplements to this agreement require the written form and if legally required an additional notary's authentication. This also applies to a change of this written form clause. The written form clause should not be contracted out of the agreement formlessly, especially not orally.
' 18 ESCAPE CLAUSE
If clauses of this agreement or a clause included in it in future are fully or partially legally invalid or not executable or later lose their validity or practicability, the validity of the other clauses is not affected. The same applies if it should be shown that the agreement has a gap in the regulations.
In place of the invalid or impracticable clause or to fill the gap an appropriate regulation should apply which in so far as legally possible is as nearest to what the parties desired or would have wanted defined by and for the purpose of the agreement in so far as they had considered the matter on concluding the agreement or when later including a point.
The same also applies if the invalidity of a clause is based on a measure of performance or time (deadline) specified in the agreement; in this case the legally permissible measure of performance or time (deadline) as near to the one desired should apply.
The parties are obliged to lay down whatever is valid according to paragraphs 1-3 through a formal modification or supplement to the text of the agreement in proper form.
PARTS OF THE AGREEMENT
This agreement was concluded with reference to the following appendices:
Appendix 1: Company valuation of accountant Hortense Thielsen Appendix 2: List of the development of the fixed assets as of 01/01/1996 Appendix 3: Copies of brand and trademark registrations Appendix 4: Sales agreements with manufacturers Appendix 5: List of customers Appendix 6: List of liabilities Appendix 7: List of stock in hand Appendix 8: List of accounts receivables Appendix 9: Letter from Bankhaus Wolbern of 23/07/97 Appendix 10: List of "Daily bank statements" Appendix 11: List of employees with wage/salary specifications Appendix 12: Sample contract of employment sales representatives Appendix 13: Sample contract of employment in-house staff Appendix 14: Modification to the Managing director contract of employment Appendix 15: List of liabilities of the Seller owed to the Company as well as loans to third parties |
The following negotiation was read out to those appearing, approved by them and signed by their own hand as follows:
signed G. Roepstorff
signed Volker D. Anheuser L.S.
signed Mallick, notary
EXHIBIT 10.45
SUPPLEMENTARY AGREEMENT #2 TO THE MANAGING DIRECTOR'S CONTRACT
OF EMPLOYMENT DATED JANUARY 1, 1998 BETWEEN DOMILENS AND
GUENTHER ROEPSTORFF
ADDENDUM
TO THE MANAGING DIRECTOR'S CONTRACT OF 22 JUNE 1993
(seal of Axel Mallick, notary in Pinneberg)
signature
Notary
The contract of employment shall be amended as from 1 January 1998:
Article 1
Paragraph 1
shall be amended as follows:
Mr. Roepstorff is no longer exempted from the restrictions set out in section 181 of the German Civil Code (BGB).
Paragraph 2
shall be amended as follows:
- He shall comply with the restrictions set out therein. He shall follow the resolutions and instructions of the meeting of shareholders.
- Mr. Roepstorff must obtain the prior approval of the meeting of shareholders for all measures and transactions which go beyond the Company's usual trading operations. This shall particularly include:
1. The purchase of real estate and all dispositions concerning such real estate, rights lo real estate, rights in respect of a real estate right and the obligation to exercise such real estate rights.
2. Structural building measures including conversions and repairs. (structural building measures crossed out and replaced by "important measures"? - translator's note)
3. The granting of all types of securities, the approval of loans outside or inside the usual business transactions and the assumption of third-party liabilities, the granting of loans and guarantees to the Company's employees.
4. The taking out of new loans which go beyond the credit limit of the existing loan of DM 1 ,500000.- and the termination of loans.
5. The granting of new powers of procuration (prokura) and commercial authority (Handlungsvollmachten - narrower than "prokura" (translator's note) and the revocation of such.
6. The setting up, sale and closure of offices and plants.
7. The purchase of other enterprises, the purchase, change or termination of dormant equity holdings including the purchase of shares in the Company; furthermore voting in associated companies.
8. Taking on and ending continuous obligations if the obligations under the contract may exceed 150,000.- in total.
9. The conclusion and amendment of pool agreements, integrated inter-company relations and co-operations
10. The closure or any major restriction in the lines of business in which the Company engages and the inclusion of new lines of business which have nothing to do with the field of ophthalmology
11. Promising gifts and hand gifts which go beyond what is usual
12. Agreements with any kind of relatives and with companies in which the managing director or his relatives are shareholders.
13. The recruitment of employees who are to have a annual gross salary in excess of DM 120,000.-.
14. Any (major) change in the employees' remuneration and all other major amendments to contracts of employment. ("major" inserted in handwriting - translator's note)
15. Taking legal action other than such action as is necessary to collect outstanding debts. (an illegible word inserted in handwriting before legal action - translator's note)
16. The conclusion, amendment and ending of contracts which grant the right to share in the Company's earnings in any kind of form
17. The restrictions set out in Article 6 of the Company's shareholders' agreement shall apply in addition.
- Mr. Roepstorff shall at all times protect the Company's economic, financial and organizational interests. In all decisions he must act immediately, exercising the care of a proper businessman as laid down by the law, the resolutions of the shareholders, the rules of procedure, in as far as they exists, and the provisions of this agreement.
- Mr. Roepstorff may not grant other shareholders or himself or persons or companies close to him any advantages of any kind under contract or through unilateral acts. In the event of any breach of this rule the Company must be compensated for the advantage which has been granted.
- Mr Roepstorff must devote his entire energies and all his expertise and experience solely to the Company. He must be available for service if and in as far as this is in the interests of the Company. Any acceptance of a non-gratuitous or a gratuitous side-line occupation and of any positions on supervisory boards, advisory boards or similar positions shall require the prior written approval of the meeting of shareholders. (Crossed out: This does not apply to the Consulting Agreement with the shareholders of the STAAR SURGICAL Group.)
Paragraph 4
To be deleted in full.
Article 2
Paragraph 1
shall be amended as follows:
The contract shall be prolonged until the end of 31 December 2007. During this time neither party may terminate the contract unless there are important grounds for doing so. Such important grounds include:
- Any breach of this contract and the shareholders' agreement
- Any irreconcilable difference in business policy
- Any criminal acts to the detriment of the Company
Article 3
Paragraph 1a-d shall be documented as follow in accordance with the existing agreements:
a. As previously, the annual salary shall amount to DM 450,000.-. It shall be paid in the following installments, each of which shall be due at the end of the month:
b. To be deleted in full.
c. The management bonus shall amount to 5% of the net annual profit.
d. Expenses shall be reimbursed on the production of a voucher according to the tax laws.
The following clause is to be added:
Mr. Roepstorff agrees that the meeting of shareholders may adjust his pay as
appropriate if the Company's economic circumstances should deteriorate. This
shall be irrebutably assumed if the Company's earnings position declines
(crossed out: by half or more than the earnings achieved in 1996 (replaced by:
to DM 1 .0 million or less).
Paragraph 2
The following clause is to be added:
In as far as the vehicle is permanently or temporarily equipped with a car telephone Mr. Roepstorff shall not be permitted to conduct private conversations. He must strictly observe this prohibition.
Furthermore the contract shall be supplemented as follows:
I. For the duration of this contract of employment Mr. Roepstorff may not become a shareholder in enterprises that compete with the Company or with which the Company has business relations, neither directly nor indirectly.
II. For the duration of two year after the end of this contract of employment Mr. Roepstorff undertakes not to work in any way for a company that operates in the same area as the company and in this area not to conduct any transactions on his own account or on the account of a third party and not to acquire any indirect or direct share in a company that operates in the same area as the Company.
III. Mr. Roepstorff undertakes to maintain strict confidentiality vis-a-vis third parties concerning all matters confided to him or otherwise revealed to him, particularly concerning the participating interests in the Company and concerning such business matters which are regarded as business secrets. This particularly means lists of customers, contracts, business policy and supply sources. The provisions of the Data Protection Act must be observed. The above obligations shall also continue after Mr. Roepstorff has left the Company.
IV. On leaving the Company or on being discharged of his obligation to serve the Company Mr. Roepstorff must immediately surrender all documents, correspondence, records and similar which concern the Company's interests and which are in his possession. It is expressly agreed that he shall have no right of retention in respect of such documents. It is also expressly prohibited to make photocopies/duplicates of statements of costs, statistic and similar or to pass them on to third parties.
V. All inventions, trade marks, patents, copyrights and other working results that qualify for protection shall be the property of the Company, even if they should be created by pure chance. Mr. Roepstorff therefore guarantees that all rights shall be granted free of charge in this respect. This also applies to such rights in the above meaning which Mr. Roepstorff obtains, publishes and/or invents, in part or in full, two years after the expiry of the contract of employment.
(signature) (signature)
EXHIBIT 10.46
SUPPLEMENTARY AGREEMENT #3 TO THE MANAGING DIRECTOR'S CONTRACT OF
EMPLOYMENT DATED JANUARY 1, 2003 BETWEEN DOMILENS AND GUENTHER ROEPSTORFF
SECTION 3 REMUNERATION
Section 3, sub-paragraph 1 a) to c) shall be revised as follows:
(1) The annual remuneration amounts to E292.500,00 effective as of 1st January 2003. This annual remuneration shall be paid in equal monthly amounts of E22.500,00, respectively due for payment at the end of the month. At the end of November the amount shall be increased to E45.000,00.
(2) Furthermore, Mr Roepstorff shall receive an annual bonus payment up to an amount of maximum E150.000,00. The payment of the bonus is dependent on Mr Roepstorff reaching variable milestones which will be newly determined every year by the CEO of Staar Surgical or his authorized representative.
A company car was made available to Mr Roepstorff for his work in the framework of this Agreement, which may also be used on a private basis. Mr Roepstorff shall keep records of the kilometers driven in the company car for his private use. The parties herewith intend to clarify and record the fact that Mr Roepstorff also has a future claim to a company car corresponding to the value of the car currently driven.
SECTION 4 REMUNERATION IN THE CASE OF SICKNESS, DEATH
(1) In the case of a temporary incapacity to work on the part of Mr Roepstorff caused by sickness or other reasons for which Mr Roepstorff is not responsible, the remuneration shall continue to be paid for six months according to Section 3 (1) during the period of the incapacity to work. The amount will hereby be deducted which corresponds to the sickness allowance paid by the health insurance company. The continuation of the payment of the remuneration shall only be made to the end of the Agreement at the latest.
(2) Should Mr Roepstorff pass away during the term of this Agreement, his widow and legitimate children, provided they have not yet reached the age of 25 and are still in professional training, shall have a claim as joint and several creditors to the continuation of payment of the salary according to Section 3 for the month in which Mr Roepstorff passed away and the following six months.
SECTION 5 HOLIDAY
(1) The holiday claim agreed up to now with Mr Roepstorff of an annual holiday of 30 workdays shall be increased every third year of employment by one day, whereby the first increase in the annual holiday shall take place in the year in which Mr Roepstorff has reached the age of 58. Further increases shall subsequently take place on a three-year basis.
The parties are furthermore in agreement that Mr Roepstorff is entitled to transfer each year ten days of his annual holiday to the next calendar year. The transferred holiday expires at the end of the transferred year to which the annual holiday was transferred, should Mr Roepstorff not have taken the transferred annual holiday.
In other respects the Agreement shall be supplemented as follows:
Change in Control
The parties are in agreement that the contractual relationship on hand shall be continued with unchanged conditions even in the case of there being a change in control. This shall not apply if a possible successor of the present shareholders wishes to terminate the contractual relationship. In this case Mr Roepstorff shall receive a redundancy payment to the amount of half a month's salary for each year he has been employed with the company. The same correspondingly applies in the case of his position being considerably reduced as a result of the change in control or if the headquarters of the company is relocated to over 75 km away from the present headquarters. Mr Roepstorff is entitled to end the contractual relationship himself within the first six months of acquiring knowledge of the change in control with a notice period of twelve months. After this period, Mr Roepstorff shall receive a bonus of six monthly salaries if he has continued to manage the business during the notice period of twelve months.
Euro conversion
The parties are in agreement that sums of money, in as far as they have been shown up to now in Deutsche Mark, shall be converted to euros. This particularly applies to sums of money included in Section 1, paragraph 2 of the Supplementary Agreement dated 25th November 1997.
/s/ Gunther Roepstorff CEO STAAR Surgical --------------------- Domilens GmbH /s/ David Bailey --------------------------- |
Exhibit 10.56
PROMISSORY NOTE
$560,000.00 MARCH 29, 2002
LOS ANGELES, CALIFORNIA
FOR VALUE RECEIVED, the receipt and sufficiency of which is acknowledged, POLLET & RICHARDSON, A LAW CORPORATION ("Maker"), hereby promises to pay STAAR SURGICAL COMPANY, or order ("Holder"), at the address designated on the signature page of this Note, or at such other place as Holder may designate by written notice to Maker, the principal sum herein below described ("Principal Amount"), together with interest thereon, in the manner and at the times provided and subject to the terms and conditions described herein.
1. PRINCIPAL AMOUNT.
The Principal Amount means the sum of $560,000.00
2. INTEREST.
Interest on the Principal Amount from time-to-time remaining unpaid shall accrue from the Commencement Date (as that term is defined herein) at the rate of five percent (5%) per annum, compounded annually. Interest shall be computed on the basis of a three hundred sixty (360) day year and a thirty (30) day month.
3. PAYMENT OF PRINCIPAL AND INTEREST.
Subject to paragraph 9, below, Maker shall pay the Principal Amount and all accrued and unpaid interest on the Principal Amount and all other indebtedness due under this Note in forty-seven (47) equal monthly installments of ten thousand dollars ($10,000) each, commending one (1) month from the Commencement Date, and concluding three (3) years and eleven (11) months from the Commencement Date, and one (1) payment due four (4) years from the Commencement Date, for all sums remaining due under this Note (i.e., approx. $153,552). If the date set for payment by Maker of any installment or other sum due under this Note falls on a Saturday, Sunday or holiday recognized by either the United States of America or the State of California, payment under this Note shall be due on the first subsequent business day.
4. COMMENCEMENT DATE.
The Commencement Date shall be June 1, 2002.
5. SECURITY/RELEASE OF SECURITY.
Maker shall pledge as security for the repayment of all sums payable under this Note all of Maker's accounts receivable, both those existing at the time of the execution of this Note and those which come into existence at a future date prior to the exoneration of this Note. Maker shall execute a Security Agreement of even date evidencing Holder's security interest in the accounts receivable. If, at a future date, Maker obtains a line of credit from a third party, not to exceed $250,000, secured by Maker's accounts receivable, Holder's security interest in Maker's accounts receivable will be subordinated to the security interest of the party which
extends the line of credit to Maker. This Note shall be recourse as to Maker, but non-recourse as to Maker's shareholders, officers, directors, agents and employees.
6. PREPAYMENTS.
Maker shall have the right to prepay any portion of the Principal Amount and interest due without prepayment penalty or premium or discount.
7. MANNER OF PAYMENTS/CREDITING OF PAYMENTS.
Payments of any amount required hereunder shall be made in lawful money of the United States or in such other property as Holder, in its sole and absolute discretion, may accept, without deduction or offset, and shall be credited first against accrued but unpaid fees and costs, if any, thereafter against accrued but unpaid interest, if any, and thereafter against the unpaid balance of the Principal Amount.
8. INTEREST ON DELINQUENT PAYMENTS.
Any payment under this Note not paid when due shall bear interest at the same rate and method as interest is charged on the Principal Amount from the due date until paid.
9. ACCELERATION UPON DEFAULT.
At the option of Holder, all or any part of the indebtedness of Maker hereunder shall immediately become due and payable, irrespective of any agreed maturity date, upon the happening of any of the following events of default:
(a) If Maker shall breach any condition or obligation imposed on Maker pursuant to the terms of this Note, the Settlement Agreement and General Release or even date, or the Security Agreement of even date, provided however that if any such breach is reasonably susceptible of being cured, Maker shall be entitled to a grace period of fifteen (15) days following written notice of such event of default to cure;
(b) If Maker shall make an assignment for the benefit of creditors;
(c) If a custodian, trustee, receiver, or agent is appointed or takes possession of substantially all of the property of maker;
(d) If Maker shall be adjudicated bankrupt or insolvent or admit in writing Maker's inability to pay Maker's debts as they become due;
(e) If any petition is filed against Maker under the Bankruptcy Code and either (A) the Bankruptcy Court orders relief against Maker, or (B) such petition is not dismissed by the Bankruptcy Court within thirty (30) days of the date of filing;
(f) If any attachment, execution or other writ is levied on substantially all of the assets of Maker and remains in effect for more than five (5) days; or
(g) If Maker shall apply for or consent to the appointment of a custodian, trustee, receiver, intervenor, liquidator or agent of maker, or commence any proceeding related to Maker under any bankruptcy or reorganization statute, or under any arrangement, insolvency,
readjustment of debt, dissolution, or liquidation law of any jurisdiction, whether now or hereafter in effect.
Maker shall notify Holder immediately if any event of default occurs.
10. COLLECTION COSTS AND ATTORNEY'S FEES.
Maker agrees to pay Holder all costs and expenses, including reasonable attorneys' fees, paid or incurred by Holder in connection with the collection or enforcement of this Note or any instrument securing payment of this Note, including without limitation, defending the priority of such instrument or conducting a trustee sale thereunder. In the even any litigation is initiated concerning the enforcement, interpretation or collection of this Note by the parties hereto, the prevailing party in any such proceeding shall be entitled to receive from the non-prevailing party all costs and expenses including, without limitation, reasonable attorneys' and other fees incurred by the prevailing party in connection with such action or proceeding.
11. NOTICE.
Any notice to either party under this Note shall be given by personal delivery or by express mail, Federal Express, DHL or similar airborne/overnight delivery service, or by mailing such notice by first class or certified mail, return receipt requested, addressed to such party at the address set forth below, or to such other address as either party from time to time may designate by written notice. Notices delivered by overnight delivery service shall be deemed delivered the next business day following consignment to such delivery service. Mailed notices shall be deemed delivered and received in accordance with this provision three (3) days after deposit in the United States mail.
12. USURY COMPLIANCE.
All agreements between Maker and Holder are expressly limited, so that in no event or contingency whatsoever, whether by reason of the consideration given with respect to this Note, the acceleration of maturity of the unpaid Principal Amount and interest thereon, or otherwise, shall the amount paid or agreed to be paid to Holder for the use, forbearance, or detention of the indebtedness which is the subject of this Note exceed the highest lawful rate permissible under the applicable usury laws. If, under any circumstances whatsoever, fulfillment of any provision of this Note shall involve transcending the highest interest rate permitted by law which a court of competent jurisdiction deems applicable, then the obligations to be fulfilled shall be reduced to such maximum rate, and if, under any circumstances whatsoever, Holder shall ever receive as interest an amount that exceeds the highest lawful rate, the amount that would be excessive interest shall be applied to the reduction of the unpaid Principal Amount under this Note and not to the payment of interest, or, if such excessive interest exceeds the unpaid balance of the Principal Amount under this Note, such excess shall be refunded to Maker. This provision shall control every other provision of all agreements between Maker and Holder.
13. JURISDICTION; VENUE.
This Note shall be governed by, interpreted under and construed and enforced in accordance with the laws of the State of California, excluding any law relating to the conflict of laws. Any action to enforce payment of this Note shall be filed and heard solely in Los Angeles County, California.
14. BUSINESS PURPOSE.
This Note is entered into by Maker in connection with a business transaction and not for personal, family or household purposes.
MAKER:
Pollet & Richardson
A Law Corporation
By: /s/ Eric E. Richardson, Jr. ----------------------------- Eric E. Richardson, President |
MAKER'S ADDRESS:
10900 Wilshire Boulevard, Suite 500
Los Angeles, California 90024
HOLDER'S ADDRESS:
STAAR SURGICAL COMPANY
1911 Walker Avenue
Monrovia, California 91016
Attn: Chief Financial Officer
EXHIBIT 14.1
STAAR SURGICAL CODE OF ETHICS
This Code of Ethics (the Code) has been adopted by the Board of Directors of STAAR Surgical (the Company) as a supplement to the existing codes and policies of the Company.
1. Scope. This Code of Ethics applies to all directors, officers and employees of the Company.
2. Ethical Conduct. Each director, officer and employee shall promote honest and ethical conduct, including the avoidance and ethical handling of actual or apparent conflicts of interest between personal and professional relationships.
a. We encourage participation in the political process, and recognize that participation is primarily a matter of individual involvement. Any payment of corporate funds to any political party, candidate or campaign may be made only if permitted under applicable law and approved in advance by the Chief Executive Officer.
b. Gifts of cash or property may not be offered or made to any officer or employee of a customer or supplier or any government official or employee unless the gift is nominal in value and legal.
c. Employees of the Company should decline or turn over to the Company gifts of more than nominal c value or cash from persons or companies that do (or may expect to do) business with STAAR Surgical.
d. Business entertainment (whether we do the entertaining or are entertained) must have a legitimate business purpose, may not be excessive, and must be legal.
e. An employee who has a financial interest in, or performs work for, a company with which we do business must disclose that interest or work to the appropriate human resource manager. A "financial interest" in another company includes stock ownership by the employee, members of his or her immediate family and any related trusts or estates but excludes ownership of a small amount of stock in a publicly held company.
f. We do not discriminate in the hiring, discharge, compensation, promotion, or benefits offered to any employee, applicant or retiree on the basis of race, sex, religion, age, disability, or any other unlawful basis. We respect the privacy and dignity of our employees. Harassment of any form is strictly prohibited.
g. We conduct our business in compliance with applicable governmental laws, rules and regulations.
3. Company Records and Communications. Accurate and reliable records of many kinds are necessary to meet the Company's legal and financial obligations and manage our business. Therefore, the Chief Executive Officer, Chief Financial Officer and all accounting employees shall promote full, fair, accurate, timely and understandable disclosure reports and documents that the Company files with, or submits to, the Securities and Exchange Commission and in other public communications made by the company such as:
a. Becoming familiar with the disclosure requirements applicable to the Company as well as the business and financial operations of the Company.
b. Providing a system for the careful review of all such reports, documents and communications.
c. Adequately supervising the preparation of the financial disclosure in the periodic reports required by the the Company, including reviewing and analyzing the financial information to be disclosed.
d. Consulting, when appropriate, with professional advisors for advice with respect to such reports, documents and communications.
e. Fully complying with the provisions of the Company's Insider Trading Policy and the Company's Corporate Communication Policy.
4. Prompt Internal Reporting. Violations (or potential violations ) of this code must be reported to the Chairman of the Board of Directors or the Chairman of the Audit Committee either by direct contact or the use of the Company "hot-line". The report through the Company hot-line can be made anonymously. Employees who make reports of suspected violations of the Code, or other matters regarding accounting, internal accounting controls or audit matters, will be protected from retaliation such as discipline or involuntary termination of employment as a result of their reports. Every reported allegation of illegal or unethical behavior will be thoroughly and promptly investigated.
5. Any amendment to this code must be approved by the Board of Directors of the Company, and the Company shall, within 5 business days of such amendment (other than a technical, administrative or other non-substantive amendment), report such amendment on a form 8-K.
6. If the company approves any material departure from the provisions of the Code, or if the Company fails to take action within a reasonable period of time, the Company shall, within 5 business days of such an event, report such event on form 8-K.
7. Each designated manager will be asked to certify annually, in writing, their compliance with the Code substantially as follows:
a. I have reviewed and understand the Code of Ethics. I hereby confirm that during (the most recently completed year)
i. I have complied with the Code.
ii. I do not have personal knowledge of any code violations by others; and
iii. All who report directly to me have certified in writing their compliance with the Code.
b. The Assistant Vice President of Human Resources will be responsible for obtaining certifications not later than February 15 with respect to the preceding year.
8. Sanctions. If a Compliance Officer determines that a person may have violated a provision of this code, the violation shall be reported to the Board of Directors of the Company. If the Board of Directors determines that a violation has occurred, it may, among other things:
- Terminate the employment of such person (this shall be deemed to be "for cause" for any employee with an employment agreement).
- Place such person on a leave of absence.
- Counsel such person.
- Authorize such other action as it deems appropriate.
.
.
.
EXHIBIT 21.1
LIST OF SIGNIFICANT SUBSIDIARIES
STATE OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZATION OF EACH SUCH SIGNIFICANT SUBSIDIARY, AND NAMES (IF ANY) UNDER WHICH NAME OF SIGNIFICANT SUBSIDIARY EACH SUCH SIGNIFICANT SUBSIDIARY DOES BUSINESS ------------------------------ ---------------------------------------------- STAAR Surgical AG Switzerland Canon STAAR Co., Inc. Japan (Canon STAAR Kabushiki Kaisha) Domilens GmbH Germany (Domilens fuer medizinische produkte GmbH) |
EXHIBIT 23.1
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM'S CONSENT
To the Board of Directors
STAAR Surgical Company
We consent to incorporation by reference in the Registration Statements on Forms S-8 (No. 333-111154) and (No. 333-60241) and S-3 (No. 333-116901), (No. 333-111140) and (No. 333-106989) of STAAR Surgical Company of our reports dated March 16, 2005 relating to the consolidated financial statements, related schedule and the effectiveness of STAAR Surgical Company's internal control over financial reporting, which appear in this Form 10-K.
/s/ BDO SEIDMAN, LLP Los Angeles, California March 16, 2005 |
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; | |
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | |
c) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and | |
d) Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and |
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and | |
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting. |
By: | /s/ David Bailey |
|
|
David Bailey | |
President, Chief Executive Officer, Chairman and | |
Director (principal executive officer) |
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; | |
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | |
c) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and | |
d) Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and |
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and | |
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting. |
By: | /s/ John Bily |
|
|
John Bily | |
Chief Financial Officer | |
(principal accounting and financial officer) |
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and | |
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Registrant as of and for the periods presented in the Report. |
By: | /s/ David Bailey |
|
|
David Bailey | |
President, Chief Executive Officer, | |
Chairman and Director | |
(principal executive officer) |
By: | /s/ John Bily |
|
|
John Bily | |
Chief Financial Officer (principal | |
accounting and financial officer) |